0001493152-19-017023.txt : 20191113 0001493152-19-017023.hdr.sgml : 20191113 20191113155959 ACCESSION NUMBER: 0001493152-19-017023 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 63 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191113 DATE AS OF CHANGE: 20191113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sintx Technologies, Inc. CENTRAL INDEX KEY: 0001269026 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33624 FILM NUMBER: 191213802 BUSINESS ADDRESS: STREET 1: 1885 WEST 2100 STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84119 BUSINESS PHONE: 801-839-3516 MAIL ADDRESS: STREET 1: 1885 WEST 2100 STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84119 FORMER COMPANY: FORMER CONFORMED NAME: AMEDICA Corp DATE OF NAME CHANGE: 20121231 FORMER COMPANY: FORMER CONFORMED NAME: AMEDICA CORP DATE OF NAME CHANGE: 20031104 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2019

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-33624

SINTX Technologies, Inc.

(previously known as “Amedica Corporation”)

(Exact name of registrant as specified in its charter)

DELAWARE		84-1375299
(State or other jurisdiction		(IRS Employer
of incorporation or organization)		Identification No.)

1885 West 2100 South, Salt Lake City, UT		84119
(Address of principal executive offices)		(Zip Code)

(801) 839-3500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbols		Name of each exchange on which registered
Common Stock		SINT		The NASDAQ Capital Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days: Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files); Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	[ ]	Accelerated filer	[ ]

Non-accelerated filer	[ ]	Smaller reporting company	[X]

		Emerging growth company	[ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes [ ] No [X]

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

2,434,008 shares of common stock, $0.01 par value, were outstanding at November 12, 2019.

SINTX Technologies, Inc.

(previously known as Amedica Corporation)

Table of Contents

Part I. Financial Information
Item 1. Financial Statements
Condensed Consolidated Balance Sheets (unaudited)	3
Condensed Consolidated Statements of Operations (unaudited)	4
Condensed Consolidated Statements of Stockholders’ Equity (unaudited)	5
Condensed Consolidated Statements of Cash Flows (unaudited)	6
Notes to Condensed Consolidated Financial Statements (unaudited)	7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
Item 3. Quantitative and Qualitative Disclosures About Market Risk	26
Item 4. Controls and Procedures	26
Part II. Other Information
Item 1. Legal Proceedings	27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	27
Item 3. Defaults Upon Senior Securities	27
Item 4. Mine Safety Disclosures	27
Item 5. Other Information	27
Item 6. Exhibits	28
Signatures	29

SINTX Technologies, Inc.

(previously known as Amedica Corporation)

Condensed Consolidated Balance Sheets - Unaudited

(in thousands, except share and per share data)

	September 30, 2019			December 31, 2018

Assets
Current assets:
Cash and cash equivalents	$	2,926		$	5,447
Trade accounts receivable, net of allowance of $0 and $56, respectively		113			263
Prepaid expenses and other current assets		137			171
Inventories, net		86			52
Notes receivable, current portion		1,603			1,084
Total current assets		4,865			7,017

Inventories, net		625			624
Property and equipment, net		207			124
Intangible assets, net		43			46
Long-term note receivable, net of current portion		2,383			3,669
Operating lease right-of-use-asset		2,440			-
Other long-term assets		35			35
Total assets	$	10,598		$	11,515

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	166		$	301
Accrued liabilities		1,066			838
Derivative liabilities, current portion		317			1,062
Current portion of operating lease liability		475			169
Current portion of debt		6			-
Other current liabilities		23			10
Total current liabilities		2,053			2,380

Operating lease liability, net of current portion		1,959			-
Derivative liabilities, net of current portion		452			504
Long term debt		15			-
Other long-term liabilities		91			232
Total liabilities		4,570			3,116

Commitments and contingencies		-			-

Stockholders’ equity:
Convertible preferred stock, $0.01 par value, 130,000,000 shares authorized; 249 shares and 4,074 shares issued and outstanding at September 30, 2019 and December 31, 2018.		-			-
Common stock, $0.01 par value, 250,000,000 shares authorized; 2,363,991 shares, and 726,455 shares issued and outstanding at September 30, 2019 and December 31, 2018.		24			7
Additional paid-in capital		239,090			237,673
Accumulated deficit		(233,086	)		(229,281	)
Total stockholders’ equity		6,028			8,399
Total liabilities and stockholders’ equity	$	10,598		$	11,515

The condensed consolidated balance sheet as of December 31, 2018, has been prepared using information from the audited consolidated balance sheet as of that date.

The accompanying notes are an integral part of these condensed consolidated financial statements.

SINTX Technologies, Inc.

(previously known as Amedica Corporation)

Condensed Consolidated Statements of Operations - Unaudited

(in thousands, except share and per share data)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018
Product revenue	$	173		$	-		$	437		$	-
Costs of revenue		151			-			364			-
Gross profit		22			-			73			-
Operating expenses:
Research and development		869			549			2,557			2,383
General and administrative		714			654			2,166			2,912
Sales and marketing		139			-			303			42
Goodwill impairment		-			6,162			-			6,162
Total operating expenses		1,722			7,365			5,026			11,499
Loss from operations		(1,700	)		(7,365	)		(4,953	)		(11,499	)
Other income (expenses):
Interest expense		(1	)		(83	)		(3	)		(1,367	)
Interest income		111			-			349			-
Change in fair value of derivative liabilities		144			4,480			754			6,500
Loss on extinguishment of debt		-			-			-			(340	)
Offering costs		-			-			-			(682	)
Loss on extinguishment of derivative liabilities		-			-			-			(1,252	)
Other income, net		-			1			48			6
Total other income, net		254			4,398			1,148			2,865
Net loss from continuing operations before income taxes		(1,446	)		(2,967	)		(3,805	)		(8,634	)
Provision for income taxes		-			-			-			-
Loss from continuing operations		(1,446	)		(2,967	)		(3,805	)		(8,634	)
Loss from discontinued operations		-			(280	)		-			(324	)
Net loss		(1,446	)		(3,247	)		(3,805	)		(8,958	)
Deemed dividend related to the beneficial conversion feature and accretion of a discount on series B preferred stock		(345	)		(6,353	)		(2,703	)		(13,686	)
Net loss attributable to common stockholders	$	(1,791	)	$	(9,600	)	$	(6,508	)	$	(22,644	)
Net loss per share – basic and diluted
Basic – continuing operations	$	(0.68	)	$	(7.09	)	$	(3.00	)	$	(35.45	)
Basic – discontinued operations		-			(0.67	)		-			(1.33	)
Basic - deemed dividend and accretion of a discount on conversion of series B preferred stock		(0.16	)		(15.17	)		(2.13	)		(56.20	)
Basic – attributable to common stockholders	$	(0.84	)	$	(22.93	)	$	(5.13	)	$	(92.98	)

Diluted – continuing operations	$	(0.75	)	$	(17.80	)	$	(3.59	)	$	(49.53	)
Diluted – discontinued operations		-			(0.67	)		-			(1.07	)
Diluted - deemed dividend and accretion of a discount on conversion of series B preferred stock		(0.16	)		(15.17	)		(2.13	)		(45.10	)
Diluted – attributable to common stockholders	$	(0.91	)	$	(33.64	)	$	(5.72	)	$	(95.70	)
Weighted average common shares outstanding:
Basic		2,127,293			418,638			1,269,106			243,543
Diluted		2,127,293			418,692			1,269,106			303,476

The accompanying notes are an integral part of these condensed consolidated financial statements.

SINTX Technologies, Inc.

(previously known as Amedica Corporation)

Condensed Consolidated Statements of Stockholders’ Equity - Unaudited

(in thousands, except share and per share data)

	Preferred Stock					Common Stock				Paid-In			Accumulated			Total
	Shares			Amount		Shares		Amount		Capital			Deficit			Equity
Balance at December 31, 2017		-		$	-		100,935	$	1	$	226,070		$	(220,629	)	$	5,442
Common stock issued from exercise of warrants		-			-		36,205		-		1,653			-			1,653
Issuance of common stock in exchange for reduction in debt		-			-		19,348		-		1,453			-			1,453
Issuance of preferred stock from offering, net of issuance costs		15,000			-		-		-		6,748			-			6,748
Warrants issued in association with debt		-			-		-		-		98			-			98
Loss on extinguishment of derivative liabilities		-			-		-		-		1,040			-			1,040
Deemed dividend related to adjustment of the exercise price of warrants issued with debt		-			-		-		-		(9	)		-			(9	)
Accretion of change in warrant exercise price		-			-		-		-		9			-			9
Common stock issued due to conversion of preferred stock		(10,598	)		-		544,911		5		(5	)		-			-
Accretion of convertible preferred stock discount		-			-		-		-		13,687			-			13,687
Deemed dividend related to the issuance of preferred stock		-			-		-		-		(13,687	)		-			(13,687	)
Extinguishment of derivative liabilities		-			-		-		-		575			-			575
Stock-based compensation		-			-		-		-		39			-			39
Net loss		-			-		-		-		-			(8,958	)		(8,958	)
Balance at September 30, 2018		4,402		$	-		701,399	$	6	$	237,671		$	(229,587	)	$	8,090

	Preferred Stock					Common Stock				Paid-In			Accumulated			Total
	Shares			Amount		Shares		Amount		Capital			Deficit			Equity
Balance at December 31, 2018		4,074		$	-		726,455	$	7	$	237,673		$	(229,281	)	$	8,399
Common stock issued from exercise of warrants		-			-		35,874		-		103			-			103
Common stock issued due to conversion of preferred stock		(3,825	)		-		1,143,784		12		(12	)		-			-
Stock based compensation		-			-		-		-		2			-			2
Common stock issued for cash		-			-		457,878		5		1,280			-			1,285
Removal of derivative liability upon exercise of warrant		-			-		-		-		44			-			44
Net loss		-			-		-		-		-			(3,805	)		(3,805	)
Balance at September 30, 2019		249		$	-		2,363,991	$	24	$	239,090		$	(233,086	)	$	6,028

The accompanying notes are an integral part of these condensed consolidated financial statements.

SINTX Technologies, Inc.

(previously known as Amedica Corporation)

Condensed Consolidated Statements of Cash Flows - Unaudited

(in thousands)

	Nine Months Ended September 30,
	2019			2018
Cash flow from operating activities
Net loss from continuing operations	$	(3,805	)	$	(8,958	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		79			75
Non-cash lease expense		264			-
Amortization of intangible assets		4			-
Amortization of lease incentive for tenant improvements		-			25
Non-cash interest income		(344	)		-
Non-cash interest expense		-			956
Loss on extinguishment of debt		-			340
Stock based compensation		2			40
Change in fair value of derivative liabilities		(754	)		(6,500	)
Loss on extinguishment of derivative liabilities		-			1,252
Loss on disposal of equipment		-			54
Loss on impairment of goodwill		-			6,162
Bad debt expense		(3	)		-
Changes in operating assets and liabilities:
Trade accounts receivable		154			-
Prepaid expenses and other current assets		33			(246	)
Inventories		(35	)		(47	)
Accounts payable and accrued liabilities		83			(899	)
Net cash used in operating activities - continuing operations		(4,322	)		(7,746	)
Net cash used in operating activities - discontinued operations		-			(207	)
Net cash used in operating activities		(4,322	)		(7,953	)
Cash flows from investing activities
Purchase of property and equipment		(141	)		(152	)
Proceeds from notes receivable, net of imputed interest		1,111			-
Proceeds from sale of property and equipment		-			8
Purchase of intangible asset		-			(50	)
Net cash used in investing activities		970			(194	)
Cash flows from financing activities
Proceeds from issuance of stock in connection with exercise of warrants, net of issuance costs		103			1,652
Proceeds from issuance of common stock, net of fees ($245)		1,285			-
Proceeds from issuance of preferred stock, net of issuance costs ($668)		-			6,749
Proceeds from issuance of warrant derivative liabilities, net of issuance costs ($682)		-			7,577
Payments on operating lease liability		(557	)		-
Proceeds from issuance of debt		-			705
Payments on debt		-			(2,282	)
Net cash provided by financing activities		831			14,401
Net increase (decrease) in cash and cash equivalents		(2,521	)		6,254
Cash and cash equivalents at beginning of period		5,447			539
Cash and cash equivalents at end of period	$	2,926		$	6,793

Noncash investing and financing activities
Right-of-use assets and assumption of operating lease liability	$	2,704		$	-
Reduction of derivative liability due to exercise of warrants		44			-
Hercules and MEF I, LP/Anson Investments Debt Exchange		-			2,265
Issuance of common stock in exchange for reduction in debt		-			1,453
Extinguishment of derivative liabilities through exercise of warrants		-			565
Warrants issued in association with debt		-			98
Issuance of debt for equipment		21			-
Supplemental cash flow information
Cash paid for interest	$	2		$	405

The accompanying notes are an integral part of these condensed consolidated financial statements.

SINTX TECHNOLOGIES, INC.

(PREVIOUSLY KNOWN AS AMEDICA CORPORATION)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Organization and Summary of Significant Accounting Policies

Organization

SINTX Technologies, Inc. (“SINTX” or “the Company”) (previously known as Amedica Corporation) was incorporated in the state of Delaware on December 10, 1996. SINTX is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The Company believes it is the first and only manufacturer to use silicon nitride in medical applications. The Company acquired US Spine, Inc. (“US Spine”), a Delaware spinal products corporation with operations in Florida, on September 20, 2010. The Company’s products are primarily sold in the United States.

As further explained in Note 12, On October 1, 2018, the Company completed the sale of its retail spine business to CTL Medical, a Dallas, Texas-based privately held medical device manufacturer. As a result of the sale, CTL Medical is now the exclusive owner of SINTX’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies. Manufacturing, R&D, and all intellectual property related to the core, non-spine, biomaterial technology of silicon nitride remains with the Company. The Company will serve as CTL’s exclusive OEM provider of silicon nitride products.

On October 30, 2018, the Company amended its Certificate of Incorporation with the State of Delaware to change its corporate name to SINTX Technologies, Inc. in order to better reflect its focus on silicon nitride science and technologies and pipeline of silicon nitride-based products in various biomedical applications. The Company also changed its trading symbol on the NASDAQ Capital Market to “SINT”. The Company also changed the name of its wholly owned subsidiary US Spine, Inc. to “ST Sub, Inc.”

The previous name, Amedica, has transferred to CTL Medical, which is now CTL-Amedica. The Company’s new corporate brand reflects both the Company’s core competence in the science and production of silicon nitride ceramics, as well as encouraging prospects for the future, as an OEM supplier of spine implants to CTL-Amedica, and several opportunities outside of spine. The Company will focus on developing silicon nitride in terms of product design, and future biomaterial formulations, for a variety of OEM customers.

Reverse Stock Split

On July 26, 2019 the Company effected a 1 for 30 reverse stock split of the Company’s common stock. The par value and the authorized shares of the common and convertible preferred stock were not adjusted as a result of the reverse stock split. All common stock shares, equivalents, and per-share amounts for all periods presented in these consolidated financial statements have been adjusted retroactively to reflect the reverse stock split.

Basis of Presentation

These unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and include all assets and liabilities of the Company and its wholly owned subsidiary, ST Sub, Inc. All material intercompany transactions and balances have been eliminated in consolidation. SEC rules and regulations allow the omission of certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, so long as the statements are not misleading. In the opinion of management, these financial statements and accompanying notes contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position and results of operations for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on March 11, 2019. The results of operations for the nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the year ending December 31, 2019. The Company’s significant accounting policies are set forth in Note 1 to the consolidated financial statements in its Annual Report on Form 10-K for the year ended December 31, 2018.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the periods then ended. Actual results could differ from those estimates. The most significant estimates relate to inventory, long-lived and intangible assets and the liability for preferred stock and common stock warrants.

Liquidity and Capital Resources

The condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern within one year from the date of issuance of these condensed consolidated financial statements.

For the nine months ended September 30, 2019 and 2018, the Company incurred net losses from continuing operations of approximately $3.8 million and $8.6 million, respectively, and used cash in continuing operations of approximately $4.3 million and $7.7 million, respectively. The Company had an accumulated deficit of approximately $233 million and $229 million as of September 30, 2019 and December 31, 2018, respectively. To date, the Company’s operations have been principally financed by proceeds received from the issuance of preferred and common stock, convertible debt and bank debt and, to a lesser extent, cash generated from product sales. It is anticipated that the Company will continue to generate operating losses and use cash in operating activities. The Company’s continuation as a going concern is dependent upon its ability to increase sales and/or raise additional funds through the capital markets. Whether and when the Company can attain profitability and positive cash flows from operating activities or obtain additional financing is uncertain.

The Company is actively generating additional scientific and clinical data confirming the beneficial attributes of silicon nitride and intends to publish the results in leading industry publications. The unique features of the Company’s silicon nitride material are not well known, and the Company believes that the publication of such data would help sales efforts as the Company approaches new prospects. The Company is also making additional changes to the sales strategy, including a focus on revenue growth by expanding the use of silicon nitride in other areas outside of spinal fusion applications.

The Company has common stock that is publicly traded and has been able to successfully raise capital when needed since the date of the Company’s initial public offering in February 2014. In March 2018, the Company closed on gross proceeds of $1.4 million, before payment of placement agent fees and costs on a warrant reprice and exercise transaction. Additionally, on May 14, 2018, the Company closed on a public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15 million, which excludes underwriting discounts and commissions and offering expenses payable by the Company. On June 4, 2019, the Company entered into an Equity Distribution Agreement, (the “Distribution Agreement”), with Maxim Group LLC (“Maxim”), pursuant to which the Company may sell from time to time, shares of its common stock, having an aggregate offering price of up to $1.6 million through Maxim, as agent (the “ATM Offering”). On September 12, 2019, the Company entered into an amendment to the Distribution Agreement with Maxim, which increased the maximum aggregate offering price of the shares of the Company’s common stock from $1.6 million to $2.5 million. Subject to the terms and conditions of the Distribution Agreement, Maxim will use its commercially reasonable efforts to sell the shares from time to time, based on the Company’s instructions. The Company has no obligation to sell any of the shares and may at any time suspend offers under the Distribution Agreement. The Offering will terminate upon the earlier of (i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020. The Company agrees to pay Maxim a transaction fee at a fixed rate of 4.25% of the gross sales price of shares sold under the Distribution Agreement and agreed to provide indemnification and contribution to Maxim with respect to certain liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2019 the Company raised approximately $1.3 million, net of fees, through the issuance of 457,878 shares of common stock under the Distribution Agreement with Maxim. The Company is eligible to raise an additional $1.2 million under this offering. In addition, during the nine months ended September 30, 2019, the Company converted 3,825 shares of preferred stock into 1,143,784 shares of common stock. The Company is engaged in discussions with investment and banking firms to examine financing alternatives, including options for a public offering of the Company’s preferred or common stock. On October 1, 2018, the Company sold the retail spine business. This sale will continue to provide cash flows from November 2019 totaling $1.0 million over the next seven months and $3.5 million for the following 18 months. The buyer also assumed the Company’s $2.5 million related party note payable.

Although the Company is seeking to obtain additional equity and/or debt financing, such funding is not assured and may not be available to the Company on favorable or acceptable terms and may involve significant restrictive covenants. Any additional equity financing is also not assured and, if available to the Company, will most likely be dilutive to its current stockholders. If the Company is not able to obtain additional debt or equity financing on a timely basis, the impact on the Company will be material and adverse.

These uncertainties create substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Significant Accounting Policies

Except as explained below, no material changes were made to the Company’s significant accounting policies as described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

Accounting Pronouncements Adopted During the Nine Months Ended September 30, 2019

In August 2016, the FASB updated accounting guidance on the following eight specific cash flow classification issues: (1) debt prepayment or debt extinguishment costs; (2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; (3) contingent consideration payments made after a business combination; (4) proceeds from the settlement of insurance claims; (5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (6) distributions received from equity method investees; (7) beneficial interests in securitization transactions; and (8) separately identifiable cash flows and application of the predominance principle. Under prior U.S. GAAP, there was no specific guidance on the eight cash flow classification issues aforementioned. The Company adopted the new guidance effective January 1, 2019. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.

In February 2016, the FASB updated the accounting guidance related to leases as part of a joint project with the International Accounting Standards Board (“IASB”) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The Company adopted the new guidance effective January 1, 2019 (see Note 13), using the modified retrospective approach. Adoption of the new guidance resulted in the Company being required to record an additional operating lease right-of-use asset totaling approximately $0.7 million and liability totaling approximately $0.9 million (with $0.7 million incremental to adoption of the new guidance) on the date of adoption. Subsequent to the initial adoption of the new standard the Company amended the lease (see Note 13). The standard did not materially impact the consolidated net loss and had no impact on cash flows.

In May 2014, in addition to several amendments issued during 2016, the FASB updated the accounting guidance related to revenue from contracts with customers, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The Company adopted the new guidance effective January 1, 2019. The core principle of the new guidance is that a company should recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. The standard defines a five-step process to achieve this core principle and, in doing so, more judgment and estimates are often required within the revenue recognition process than were required under prior U.S. GAAP. The Company has one primary customer (see Note 12) and related contract that has one performance obligation to which revenue is allocated. Revenue under this contract is recognized when the product is shipped to the customer. The Company generally bills its customer upon shipment of the product and invoices are generally due within 30 days. The Company does provide certain rights of return, which historically have not been significant. The Company does not anticipate incurring significant incremental costs to obtain contracts with future customers. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.

New Accounting Pronouncements Not Yet Adopted

The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that no other pronouncements will have a significant effect on its financial statements.

Reclassification

Certain reclassifications were made to the nine months ended September 30, 2018, Statement of Operations to conform to the presentation for the nine months ended September 30, 2019, Statement of Operations. Research and development expenses in 2018 increased by $0.4, million offset by a decrease in general and administrative expenses by the same amount. The reclassification did not affect the 2018 net loss.

2. Basic and Diluted Net Loss per Common Share

Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share is calculated by dividing the net loss by the weighted-average number of common share equivalents outstanding for the period that are determined to be dilutive. Common stock equivalents are primarily comprised of preferred stock, warrants for the purchase of common stock and stock options. The Company had potentially dilutive securities, totaling approximately 0.5 million and 0.8 million as of September 30, 2019 and 2018, respectively.

Below are basic and diluted loss per share data for the three months ended September 30, 2019, which are in thousands except for share and per share data:

	Basic Calculation			Effect of Dilutive Warrant Securities			Diluted Calculation
Numerator:
Loss from continuing operations	$	(1,446	)	$	(144	)	$	(1,590	)
Deemed dividend and accretion of a discount		(345	)		-			(345	)
Net loss attributable to common stockholders	$	(1,791	)	$	(144	)	$	(1,935	)

Denominator:
Number of shares used in per common share calculations:		2,127,293			-			2,127,293

Net loss per common share:
Loss from continuing operations	$	(0.68	)	$	(0.07	)	$	(0.75	)
Deemed dividend and accretion of a discount		(0.16	)		-			(0.16	)
Net loss attributable to common stockholders	$	(0.84	)	$	(0.07	)	$	(0.91	)

Below are basic and diluted loss per share data for the nine months ended September 30, 2019, which are in thousands except for share and per share data:

	Basic Calculation			Effect of Dilutive Warrant Securities			Diluted Calculation
Numerator:
Loss from continuing operations	$	(3,805	)	$	(753	)	$	(4,558	)
Deemed dividend and accretion of a discount		(2,703	)		-			(2,703	)
Net loss attributable to common stockholders	$	(6,508	)	$	(753	)	$	(7,261	)

Denominator:
Number of shares used in per common share calculations:		1,269,106			-			1,269,106

Net loss per common share:
Loss from continuing operations	$	(3.00	)	$	(0.59	)	$	(3.59	)
Deemed dividend and accretion of a discount		(2.13	)		-			(2.13	)
Net loss attributable to common stockholders	$	(5.13	)	$	(0.59	)	$	(5.72	)

Below are basic and diluted loss per share data for the three months ended September 30, 2018, which are in thousands except for share and per share data:

	Basic Calculation			Effect of Dilutive Warrant Securities			Diluted Calculation
Numerator:
Loss from continuing operations	$	(2,967	)	$	(4,485	)	$	(7,452	)
Income from discontinued operations		(280	)		-			(280	)
Deemed dividend and accretion of a discount		(6,353	)		-			(6,353	)
Net loss attributable to common stockholders	$	(9,600	)	$	(4,485	)	$	(14,085	)

Denominator:
Number of shares used in per common share calculations:		418,638			54			418,692

Net loss per common share:
Loss from continuing operations	$	(7.09	)	$	(10.71	)	$	(17.80	)
Loss from discontinued operations		(0.67	)		-			(0.67	)
Deemed dividend and accretion of a discount		(15.17	)		-			(15.17	)
Net loss attributable to common stockholders	$	(22.93	)	$	(10.71	)	$	(33.64	)

Below are basic and diluted loss per share data for the nine months ended September 30, 2018, which are in thousands except for share and per share data:

	Basic Calculation			Effect of Dilutive Warrant Securities			Diluted Calculation
Numerator:
Loss from continuing operations	$	(8,634	)	$	(6,396	)	$	(15,030	)
Income from discontinued operations		(324	)		-			(324	)
Deemed dividend and accretion of a discount		(13,686	)		-			(13,686	)
Net loss attributable to common stockholders	$	(22,644	)	$	(6,396	)	$	(29,040	)

Denominator:
Number of shares used in per common share calculations:		243,543			59,933			303,476

Net loss per common share:
Loss from continuing operations	$	(35.45	)	$	(14.08	)	$	(49.53	)
Loss from discontinued operations		(1.33	)		0.26			(1.07	)
Deemed dividend and accretion of a discount		(56.20	)		11.10			(45.10	)
Net loss attributable to common stockholders	$	(92.98	)	$	(2.72	)	$	(95.70	)

3. Inventories

Inventories consisted of the following (in thousands):

	September 30, 2019		December 31, 2018
Raw materials	$	625	$	624
Intermediate goods		16		-
WIP		70		47
Finished goods		-		5
	$	711	$	676

As of September 30, 2019, inventories totaling approximately $0.1 million and $0.6 million were classified as current and long-term, respectively. Inventories classified as current represent the carrying value of inventories as of September 30, 2019, that management estimates will be sold by September 30, 2020.

4. Intangible Assets

Intangible assets consisted of the following (in thousands):

	September 30, 2019			December 31, 2018
Trademarks	$	50		$	50
Less: accumulated amortization		(7	)		(4	)
	$	43		$	46

5. Fair Value Measurements

Financial Instruments Measured and Recorded at Fair Value on a Recurring Basis

The Company has issued certain warrants to purchase shares of common stock, which are considered derivative liabilities because they have registration rights which could require a cash settlement and are re-measured to fair value at each reporting period in accordance with accounting guidance. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows:

	Level 1 -	quoted market prices for identical assets or liabilities in active markets.

	Level 2 -	observable prices that are based on inputs not quoted on active markets but corroborated by market data.

	Level 3 -	unobservable inputs reflecting management’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

The Company classifies assets and liabilities measured at fair value in their entirety based on the lowest level of input that is significant to their fair value measurement. No financial assets were measured on a recurring basis as of September 30, 2019 and December 31, 2018. The following tables set forth the financial liabilities measured at fair value on a recurring basis by level within the fair value hierarchy as of September 30, 2019 and December 31, 2018:

	Fair Value Measurements as of September 30, 2019
Description	Level 1		Level 2		Level 3		Total
Derivative liability
Common stock warrants	$	-	$	-	$	769	$	769

	Fair Value Measurements as of December 31, 2018
Description	Level 1		Level 2		Level 3		Total
Derivative liability
Common stock warrants	$	-	$	-	$	1,566	$	1,566

The Company did not have any transfers of assets and liabilities between Level 1 and Level 2 of the fair value measurement hierarchy during the nine months ended September 30, 2019 and 2018.

	Common Stock Warrants
Balance at December 31, 2017	$	(1,357	)
Issuances of warrants classified as derivatives		(7,577	)
Change in fair value		6,500
Exercise of warrants		575
Other, net		(212	)
Balance at September 30, 2018	$	(2,071	)

Balance at December 31, 2018	$	(1,566	)
Change in fair value		754
Exercise of warrants		44
Other, net		(1	)
Balance at September 30, 2019	$	(769	)

Common Stock Warrants

The Company has issued certain warrants to purchase shares of common stock, which are considered derivative liabilities because they have registration rights which could require a cash settlement and are re-measured to fair value at each reporting period in accordance with accounting guidance. At September 30, 2019 and December 31, 2018, approximately $0.8 million and $1.6 million, respectively, of the derivative liability was calculated using the Black-Scholes-Merton valuation model. At September 30, 2019 and December 31, 2018, no significant amount of the derivative liability was calculated using the Monte Carlo Simulation valuation model.

The assumptions used in estimating the common stock warrant liability using the Black-Scholes-Merton valuation model as of September 30, 2019 and December 31, 2018 were as follows:

	September 30, 2019			December 31, 2018
Weighted-average risk-free interest rate		1.56	%		2.51	%
Weighted-average expected life (in years)		3.61			0.9
Expected dividend yield		-	%		-	%
Weighted-average expected volatility		64	%		157	%

The assumptions used in estimating the common stock warrant liability using the Monte Carlo Simulation valuation model at September 30, 2019 and December 31, 2018 were as follows:

	September 30, 2019			December 31, 2018
Weighted-average risk-free interest rate		1.59	%		2.46	%
Weighted-average expected life (in years)		2.16			3.1
Expected dividend yield		-	%		-	%
Weighted average expected volatility		65	%		68	%

In addition, if any time after the second anniversary of the issuance of the warrant, both: (1) the 30-day volume weighted average price of the Company’s stock exceeds $594.00; and (2) the average daily trading volume for such 30-day period exceeds $126 million, the Company may call this warrant for $3.60 per share. For those warrants that have a call provision, management believes the Monte Carlo Simulation valuation model provides a better estimate of fair value for the warrants issued during 2018 and 2017 than the Black-Scholes-Merton valuation model.

Other Financial Instruments

The Company’s recorded values of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded value of debt approximates the fair value as the interest rate approximates market interest rates.

6. Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

	September 30, 2019		December 31, 2018
Payroll and related expense	$	454	$	388
Resterilization and repackaging costs		365		344
Other		247		106
	$	1,066	$	838

7. Debt

L2 Capital Debt

On May 14, 2018, the Company closed on an underwritten public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million. Part of the proceeds from this offering were used to pay off the outstanding debt with L2 Capital. The total payoff was $1.1 million, with $0.7 million in principal and $0.4 million in interest.

Hercules and MEF I, LP/Anson Investments Debt Exchange

On January 3, 2018, the Company entered into an Assignment Agreement (the “Assignment Agreement”) with MEF I, LP and Anson Investments Master Fund (collectively the “Assignees” and each an “Assignee”), Hercules Technology III, L.P. (“HT III”) and Hercules Capital, Inc. (“HC” and, together with HT III, “Hercules”), pursuant to which Hercules assigned to the Assignees all amounts remaining due under the Loan and Security Agreement, dated June 30, 2014, as amended, between the Company and Hercules (the “Loan and Security Agreement”) and (2) the note (the “Hercules Note”) between the Company and Hercules evidencing the amounts due under the Loan and Security Agreement. The total amount assigned by Hercules to the Assignees in the aggregate was $2.3 million and was secured by the same collateral underlying the Loan and Security Agreement. Subsequently, the Company entered into an exchange agreement pursuant to which the Assignees agreed to exchange the Hercules Term Loan obligation acquired by them for two senior secured convertible promissory notes issued by the Company, each in the principal amount of $1.1 million for an aggregate principal amount of $2.2 million, (the “Exchange Notes”). The Exchange Notes were scheduled to mature on February 3, 2019 (the “Maturity Date”). The Exchange Notes had interest at a rate of 15% per annum. The Exchange Notes were secured by a first priority security interest in substantially all of the Company assets, including intellectual property, and contains covenants restricting payments to certain of our affiliates.

On May 14, 2018, the Company closed on an underwritten public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million. Part of the proceeds from this offering were used to pay off the outstanding debt with MEF I, L.P and Anson Investments. The total payoff was $1.6 million, with $1.4 million in principal and $0.2 million in interest.

North Stadium Term Loan – Related Party

On July 28, 2017, the Company entered into a $2.5 million term loan (the “North Stadium Loan”) with North Stadium Investments, LLC (“North Stadium”), a company owned and controlled by the Company’s Chief Executive Officer and Chairman of the Board. The North Stadium Loan bore interest at 10% per annum and required the Company to make monthly interest only payments from September 5, 2017 through July 5, 2018. All principal and unpaid interest (if any) under the North Stadium Loan was due and payable on July 28, 2018. The North Stadium Loan was secured by substantially all of the Company’s assets but was junior to security interest in assets encumbered by the Hercules Term Loan (see below). In connection with the North Stadium Loan the Company also issued North Stadium a warrant to purchase up to 1,834 shares of the Company’s common stock at a purchase price of $151.20 per share, subject to a 5-year term. The relative estimated value of the warrants on the date of grant approximated $0.2 million, which was being amortized as interest expense over the life of the term loan.

On October 1, 2018, CTL Medical assumed the North Stadium Term Loan debt as part of the sale of the retail spine business. As of December 31, 2018, the Company has been released by North Stadium from any and all obligations related to this debt.

Hercules Term Loan

On June 30, 2014, the Company entered into a Loan and Security Agreement with Hercules which provided the Company with a $20.0 million term loan. The Hercules Term Loan matured on January 1, 2018. The Hercules Term Loan included a $0.2 million closing fee, which was paid to Hercules on the closing date of the loan. The closing fee was recorded as a debt discount and was being amortized to interest expense over the life of the loan. The Hercules Term Loan also included a non-refundable final payment fee of $1.7 million. The final payment fee was being accrued and recorded to interest expense over the life of the loan.

On January 3, 2018, the Hercules Term Loan and all amounts owing thereunder was assigned to MEF I and Anson Investments. See discussion above under “Hercules and MEF I, LP/Anson Investments Debt Exchange” for a more detailed description of that transaction.

Equipment Loan

In September of 2019 the Company entered into a debt arrangement with a finance company to purchase equipment. The debt balance at September 30, 2019, totaled $0.02 million. The debt incurs interest at 12%, is collateralized by the equipment and is payable in monthly payments of $0.001 million (including interest) over 36 months.

8. Equity

Preferred Stock Conversion

From July through December of 2018, Series B Convertible Preferred shareholders of the Company converted 10,926 shares of Series B Convertible Preferred Stock into 569,966 shares of common stock.

During May 2018 and June 2018, Series B Convertible Preferred shareholders of the Company converted a total of 4,072 shares of Series B Convertible Preferred Stock into 102,886 shares of common stock.

During the nine months ended September 30, 2019, Series B Convertible Preferred shareholders of the Company converted 3,825 shares of Series B Convertible Preferred Stock into 1,143,784 shares of common stock.

August 2018 Warrant Exercise

During August 2018, pursuant to the cashless exercise provision contained in their warrant, L2 Capital exercised its warrants and was issued 8,069 shares of common stock. The L2 Capital warrant is no longer outstanding.

July 2018 Warrant Exercise

During May 2018, the Company closed on a public offering, consisting of both convertible preferred stock and warrants. During July 2018, 998 of the warrants were exercised and converted into 998 shares of common stock.

May 2018 Warrant Exercise (July 2016 Warrants)

During March 2018, the Company repriced 27,733 warrants dated July 8, 2016, from $360 to $63.75 (for further description see Warrant Reprice March 2018 below). During May 2018, an additional 4,861 of the repriced warrants were exercised resulting in gross proceeds to the Company of $0.3 million.

August 2019 Warrant Exercise (May 2018 Warrants)

During the nine months ended September 30, 2019, 35,874 warrants were exercised resulting in gross proceeds to the Company of approximately $0.1 million.

May 2018 Unit Offering

On May 14, 2018, the Company closed on an underwritten public offering of units (“the Units”), consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million, which excludes underwriting discounts and commissions and offering expenses payable by SINTX. The offering was priced at a public offering price of $1,000 per unit. Each unit consisted of one share of Series B Convertible Preferred Stock, with a stated value of $1,100, and warrants to purchase up to 25 shares of common stock (the “May 2018 Warrants”). The May 2018 Warrants are initially exercisable at an exercise price of $48 per share and expire 5 years from the date of issuance. The Series B Preferred Stock is convertible into shares of common stock by dividing the stated value of $1,100 by: (i) for the first 40 trading days following the closing of this offering, $43.54 (the “Conversion Price”), (ii) after 40 trading days but prior to the 81st trading day, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the 41st trading day, and (iii) after 80 trading days, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the date of the notice of conversion. In the case of (ii)(b) and (iii)(b) above, the share price shall not be less than $2.94 (the “Floor Price”). Each of the Conversion Price and Floor Price is subject to adjustment in certain circumstances.

The Company raised $15.0 million associated with the issuance of the Units, with $6.8 million, net of issuance costs of $0.6 million, allocated to the preferred stock and $6.9 million, net of issuance costs of $0.7 million, allocated to the warrants. In association with the warrants that were recorded as a derivative liability, the Company immediately expensed approximately $0.7 million of issuance costs. The 15,000 preferred shares were initially convertible into 378,997 shares of common stock and had an effective conversion rate of $43.50 per share based on the proceeds that were allocated to them. The conversion price was adjusted to $19.63, effective July 12, 2018, and was adjusted again on September 7, 2018 to $14.40. During the nine months ended September 30, 2019 the conversion price was adjusted down on several occasions and ultimately settled at $2.84 as of September 30, 2019.

Warrant Reprice March 2018

During the six months ended June 30, 2018 the Company entered into a warrant amendment agreement (the “Amendment Agreement”) with certain holders of previously issued Series E Common Stock Purchase Warrants (collectively, “Investors”). In connection with that certain Series E Common Stock Purchase Warrant between the Company and Investors dated July 8, 2016, the Company issued to Investors warrants to purchase up to 27,733 shares of common stock (the “Warrant Shares”) at an exercise price of $360.00 per share, (the “Investors Warrants”). Under the terms of the Amendment Agreement, in consideration of Investors exercising 22,279 of the Investors Warrants (the “Warrant Exercise”), the exercise price per share of the Investors Warrants was reduced to $63.75 per share. 22,278 of the Investors Warrants were exercised resulting in gross proceeds to the Company of $1.4 million before payment of placement agent fees and costs. In addition, and as further consideration, the Company issued to Investors new warrants to purchase up to the number of shares of common stock equal to 100% of the number of Warrant Shares issued pursuant to the Warrant Exercise at an exercise price per share equal to $60.00 per share.

2019 ATM Stock Offerings

During the nine months ended September 30, 2019, the Company entered into an ATM equity distribution agreement in which the Company may sell, from time to time, shares of common stock having an aggregate offering price of up to $2.5 million. The Company sold 457,878 shares during the nine months ended September 30, 2019, raising approximately $1.3 million net of issuance cost of $0.2 million. The Company is eligible to raise an additional $1.2 million under this offering.

9. Stock-Based Compensation

A summary of the Company’s outstanding stock option activity for the nine months ended September 30, 2019 is as follows:

	Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (Years)		Intrinsic Value
As of December 31, 2018		377	$	7,653		6.0	$	-
Granted		-		-		-		-
Exercised		-		-		-		-
Forfeited		-		-		-		-
Expired		-		-		-		-
As of September 30, 2019		377	$	7,653		5.6	$	-
Exercisable as of September 30, 2019		377	$	7,653		5.6	$	-

The Company estimates the fair value of each stock option on the grant date using the Black-Scholes-Merton valuation model, which requires several estimates including an estimate of the fair value of the underlying common stock on grant date. The expected volatility was based on an average of the historical volatility of a peer group of similar companies. The expected term was calculated utilizing the simplified method. The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option.

10. Commitments and Contingencies

The Company has executed agreements with certain executive officers of the Company which, upon the occurrence of certain events related to a change in control, call for payments to the executives up to three times their annual salary and accelerated vesting of previously granted stock options.

From time to time, the Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. Management believes any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the Company’s consolidated financial position, operating results or cash flows.

11. Note Receivable

On October 1, 2018, the Company completed the sale of its spine business to CTL Medical. The sale included a $6 million noninterest bearing note receivable. The 36-month term of the note receivable requires 18 payments of $138,889 followed by 18 payments of $194,444, with maturity of the note receivable on October 1, 2021. The note receivable includes an imputed interest rate of 10%, which totaled $915,725 as of October 1, 2018, and has a 36-month amortization. As of September 30, 2019, the net carrying value of the note receivable was approximately $4.0 million.

12. Discontinued Operations

As explained in Note 1, on October 1, 2018, the Company completed the sale of its retail spine business to CTL Medical. The gain on the sale of the retail spine business is estimated to approximate $1.4 million, which was recognized during the quarter ended December 31, 2018.

The Company and CTL Medical entered in an asset purchase agreement whereby CTL Medical agreed to acquire all of the Company’s commercial spine business for total consideration of $8.5 million, which includes a $6.0 million (including interest) note receivable (See Note 7) and CTL Medical’s assumption of the Company’s $2.5 million related party note payable to North Stadium (see Note 11). As a result of the closing, CTL Medical is now the exclusive owner of SINTX’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies. The Company has agreed to pay the cost, if any, to re-sterilize and re-package select silicon nitride spinal inventories sold to CTL Medical if the sterilization date expires prior to CTL Medical selling the inventories to a third-party customer. This agreement extends for a total of 24 months, ending on September 30, 2020. The Company estimates the sterilization and repackaging cost to approximate $0.5 million. Manufacturing, R&D, and all intellectual property related to the core, non-spine, biomaterial technology of silicon nitride remains with the Company in Salt Lake City. The Company will serve as CTL’s exclusive OEM provider of silicon nitride products.

13. Leases

The Company leases office, warehouse and manufacturing space under a single operating lease, which lease originally expired during 2019 (see Note 1 under Accounting Pronouncements Adopted During the Nine Months Ended September 30, 2019). On June 7, 2019, the lease was amended to extend the rental period through 2024 and reduce the amount of space leased from 54,428 square feet to 29,534 square feet. The new rent is effective the earlier of January 1, 2020 or when the Company vacates the portion of the property that will not be part of the new lease. The amended lease has two five-year extension options. As of September 30, 2019, the operating lease right-of-use asset totaled approximately $2.5 million and the operating lease liability totaled approximately $2.4 million. Non-cash operating lease expense during the nine months ended September 30, 2019, totaled approximately $0.3 million. As of September 30, 2019, the weighted-average discount rate for the Company’s operating lease totaled 6.5%. During the three months ended September 30, 2019, the Company recorded a loss of approximately $0.12 million in association with the lease amendment.

Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease. The Company accounts for lease components separately from the non-lease components. The depreciable life of the assets and leasehold improvements are limited by the expected lease term.

Operating lease future minimum payments together with the present values as of September 30, 2019, are summarized as follows:

	September 30, 2019
2019	$	245
2020		494
2021		509
2022		525
2023		540
Thereafter		556
Total future minimum lease payments		2,869
Less amounts representing interests		(435	)
Present value of lease liability		2,434

Current-portion of operating lease liability		475
Long-term portion operating lease liability	$	1,959

14. Subsequent Events

On November 1, 2019, the Company filed a Form S-1 Registration Statement with the United States Securities and Exchange Commission to distribute to holders of the Company’s common stock, Series B Preferred Stock, and holders of our May 2018 Warrants, as of the Record Date, non-transferable Subscription Rights to purchase Units at a price of $1,000 per Unit. The Subscription Rights will not be tradable. Each Unit consists of one share of our Preferred Stock and yet to be decided number of Warrants. The common stock to be issued upon conversion of the Preferred Stock or exercise of the Warrants, like our existing shares of common stock, will be traded on the NASDAQ Capital Market under the symbol “SINT.”

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our consolidated financial statements for the year ended December 31, 2018 and the notes thereto, along with Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in our Annual Report on Form 10-K for the year ended December 31, 2018, filed separately with the U.S. Securities and Exchange Commission. This discussion and analysis contains forward-looking statements based upon current beliefs, plans, expectations, intentions and projections that involve risks, uncertainties and assumptions, such as statements regarding our plans, objectives, expectations, intentions and projections. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2018, and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q and in other filings with the Securities and Exchange Commission we may make from time-to-time.

Overview

We are an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. We believe that silicon nitride has a superb combination of properties that make it ideally suited for long-term human implantation. Other biomaterials are based on bone grafts, metal alloys, and polymers, all of which have well-known practical limitations and disadvantages. In contrast, silicon nitride has a legacy of success in the most demanding and extreme industrial environments. As a human implant material, silicon nitride offers bone ingrowth, resistance to bacterial and viral infection, ease of diagnostic imaging, resistance to corrosion, and superior strength and fracture resistance, among other advantages, all of which claims are validated in our large and growing inventory of peer-reviewed, published literature reports. We believe that our versatile silicon nitride manufacturing expertise positions us favorably to introduce new and innovative devices in the medical and non-medical fields.

We also believe that we are the first and only company to commercialize silicon nitride medical implants. Prior to October 1, 2018, we designed, manufactured and commercialized silicon nitride products for our own behalf in the spine implant market. Over 35,000 of our spinal implants manufactured with silicon nitride have been implanted into patients, with an excellent safety record. On October 1, 2018, we sold our spine implant business to CTL Medical and now manufacture spine implants made with silicon nitride for CTL Medical. Prior to selling our spine implant business to CTL Medical, we had received 510(k) regulatory clearance in the United States, a CE mark in Europe, ANVISA approval in Brazil, and ARTG and Prostheses approvals in Australia for a number of silicon nitride spine implant products designed for spinal fusion surgery. Spine implant products manufactured by us from silicon nitride are currently marketed and sold by CTL Medical under the Valeo® brand to surgeons and hospitals in the United States and to selected markets in Europe and South America. These implants are designed for use in cervical (neck) and thoracolumbar (lower back) spine surgery. We are collaborating with CTL Medical to establish a commercial partner in Australia and also working with other partners to obtain regulatory approval for silicon nitride implants in Japan.

The sale of our spine implant business to CTL Medical enables us to now focus on our core competencies. These include research and development of silicon nitride and the design and manufacture of medical and nonmedical products manufactured from silicon nitride and other ceramic materials for our own account and in collaboration with other medical device manufacturers. We are targeting original equipment manufacturer (“OEM”) – including CTL Medical - and private label partnerships in order to accelerate adoption of silicon nitride in future markets such as coating products with silicon nitride, hip and knee replacements, dental and maxillofacial implants, extremities, trauma, and sports medicine. Existing biomaterials, based on plastics, metals, and bone grafts have well-recognized limitations that we believe are addressed by silicon nitride, and we are uniquely positioned to convert existing, successful implant designs made by other companies into products manufactured with silicon nitride. OEM and private label partnerships allow us to work with a variety of partners, accelerate the adoption of silicon nitride, and realize incremental revenue at improved operating margins, when compared to the cost-intensive direct sales model.

We believe that silicon nitride addresses many of the biomaterial-related limitations in fields such as hip and knee replacements, dental and maxillofacial implants, sports medicine, extremities, and trauma surgery. We further believe that the inherent material properties of silicon nitride, and the ability to formulate the material in a variety of compositions, combined with precise control of the surface properties of the material, opens up a number of commercial opportunities across orthopedic surgery, neurological surgery, maxillofacial surgery, other medical disciplines, as well as commodity items such as industrial fasteners, bushings, and valves to addressing more complex demands of hypersonic missile radomes, aerospace, air-conditioning systems, beverage dispensers, touch-screen glass, and agribusiness fungicides.

Components of our Results of Operations

We manage our business within one reportable segment, which is consistent with how our management reviews our business, makes investment and resource allocation decisions and assesses operating performance.

Product Revenue

We derive our product revenue primarily from the manufacture and sale of spinal fusion products used in the treatment of spine disorders to CTL Medical, with whom we have a 10-year exclusive sales agreement in place. We are currently pursuing other sales opportunities for silicon nitride products outside the spinal fusion application. We generally recognize revenue from sales at the time the product is shipped. In general, our customers do not have any rights of return or exchange.

We believe our product revenue will increase as CTL Medical increases sales of silicon nitride spinal fusion products, as we secure other opportunities to manufacture third party products with silicon nitride, and as we continue to introduce new products into the market.

Cost of Revenue

The expenses that are included in cost of revenue include all in-house manufacturing costs for the products we manufacture.

Gross Profit

Our gross profit measures our product revenue relative to our cost of revenue. We expect our gross profit to decrease as we expand the penetration of our silicon nitride technology platform through OEM and private label partnerships, which offer additional avenues for the adoption of silicon nitride. Prior to the sale of our retail spine business, our revenues and gross profits were based on our retail sales. With the focus on OEM and private label partnerships, the margins are lower, thus causing the decrease in gross profit.

Research and Development Expenses

Our research and development costs are expensed as incurred. Research and development costs consist of engineering, product development, clinical trials, test-part manufacturing, testing, developing and validating the manufacturing process, manufacturing, facility and regulatory-related costs. Research and development expenses also include employee compensation, employee and non-employee stock-based compensation, supplies and materials, consultant services, and travel and facilities expenses related to research and development activities.

We expect to incur additional research and development costs as we continue to develop new spinal fusion products, our product candidates for total joint replacements, such as our total hip replacement product candidate, and dental applications which, may increase our total research and development expenses.

General and Administrative Expenses

General and administrative expenses consist primarily of salaries, benefits and other related costs, including stock-based compensation for certain members of our executive team and other personnel employed in finance, compliance, administrative, information technology, customer service, executive and human resource departments. General and administrative expenses also include other expenses not part of the other cost categories mentioned above, including facility expenses and professional fees for accounting and legal services.

RESULTS OF OPERATIONS

The following is a tabular presentation of our condensed consolidated operating results for the three and nine months ended September 30, 2019 and 2018 (in thousands):

	Three Months Ended September 30,						$			%			Nine Months Ended September 30,						$			%
	2019			2018			Change			Change			2019			2018			Change			Change
Product revenue	$	173		$	-		$	173			100	%	$	437		$	-		$	437			100	%
Cost of revenue		151			-			151			100	%		364			-			364			100	%
Gross profit		22			-			22			100	%		73			-			73			100	%
Gross profit %		13	%		-	%		13	%		100	%		17	%		0	%		17	%		100	%

Operating expenses:
Research and development		869			549			320			58	%		2,557			2,383			174			7	%
General and administrative		714			654			60			9	%		2,166			2,912			(746	)		-26	%
Sales and marketing		139			-			139			100	%		303			42			261			621	%
Goodwill Impairment		-			6,162			(6,162	)		-100	%		-			6,162			(6,162	)		-100	%
Total operating expenses		1,722			7,365			(5,643	)		-77	%		5,026			11,499			(6,473	)		-56	%
Loss from operations		(1,700	)		(7,365	)		5,665			-77	%		(4,953	)		(11,499	)		6,546			-57	%
Other income (expense)		254			4,398			(4,144	)		-94	%		1,148			2,865			(1,717	)		-60	%
Net loss before taxes		(1,446	)		(2,967	)		1,521			-51	%		(3,805	)		(8,634	)		4,829			-56	%
Provision for income taxes		-			-			-						-			-			-
Loss – continuing		(1,446	)		(2,967	)		1,521			-51	%		(3,805	)		(8,634	)		4,829			-56	%
Loss – discontinued		-			(280	)		280			-100	%		-			(324	)		324			-100	%
Net loss	$	(1,446	)	$	(3,247	)	$	1,801			-55	%	$	(3,805	)	$	(8,958	)	$	5,153			-58	%

Product Revenue

For the three months ended September 30, 2019, total product revenue was $0.2 million as compared to $0.0 million in the same period 2018, an increase of $0.2 million, or 100%. This increase was due to the sale of the retail spine business in October 2018 and the related restatement of revenues for the three months ended September 30, 2018 to $0.0 million as a result of the discontinued operations.

For the nine months ended September 30, 2019, total product revenue was $0.4 million as compared to $0.0 million in the same period 2018, an increase of $0.4 million, or 100%. This increase was due to the sale of the retail spine business in October 2018 and the related restatement of revenues for the nine months ended September 30, 2018 to $0.0 million as a result of the discontinued operations.

Cost of Revenue and Gross Profit

For the three months ended September 30, 2019, our cost of revenue increased $0.2 million, or 100%, as compared to the same period in 2018. Gross profit increased $0.02 million and gross margin percentage increased by 100%. Both increases are due to the discontinued operations treatment and the related sale of the retail spine business in October 2018.

For the nine months ended September 30, 2019, our cost of revenue increased $0.4 million, or 100%, as compared to the same period in 2018. Gross profit increased $0.07 million and gross margin percentage increased by 100%. Both increases are due to the discontinued operations treatment and the related sale of the retail spine business in October 2018.

Research and Development Expenses

For the three months ended September 30, 2019, research and development expenses increased $0.3 million, or 58%, as compared to the same period in 2018. This increase was primarily attributable to an overall increase in R&D activity to support the Company’s strategic objective of developing new technologies and related products.

For the nine months ended September 30, 2019, research and development expenses increased $0.2 million, or 7%, as compared to the same period in 2018. This increase was primarily attributable to an overall increase in R&D activity to support the Company’s strategic objective of developing new technologies and related products.

General and Administrative Expenses

For the three months ended September 30, 2019, general and administrative expenses increased $0.1 million, or 9%, as compared to the same period in 2018. This increase is due to the increase in administrative related expenses to support the Company’s strategic objective of developing new technologies and related products

For the nine months ended September 30, 2019, general and administrative expenses decreased $0.7 million, or 26%, as compared to the same period in 2018. This decrease is due to the Company maintaining a lower overhead structure during the first half of 2019.

Sales and Marketing Expenses

For the three months ended September 30, 2019, sales and marketing expenses increased $0.1 million, or 100%, as compared to the same period in 2018. This increase was primarily attributable to an overall increase in marketing activities to generate interest in and exposure to the Company’s potential new product lines.

For the nine months ended September 30, 2019, sales and marketing expenses increased $0.3 million, or 621%, as compared to the same period in 2018. This increase was primarily attributable to an overall increase in marketing activities to generate interest in and exposure to the Company’s potential new product lines.

Other Expense, Net

For the three months ended September 30, 2019, other income decreased $4.1 million, or 94%, as compared to the same period in 2018. This decrease was primarily due to a decrease in interest expense of $0.1 million and an increase in interest income of $0.1 million, offset by the change in the fair value of the derivative liabilities in the amount of $4.3 million.

For the nine months ended September 30, 2019, other income decreased $1.7 million, or 60%, as compared to the same period in 2018. This decrease was primarily due to the change in the fair value of the derivative liabilities in the amount of $5.8 million offset by the decrease in the loss on the extinguishment of derivative liabilities of $1.3 million, the decrease in interest expense of $1.4 million, the decrease in the loss on extinguishment of debt of $0.3 million and the increase in interest income of $0.3 million, a decrease in offering costs of $0.7 million, and an increase of $0.1 million on other miscellaneous accounts.

Liquidity and Capital Resources

The Company has common stock that is publicly traded and has been able to successfully raise capital when needed since the date of the Company’s initial public offering in February 2014. In March 2018, the Company closed on gross proceeds of $1.4 million, before payment of placement agent fees and costs on a warrant reprice and exercise transaction. Additionally, on May 14, 2018, the Company closed on a public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15 million, which excludes underwriting discounts and commissions and offering expenses payable by the Company. On June 4, 2019, the Company entered into an Equity Distribution Agreement, (the “Distribution Agreement”), with Maxim Group LLC (“Maxim”), pursuant to which the Company may sell from time to time, shares of its common stock, having an aggregate offering price of up to $1.6 million through Maxim, as agent (the “ATM Offering”). On September 12, 2019, the Company entered into an amendment to the Distribution Agreement with Maxim, which increased the maximum aggregate offering price of the shares of the Company’s common stock from $1.6 million to $2.5 million. Subject to the terms and conditions of the Distribution Agreement, Maxim will use its commercially reasonable efforts to sell the shares from time to time, based on the Company’s instructions. The Company has no obligation to sell any of the shares and may at any time suspend offers under the Distribution Agreement. The Offering will terminate upon the earlier of (i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020. The Company agrees to pay Maxim a transaction fee at a fixed rate of 4.25% of the gross sales price of shares sold under the Distribution Agreement and agreed to provide indemnification and contribution to Maxim with respect to certain liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2019, the Company raised approximately $1.3 million, net of fees through the issuance of 457,878 shares of common stock under the Distribution Agreement with Maxim. The Company is eligible to raise an additional $1.2 million under this offering. In addition, during the nine months ended September 30, 2019, the Company converted 3,825 shares of preferred stock into 1,143,784 shares of common stock. The Company is engaged in discussions with investment and banking firms to examine financing alternatives, including options for a public offering of the Company’s preferred or common stock. On October 1, 2018, the Company sold the retail spine business. This sale will continue to provide cash flows from November 2019 totaling $1.0 million over the next seven months and $3.5 million for the following 18 months. The buyer also assumed the Company’s $2.5 million related party note payable.

Cash Flows

The following table summarizes, for the periods indicated, cash flows from operating, investing and financing activities (in thousands) – unaudited:

	Nine Months Ended September 30,
	2019			2018
Net cash used in operating activities – continuing operations	$	(4,322	)	$	(7,746	)
Net cash used in operating activities – discontinued operations		-			(207	)
Net cash used in operating activities		(4,322	)		(7,953	)
Net cash provided by investing activities		970			(194	)
Net cash provided by financing activities		831			14,401
Net increase (decrease) in cash and cash equivalents	$	(2,521	)	$	6,254

Net Cash Used in Operating Activities

Net cash used in operating activities – continuing operations decreased $3.4 million to $4.3 million during the nine months ended September 30, 2019, as compared to $7.7 million for the same period in 2018. The decrease in net cash used in operating activities – continuing operations is due to the decrease in the net loss and related non-cash add backs to the net loss during the nine months ended September 30, 2019 as compared to the same period in 2018.

Net Cash Provided by Investing Activities

Net cash provided by investing activities – continuing operations increased $1.2 million to $1.0 million during the nine months ended September 30, 2019, compared to net cash used in investing activities – continuing operations of $0.2 million for the same period in 2018. The increase in cash provided by investing activities – continuing operations during 2019 was primarily due to a $1.2 million increase in proceeds from notes receivable.

Net Cash Provided by Financing Activities

Net cash provided by financing activities was $0.8 million during the nine months ended September 30, 2019, compared to net cash provided by financing activities of $14.4 million during the same period in 2018. The $13.6 million decrease was primarily attributable to the $1.6 million net decrease in proceeds received from the exercise of common stock warrants, a decrease in proceeds from the issuance of debt of $0.7 million, a decrease in proceeds from capital offerings of $13.0 million, $0.6 million increase in the payments of operating lease obligations, all offset by a $2.3 million increase in payments for debt extinguishments.

Indebtedness

L2 Capital Debt

On January 31, 2018, the Company signed a promissory note in the aggregate principal amount of up to $0.84 million (the “L2 Note”) for an aggregate purchase price of up to $0.75 million and warrants to purchase up to an aggregate of 68,257 shares of common stock (the “Warrants”) at an exercise price of $3.31 per share. The maturity date was six months from date of funding. The L2 Note’s interest rate was 8% per year and a default interest rate of 18% per year. On May 14, 2018, the Company closed on an underwritten public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million. Part of the proceeds from this offering were used to pay off the outstanding debt with L2 Capital. The total payoff was $1.1 million, with $0.7 million in principal and $0.4 million in interest.

Hercules and MEF I, LP/Anson Investments Debt Exchange

On January 3, 2018, the Company entered into an Assignment Agreement (the “Assignment Agreement”) with MEF I, LP and Anson Investments Master Fund (collectively the “Assignees” and each an “Assignee”), Hercules Technology III, L.P. (“HT III”) and Hercules Capital, Inc. (“HC” and, together with HT III, “Hercules”), pursuant to which Hercules assigned to the Assignees all amounts remaining due under the Loan and Security Agreement, dated June 30, 2014, as amended, between the Company and Hercules (the “Loan and Security Agreement”) and (2) the note (the “Hercules Note”) between the Company and Hercules evidencing the amounts due under the Loan and Security Agreement. The total amount assigned by Hercules to the Assignees in the aggregate was $2.3 million and was secured by the same collateral underlying the Loan and Security Agreement. Subsequently, the Company entered into an exchange agreement pursuant to which the Assignees agreed to exchange the Hercules Term Loan obligation acquired by them for two senior secured convertible promissory notes issued by the Company, each in the principal amount of $1.1 million for an aggregate principal amount of $2.2 million, (the “Exchange Notes”). The Exchange Notes were scheduled to mature on February 3, 2019 (the “Maturity Date”). The Exchange Notes had interest at a rate of 15% per annum. Prior to the Maturity Date, principal and interest accrued under the Exchange Notes was payable in cash or, if certain conditions were met, payable in shares of our common stock. The Exchange Notes were secured by a first priority security interest in substantially all of the Company assets, including intellectual property, and contains covenants restricting payments to certain of our affiliates.

On May 14, 2018, the Company closed on an underwritten public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million. Part of the proceeds from this offering were used to pay off the outstanding debt with MEF I, L.P and Anson Investments. The total payoff was $1.6 million, with $1.4 million in principal and $0.2 million in interest.

North Stadium Term Loan – Related Party

Hercules Term Loan

On January 3, 2018, the Hercules Term Loan and all amounts owing thereunder was assigned to MEF I and Anson Investments. See discussion above under the heading “Hercules and MEF I, LP/Anson Investments Debt Exchange” for a more detailed description of that transaction.

Equipment Loan

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements, as defined in Item 303(a)(4) of Regulation S-K.

Critical Accounting Policies and Estimates

A summary of our significant accounting policies and estimates is discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations and in Note 1 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018. Except as referenced in New Accounting Pronouncements below, no material changes to significant accounting policies were made during the nine months ended September 30, 2019. The preparation of the financial statements in accordance with U.S. generally accepted accounting principles requires us to make judgments, estimates and assumptions regarding uncertainties that affect the reported amounts of assets and liabilities. Significant areas of uncertainty that require judgments, estimates and assumptions include the accounting for income taxes and other contingencies as well as valuation of derivative liabilities, asset impairment and collectability of accounts receivable. We use historical and other information that we consider to be relevant to make these judgments and estimates. However, actual results may differ from those estimates and assumptions that are used to prepare our financial statements.

New Accounting Pronouncements

See discussion under Note 1, Organization and Summary of Significant Accounting Policies, to the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q, for information on new accounting pronouncements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

This Report includes the certifications of our Chief Executive Officer and Principal Financial Officer required by Rule 13a-14 of the Securities Exchange Act of 1934 (the “Exchange Act”). See Exhibits 31.1 and 31.2. This Item 4 includes information concerning the controls and control evaluations referred to in those certifications.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed in the reports filed or submitted under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified by the Commission’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act are properly recorded, processed, summarized and reported within the time periods required by the Commission’s rules and forms.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (principal executive officer and principal financial officer), of the effectiveness of the design and operation of these disclosure controls and procedures, as such term is defined in Exchange Act Rule 13a-15(e), as of September 30, 2019. Based on this evaluation, the Chief Executive Officer concluded that our disclosure controls and procedures were effective as of September 30, 2019, the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control Over Financial Reporting

There were changes in our internal control over financial reporting that occurred during the third quarter of 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. During the first and second quarter of 2019 we concluded the design and operating effectiveness of our controls were inadequate to ensure that complex accounting matters are always properly accounted for and reviewed in a timely manner. During the third quarter of 2019 this material weakness was remedied.

PART II

ITEM 1. LEGAL PROCEEDINGS

We are not aware of any pending or threatened legal proceeding against us that could have a material adverse effect on our business, operating results or financial condition. The medical device industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property rights as well as improper hiring practices. As a result, we may be involved in various additional legal proceedings from time to time.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit Number	Exhibit Description	Filed Herewith	Incorporated by Reference herein from Form or Schedule	Filing Date	SEC File/ Reg. Number
10.1	Amendment to Equity Distribution Agreement, dated as of September 12, 2019, by and between SINTX Technologies, Inc. and Maxim Group LLC		Form 8-K (Exhibit 10.1)	09/12/19	001-33624

31.1	Certificate of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	X

31.2	Certificate of the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	X

32	Certifications of the Chief Executive Officer and Principal Accounting Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	X

101.INS	XBRL Instance Document	X

101.SCH	XBRL Taxonomy Extension Schema Document	X

101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document	X

101.DEF	XBRL Taxonomy Extension Definition Linkbase Document	X

101.LAB	XBRL Taxonomy Extension Label Linkbase Document	X

101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document	X

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SINTX Technologies, Inc. (previously known as Amedica Corporation)

Date: November 13, 2019	/s/ B. Sonny Bal
	B. Sonny Bal
	Chief Executive Officer (Principal Executive Officer and Principal Financial Officer)

EX-31.1 2 ex31-1.htm

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, B. Sonny Bal, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SINTX Technologies, Inc. (previously known as Amedica Corporation);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 13, 2019	By:	/s/ B. Sonny Bal
		B. Sonny Bal
		Chief Executive Officer

EX-31.2 3 ex31-2.htm

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, B. Sonny Bal, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SINTX Technologies, Inc. (previously known as Amedica Corporation);

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 13, 2019	By:	/s/ B. Sonny Bal
		B. Sonny Bal
		Chief Executive Officer and Principal Financial Officer

EX-32 4 ex32.htm

Exhibit 32

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of SINTX Technologies, Inc. (previously known as Amedica Corporation), a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The quarterly report for the quarter ended September 30, 2019 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 13, 2019	By:	/s/ B. Sonny Bal
		B. Sonny Bal
		Chief Executive Officer

	By:	/s/ B. Sonny Bal
		B. Sonny Bal
		Principal Financial Officer

EX-101.INS 5 sint-20190930.xml XBRL INSTANCE FILE 0001269026 2019-01-01 2019-09-30 0001269026 us-gaap:TrademarksMember 2019-09-30 0001269026 us-gaap:TrademarksMember 2018-12-31 0001269026 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SINT:CommonStockWarrantsMember 2019-09-30 0001269026 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember SINT:CommonStockWarrantsMember 2019-09-30 0001269026 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SINT:CommonStockWarrantsMember 2019-09-30 0001269026 us-gaap:FairValueMeasurementsRecurringMember SINT:CommonStockWarrantsMember 2019-09-30 0001269026 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SINT:CommonStockWarrantsMember 2018-12-31 0001269026 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember SINT:CommonStockWarrantsMember 2018-12-31 0001269026 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SINT:CommonStockWarrantsMember 2018-12-31 0001269026 us-gaap:FairValueMeasurementsRecurringMember SINT:CommonStockWarrantsMember 2018-12-31 0001269026 2019-09-30 0001269026 SINT:NorthStadiumLoanMember SINT:NorthStadiumInvestmentsLLCMember 2017-07-28 0001269026 SINT:NorthStadiumLoanMember SINT:NorthStadiumInvestmentsLLCMember 2017-07-27 2017-07-28 0001269026 SINT:HerculesTermLoanMember SINT:LoanAndSecurityAgreementMember 2014-06-29 2014-06-30 0001269026 SINT:MonteCarloSimulationValuationModelMember 2018-12-31 0001269026 SINT:WarrantsMember 2019-09-30 0001269026 SINT:MonteCarloSimulationValuationModelMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember 2019-01-01 2019-09-30 0001269026 SINT:CommonStockWarrantsMember 2017-12-31 0001269026 SINT:HerculesTermLoanMember SINT:LoanAndSecurityAgreementMember 2014-06-30 0001269026 SINT:MonteCarloSimulationValuationModelMember 2019-01-01 2019-09-30 0001269026 SINT:BlackScholesMertonValuationModelMember 2019-01-01 2019-09-30 0001269026 SINT:BlackScholesMertonValuationModelMember 2019-09-30 0001269026 SINT:BlackScholesMertonValuationModelMember 2018-12-31 0001269026 2018-12-31 0001269026 SINT:CommonStockWarrantsMember 2018-01-01 2018-09-30 0001269026 SINT:CommonStockWarrantsMember 2018-12-31 0001269026 SINT:L2CapitalDebtMember 2018-01-31 0001269026 SINT:HerculesTermLoanMember 2018-01-03 0001269026 SINT:HerculesTermLoanMember SINT:SeniorSecuredConvertiblePromissoryNotesOneMember 2018-01-03 0001269026 SINT:HerculesTermLoanMember SINT:SeniorSecuredConvertiblePromissoryNotesTwoMember 2018-01-03 0001269026 SINT:ExchangeNotesMember 2018-01-01 2018-01-03 0001269026 SINT:ExchangeNotesMember 2018-01-03 0001269026 SINT:HerculesTermLoanMember SINT:ClosingDateMember 2014-06-30 0001269026 us-gaap:PreferredStockMember 2018-12-31 0001269026 us-gaap:CommonStockMember 2018-12-31 0001269026 SINT:ConvertiblePreferredStockAndWarrantsMember 2018-05-13 2018-05-14 0001269026 us-gaap:IPOMember 2018-05-14 0001269026 SINT:SeriesBConvertiblePreferredStockMember 2018-05-14 0001269026 SINT:MayTwoThousandEighteenWarrantsMember 2018-05-14 0001269026 SINT:MayTwoThousandEighteenWarrantsMember 2018-05-13 2018-05-14 0001269026 us-gaap:IPOMember 2018-05-13 2018-05-14 0001269026 2018-01-01 2018-09-30 0001269026 2018-05-13 2018-05-14 0001269026 SINT:L2CapitalDebtMember 2018-05-14 0001269026 SINT:L2CapitalDebtMember 2018-05-13 2018-05-14 0001269026 SINT:MEFILPandAnsonInvestmentsMember 2018-05-13 2018-05-14 0001269026 SINT:MEFILPandAnsonInvestmentsMember 2018-05-14 0001269026 SINT:SeriesBConvertiblePreferredStockMember 2018-05-31 0001269026 us-gaap:CommonStockMember 2018-05-31 0001269026 2018-09-30 0001269026 2018-05-14 0001269026 us-gaap:PreferredStockMember 2018-05-14 0001269026 us-gaap:CommonStockMember 2018-05-14 0001269026 2018-07-12 0001269026 SINT:AugustTwoThousandEighteenWarrantExerciseMember SINT:SecondaryOfferingMember 2018-08-01 2018-08-31 0001269026 SINT:JulyTwoThousandEighteenWarrantExerciseMember SINT:PublicOfferingMember 2018-07-01 2018-07-31 0001269026 2018-09-07 0001269026 us-gaap:PreferredStockMember 2017-12-31 0001269026 us-gaap:CommonStockMember 2017-12-31 0001269026 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001269026 us-gaap:RetainedEarningsMember 2017-12-31 0001269026 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001269026 us-gaap:RetainedEarningsMember 2018-12-31 0001269026 SINT:JulyThroughDecemberOfTwoThousandAndEighteenMember SINT:SeriesBConvertiblePreferredStockMember 2019-09-30 0001269026 SINT:JulyThroughDecemberOfTwoThousandAndEighteenMember us-gaap:CommonStockMember 2019-09-30 0001269026 SINT:SeriesBConvertiblePreferredStockMember 2018-06-30 0001269026 us-gaap:CommonStockMember 2018-06-30 0001269026 SINT:AssetPurchaseAgreementMember 2018-09-29 2018-10-02 0001269026 SINT:AssetPurchaseAgreementMember SINT:NoninterestBearingNoteReceivableMember 2018-09-29 2018-10-02 0001269026 SINT:AssetPurchaseAgreementMember SINT:RelatedPartyNotePayableMember 2018-09-29 2018-10-02 0001269026 2018-10-02 0001269026 2018-09-29 2018-10-02 0001269026 SINT:SeriesECommonStockPurchaseWarrantMember 2018-06-30 0001269026 SINT:SeriesECommonStockPurchaseWarrantMember 2018-01-01 2018-06-30 0001269026 SINT:NewWarrantsMember 2018-01-01 2018-06-30 0001269026 SINT:NewWarrantsMember 2018-06-30 0001269026 2017-12-31 0001269026 us-gaap:PreferredStockMember 2019-01-01 2019-09-30 0001269026 us-gaap:PreferredStockMember 2019-09-30 0001269026 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001269026 us-gaap:CommonStockMember 2019-09-30 0001269026 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001269026 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001269026 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001269026 us-gaap:RetainedEarningsMember 2019-09-30 0001269026 us-gaap:PreferredStockMember 2018-01-01 2018-09-30 0001269026 us-gaap:PreferredStockMember 2018-09-30 0001269026 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001269026 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001269026 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001269026 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001269026 us-gaap:RetainedEarningsMember 2018-09-30 0001269026 SINT:CommonStockWarrantsMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember 2018-09-30 0001269026 SINT:RetailSpineBusinessMember 2018-10-01 2018-12-31 0001269026 2019-01-02 0001269026 2019-01-01 2019-01-02 0001269026 2019-07-01 2019-09-30 0001269026 2018-07-01 2018-09-30 0001269026 us-gaap:CommonStockMember 2018-09-30 0001269026 SINT:WarrantDerivativeMember 2018-01-01 2018-09-30 0001269026 2018-03-01 2018-03-31 0001269026 us-gaap:SubsequentEventMember SINT:RetailSpineBusinessMember SINT:NextSevenMonthsMember 2019-11-01 2019-11-30 0001269026 us-gaap:SubsequentEventMember SINT:RetailSpineBusinessMember SINT:FollowingEighteenMonthsMember 2019-10-30 2019-11-30 0001269026 SINT:CommonStockWarrantsMember SINT:BlackScholesMertonValuationModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember SINT:BlackScholesMertonValuationModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2018-12-31 0001269026 SINT:CommonStockWarrantsMember SINT:BlackScholesMertonValuationModelMember us-gaap:MeasurementInputExpectedDividendRateMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember SINT:BlackScholesMertonValuationModelMember us-gaap:MeasurementInputExpectedDividendRateMember 2018-12-31 0001269026 SINT:CommonStockWarrantsMember SINT:BlackScholesMertonValuationModelMember us-gaap:MeasurementInputOptionVolatilityMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember SINT:BlackScholesMertonValuationModelMember us-gaap:MeasurementInputOptionVolatilityMember 2018-12-31 0001269026 SINT:CommonStockWarrantsMember SINT:MonteCarloSimulationValuationModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember SINT:MonteCarloSimulationValuationModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2018-12-31 0001269026 SINT:CommonStockWarrantsMember SINT:MonteCarloSimulationValuationModelMember us-gaap:MeasurementInputExpectedDividendRateMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember SINT:MonteCarloSimulationValuationModelMember us-gaap:MeasurementInputExpectedDividendRateMember 2018-12-31 0001269026 SINT:CommonStockWarrantsMember SINT:MonteCarloSimulationValuationModelMember us-gaap:MeasurementInputOptionVolatilityMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember SINT:MonteCarloSimulationValuationModelMember us-gaap:MeasurementInputOptionVolatilityMember 2018-12-31 0001269026 SINT:SeriesBConvertiblePreferredStockMember 2019-09-30 0001269026 us-gaap:CommonStockMember 2019-09-30 0001269026 SINT:MayTwoThousandEighteenWarrantExerciseMember 2018-03-31 0001269026 SINT:MayTwoThousandEighteenWarrantExerciseMember srt:MinimumMember 2018-03-31 0001269026 SINT:MayTwoThousandEighteenWarrantExerciseMember srt:MaximumMember 2018-03-31 0001269026 SINT:MayTwoThousandEighteenWarrantExerciseMember 2018-05-31 0001269026 SINT:MayTwoThousandEighteenWarrantExerciseMember 2018-05-01 2018-05-31 0001269026 2019-06-06 2019-06-07 0001269026 2019-06-07 0001269026 SINT:EquityDistributionAgreementMember srt:MaximumMember 2019-06-03 2019-06-04 0001269026 SINT:EquityDistributionAgreementMember 2019-06-03 2019-06-04 0001269026 SINT:ATMEquityDistributionAgreementMember srt:MaximumMember 2019-01-01 2019-09-30 0001269026 SINT:ATMEquityDistributionAgreementMember 2019-01-01 2019-09-30 0001269026 2019-11-12 0001269026 2019-07-25 2019-07-26 0001269026 SINT:EquityDistributionAgreementMember srt:MaximumMember 2019-09-11 2019-09-12 0001269026 SINT:EquityDistributionAgreementMember srt:MinimumMember 2019-09-11 2019-09-12 0001269026 SINT:EquityDistributionAgreementMember 2019-09-11 2019-09-12 0001269026 SINT:CommonStockWarrantsMember SINT:BlackScholesMertonValuationModelMember us-gaap:MeasurementInputExpectedTermMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember SINT:BlackScholesMertonValuationModelMember us-gaap:MeasurementInputExpectedTermMember 2018-12-31 0001269026 SINT:CommonStockWarrantsMember SINT:MonteCarloSimulationValuationModelMember us-gaap:MeasurementInputExpectedTermMember 2019-09-30 0001269026 SINT:CommonStockWarrantsMember SINT:MonteCarloSimulationValuationModelMember us-gaap:MeasurementInputExpectedTermMember 2018-12-31 0001269026 SINT:EquipmentLoanMember 2019-09-01 2019-09-30 0001269026 SINT:EquipmentLoanMember 2019-09-30 0001269026 SINT:AugustTwoThousandNineteenWarrantExerciseMayTwoThousandEighteenWarrantsMember 2019-01-01 2019-09-30 0001269026 SINT:AugustTwoThousandNineteenWarrantExerciseMayTwoThousandEighteenWarrantsMember 2019-09-30 0001269026 SINT:RetailSpineBusinessMember 2019-09-30 0001269026 SINT:SeriesECommonStockPurchaseWarrantMember srt:MinimumMember 2018-06-30 0001269026 SINT:SeriesECommonStockPurchaseWarrantMember srt:MaximumMember 2018-06-30 0001269026 us-gaap:SubsequentEventMember SINT:HoldersMember us-gaap:SeriesBPreferredStockMember 2019-11-02 0001269026 2018-01-01 2018-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft Sintx Technologies, Inc. 10-Q 2019-09-30 false --12-31 Non-accelerated Filer

452000

504000

56000

0.01

1100

250000000

2363991

726455

2363991

726455

The following tables set forth the financial liabilities measured at fair value on a recurring basis by level within the fair value hierarchy as of September 30, 2019 and December 31, 2018:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">Fair Value Measurements as of September 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">Description</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 1</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 2</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 3</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Derivative liability</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; padding-left: 10pt">Common stock warrants</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">769</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">769</td> <td style="width: 1%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">Fair Value Measurements as of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">Description</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 1</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 2</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 3</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Derivative liability</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; padding-left: 10pt">Common stock warrants</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">1,566</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">1,566</td> <td style="width: 1%"> </td></tr> </table>

249

4074

0001269026

0.01

1100

130000000

249

4074

2282000

1100000

1600000

7577000

769000

1566000

800000

1600000

The Company did not have any transfers of assets and liabilities between Level 1 and Level 2 of the fair value measurement hierarchy during the nine months ended September 30, 2019 and 2018.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Common Stock Warrants</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Balance at December 31, 2017</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">(1,357</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Issuances of warrants classified as derivatives</td> <td> </td> <td> </td> <td style="text-align: right">(7,577</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Change in fair value</td> <td> </td> <td> </td> <td style="text-align: right">6,500</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercise of warrants</td> <td> </td> <td> </td> <td style="text-align: right">575</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Other, net</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(212</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balance at September 30, 2018</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(2,071</td> <td style="padding-bottom: 2.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Balance at December 31, 2018</td> <td> </td> <td>$</td> <td style="text-align: right">(1,566</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Change in fair value</td> <td> </td> <td> </td> <td style="text-align: right">754</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercise of warrants</td> <td> </td> <td> </td> <td style="text-align: right">44</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Other, net</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(1</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balance at September 30, 2019</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(769</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>

2500000

20000000

840000

2300000

1100000

2200000

700000

1400000

20000

151.20

3.31

60.00

63.75

360

63.75

360.00

0.10

0.08

0.15

0.10

0.12

2021-10-01

2018-07-28

2018-01-01

2019-02-03

2.84

43.54

43.50

19.63

14.40

27733

4861

35874

The assumptions used in estimating the common stock warrant liability using the Monte Carlo Simulation valuation model at September 30, 2019 and December 31, 2018 were as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Weighted-average risk-free interest rate</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">1.59</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">2.46</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Weighted-average expected life (in years)</td> <td> </td> <td> </td> <td style="text-align: right">2.16</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3.1</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected dividend yield</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Weighted average expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">65</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">68</td> <td>%</td></tr> </table>

The assumptions used in estimating the common stock warrant liability using the Black-Scholes-Merton valuation model as of September 30, 2019 and December 31, 2018 were as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Weighted-average risk-free interest rate</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">1.56</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">2.51</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Weighted-average expected life (in years)</td> <td> </td> <td> </td> <td style="text-align: right">3.61</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.9</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected dividend yield</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Weighted-average expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">64</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">157</td> <td>%</td></tr> </table>

6749000

6800000

4. Intangible Assets   Intangible assets consisted of the following (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Trademarks</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">50</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">50</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Less: accumulated amortization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(7</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(4</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">43</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">46</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Inventories consisted of the following (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Raw materials</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">625</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">624</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Intermediate goods</td> <td> </td> <td> </td> <td style="text-align: right">16</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>WIP</td> <td> </td> <td> </td> <td style="text-align: right">70</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">47</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Finished goods</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">5</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">711</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">676</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Accrued liabilities consisted of the following (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Payroll and related expense</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">454</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">388</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Resterilization and repackaging costs</td> <td> </td> <td> </td> <td style="text-align: right">365</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">344</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Other</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">247</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">106</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,066</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">838</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

true false false

6028000

8399000

7000

8090000

1000

226070000

-220629000

237673000

-229281000

5442000

24000

239090000

-233086000

237671000

-229587000

6000

-3805000

-8958000

-3805000

-8958000

-1446000

-3247000

A summary of the Company’s outstanding stock option activity for the nine months ended September 30, 2019 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Options</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted- Average Exercise Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted- Average Remaining Contractual Life (Years)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Intrinsic Value</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%">As of December 31, 2018</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">377</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">7,653</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">6.0</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Granted</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Exercised</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Forfeited</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Expired</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">As of September 30, 2019</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">377</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">7,653</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">5.6</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercisable as of September 30, 2019</td> <td> </td> <td> </td> <td style="text-align: right">377</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">7,653</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5.6</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> </table>

2019 2434008

1603000

1084000

15000000

500000

800000

50000

7000

4000

43000

46000

594.00

3.60

2.94

126000000

1357000

1566000

769000

2071000

-1000

-212000

750000

1834

68257

0.18

15000000

400000

200000

0.875

200000

1700000

4072

102886

15000

378997

10926

569966

4072

102886

3825

1143784

8069 998 998 22279

1000

P5Y

P3Y7M10D

P10M25D

P2Y1M27D

P3Y1M6D

600000

377

7653

P6Y

P5Y7M6D

2000

40000

98000

2000

39000

2000

39000

1040000 1040000 -9000 -9000

1400000

8500000

6000000

2500000

194444

138889

1.00

-3805000

-8634000

-1446000

-2967000

-6508000

-22644000

-1791000

-9600000

753000 6396000 144000 4485000

-753000

-6396000

-144000

-4485000

-4558000

-15030000

-1590000

-7452000

-324000

-280000

-7261000

-29040000

-1935000

-14085000

1269106

243543

2127293

418638

59933

1269106

303476

2127293

418692

-3.00

-35.45

-0.68

-7.09

-1.33

-0.67

-2.13 -56.20 -0.16 -15.17

-5.13

-92.98

-0.84

-22.93

-3.59

-49.53

-0.75

-17.80

-1.07

-0.67

-2.13 -45.10 -0.16 -15.17

-5.72

-95.70

-0.91

-33.64

2703000 13686000 345000 6353000

Below are basic and diluted loss per share data for the three months ended September 30, 2019, which are in thousands except for share and per share data:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Basic Calculation</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Effect of Dilutive Warrant Securities</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Diluted Calculation</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Numerator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 53%; padding-left: 10pt">Loss from continuing operations</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(1,446</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(144</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(1,590</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(345</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(345</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(1,791</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(144</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(1,935</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Number of shares used in per common share calculations:</td> <td> </td> <td> </td> <td style="text-align: right">2,127,293</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,127,293</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Net loss per common share:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Loss from continuing operations</td> <td> </td> <td>$</td> <td style="text-align: right">(0.68</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.07</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.75</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(0.16</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(0.16</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.84</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.07</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.91</td> <td>)</td></tr> </table>   Below are basic and diluted loss per share data for the nine months ended September 30, 2019, which are in thousands except for share and per share data:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Basic Calculation</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Effect of Dilutive Warrant Securities</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Diluted Calculation</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Numerator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 53%; padding-left: 10pt">Loss from continuing operations</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(3,805</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(753</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(4,558</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(2,703</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(2,703</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(6,508</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(753</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(7,261</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Number of shares used in per common share calculations:</td> <td> </td> <td> </td> <td style="text-align: right">1,269,106</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,269,106</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Net loss per common share:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Loss from continuing operations</td> <td> </td> <td>$</td> <td style="text-align: right">(3.00</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.59</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(3.59</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(2.13</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(2.13</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(5.13</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.59</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(5.72</td> <td>)</td></tr> </table>   Below are basic and diluted loss per share data for the three months ended September 30, 2018, which are in thousands except for share and per share data:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Basic Calculation</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Effect of Dilutive Warrant Securities</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Diluted Calculation</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Numerator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 53%; padding-left: 10pt">Loss from continuing operations</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(2,967</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(4,485</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(7,452</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Income from discontinued operations</td> <td> </td> <td> </td> <td style="text-align: right">(280</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(280</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(6,353</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(6,353</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(9,600</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(4,485</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(14,085</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Number of shares used in per common share calculations:</td> <td> </td> <td> </td> <td style="text-align: right">418,638</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">54</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">418,692</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net loss per common share:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Loss from continuing operations</td> <td> </td> <td>$</td> <td style="text-align: right">(7.09</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(10.71</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(17.80</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Loss from discontinued operations</td> <td> </td> <td> </td> <td style="text-align: right">(0.67</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(0.67</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(15.17</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(15.17</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(22.93</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(10.71</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(33.64</td> <td>)</td></tr> </table>   Below are basic and diluted loss per share data for the nine months ended September 30, 2018, which are in thousands except for share and per share data:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Basic Calculation</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Effect of Dilutive Warrant Securities</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Diluted Calculation</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Numerator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 53%; padding-left: 10pt">Loss from continuing operations</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(8,634</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(6,396</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(15,030</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Income from discontinued operations</td> <td> </td> <td> </td> <td style="text-align: right">(324</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(324</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(13,686</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(13,686</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(22,644</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(6,396</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(29,040</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Number of shares used in per common share calculations:</td> <td> </td> <td> </td> <td style="text-align: right">243,543</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">59,933</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">303,476</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net loss per common share:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Loss from continuing operations</td> <td> </td> <td>$</td> <td style="text-align: right">(35.45</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(14.08</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(49.53</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Loss from discontinued operations</td> <td> </td> <td> </td> <td style="text-align: right">(1.33</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">0.26</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(1.07</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(56.20</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">11.10</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(45.10</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(92.98</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(2.72</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(95.70</td> <td>)</td></tr> </table>

437000

173000

364000

151000

73000

22000

2557000

2383000

869000

549000

2166000

2912000

714000

654000

303000

42000

139000

5026000

11499000

1722000

7365000

-4953000

-11499000

-1700000

-7365000

349000

111000

-340000

-1252000

48000

6000

1000

1148000

2865000

254000

4398000

2703000

13686000

345000

6353000

-1.33

-0.67

-1.07

-0.67

1269106

303476

2127293

418692

377

7653

6900 700000

-3805000

-8634000

-1446000

-2967000

1000000

3500000

2440000

700000

2343000

900000

2704000 700000

0.065

454000

388000

365000 344000

247000

106000

625000

624000

16000

70000

47000

5000

2926000

5447000

113000

263000

137000

171000

86000

52000

4865000

7017000

207000

124000

43000

46000

2383000

3669000

35000

10598000

11515000

166000

301000

1066000

838000

317000

1062000

475000

169000

23000

10000

2053000

2380000

91000

232000

4570000

3116000

24000

7000

239090000

237673000

-233086000

-229281000

10598000

11515000

1453000 1453000 Yes Yes false

1959000

3000

1367000

1000

83000

-2.13 -45.10 -0.16 -15.17 -2.13 -56.20 -0.16 -15.17

754000

6500000

144000

4480000

15000 6748000 6748000

-3825

1143784

-10598

544911

12000

-12000

5000

-5000

4074

726455

100935

249

2363991

4402

701399

19348 13687000 13687000 -13687000 -13687000

457878

1285000

5000

1280000

44000 44000

245000

668000

682000

200000

79000

75000

4000

25000

344000

956000

-3000

-154000

-33000

246000

35000

47000

83000

-899000

-4322000

-7746000

-207000

-4322000

-7953000

1111000

50000

970000

-194000

103000

1652000

1400000

300000

100000

1285000

557000

705000

831000

14401000

2926000

5447000

6793000

539000

44000 565000 98000

2000

405000

-54000

141000

152000

682000

-2521000

6254000

264000

1400000

-324000

-280000

The Series B Preferred Stock is convertible into shares of common stock by dividing the stated value of $1,100 by: (i) for the first 40 trading days following the closing of this offering, $43.54 (the "Conversion Price"), (ii) after 40 trading days but prior to the 81st trading day, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the 41st trading day, and (iii) after 80 trading days, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the date of the notice of conversion. In the case of (ii)(b) and (iii)(b) above, the share price shall not be less than $2.94 (the "Floor Price"). Each of the Conversion Price and Floor Price is subject to adjustment in certain circumstances.

The Company leases office, warehouse and manufacturing space under a single operating lease, which lease originally expired during 2019

The amended lease has two five-year extension options.

On June 7, 2019, the lease was amended to extend the rental period through 2024

54428

29534

245000

494000

509000

525000

540000

556000

2869000

435000

754000

6500000

120000

-7577000

44000 575000

Operating lease future minimum payments together with the present values as of September 30, 2019, are summarized as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">2019</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">245</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">2020</td> <td> </td> <td> </td> <td style="text-align: right">494</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">2021</td> <td> </td> <td> </td> <td style="text-align: right">509</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">2022</td> <td> </td> <td> </td> <td style="text-align: right">525</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">2023</td> <td> </td> <td> </td> <td style="text-align: right">540</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify">Thereafter</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">556</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify">Total future minimum lease payments</td> <td> </td> <td> </td> <td style="text-align: right">2,869</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Less amounts representing interests</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(435</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify">Present value of lease liability</td> <td> </td> <td> </td> <td style="text-align: right">2,434</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-align: justify">Current-portion of operating lease liability</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">475</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify">Long-term portion operating lease liability</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,959</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The note receivable includes an imputed interest rate of 10%, which totaled $915,725 as of October 1, 2018, and has a 36-month amortization.

-2703000 -13686000 -345000 -6353000

2265000

1453000

1. Organization and Summary of Significant Accounting Policies   Organization   SINTX Technologies, Inc. (“SINTX” or “the Company”) (previously known as Amedica Corporation) was incorporated in the state of Delaware on December 10, 1996. SINTX is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The Company believes it is the first and only manufacturer to use silicon nitride in medical applications. The Company acquired US Spine, Inc. (“US Spine”), a Delaware spinal products corporation with operations in Florida, on September 20, 2010. The Company’s products are primarily sold in the United States.   As further explained in Note 12, On October 1, 2018, the Company completed the sale of its retail spine business to CTL Medical, a Dallas, Texas-based privately held medical device manufacturer. As a result of the sale, CTL Medical is now the exclusive owner of SINTX’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies. Manufacturing, R&D, and all intellectual property related to the core, non-spine, biomaterial technology of silicon nitride remains with the Company. The Company will serve as CTL’s exclusive OEM provider of silicon nitride products.   On October 30, 2018, the Company amended its Certificate of Incorporation with the State of Delaware to change its corporate name to SINTX Technologies, Inc. in order to better reflect its focus on silicon nitride science and technologies and pipeline of silicon nitride-based products in various biomedical applications. The Company also changed its trading symbol on the NASDAQ Capital Market to “SINT”. The Company also changed the name of its wholly owned subsidiary US Spine, Inc. to “ST Sub, Inc.”   The previous name, Amedica, has transferred to CTL Medical, which is now CTL-Amedica. The Company’s new corporate brand reflects both the Company’s core competence in the science and production of silicon nitride ceramics, as well as encouraging prospects for the future, as an OEM supplier of spine implants to CTL-Amedica, and several opportunities outside of spine. The Company will focus on developing silicon nitride in terms of product design, and future biomaterial formulations, for a variety of OEM customers.   Reverse Stock Split   On July 26, 2019 the Company effected a 1 for 30 reverse stock split of the Company’s common stock. The par value and the authorized shares of the common and convertible preferred stock were not adjusted as a result of the reverse stock split. All common stock shares, equivalents, and per-share amounts for all periods presented in these consolidated financial statements have been adjusted retroactively to reflect the reverse stock split.   Basis of Presentation   These unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and include all assets and liabilities of the Company and its wholly owned subsidiary, ST Sub, Inc. All material intercompany transactions and balances have been eliminated in consolidation. SEC rules and regulations allow the omission of certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, so long as the statements are not misleading. In the opinion of management, these financial statements and accompanying notes contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position and results of operations for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on March 11, 2019. The results of operations for the nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the year ending December 31, 2019. The Company’s significant accounting policies are set forth in Note 1 to the consolidated financial statements in its Annual Report on Form 10-K for the year ended December 31, 2018.   Use of Estimates   The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the periods then ended. Actual results could differ from those estimates. The most significant estimates relate to inventory, long-lived and intangible assets and the liability for preferred stock and common stock warrants.   Liquidity and Capital Resources   The condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern within one year from the date of issuance of these condensed consolidated financial statements.   For the nine months ended September 30, 2019 and 2018, the Company incurred net losses from continuing operations of approximately $3.8 million and $8.6 million, respectively, and used cash in continuing operations of approximately $4.3 million and $7.7 million, respectively. The Company had an accumulated deficit of approximately $233 million and $229 million as of September 30, 2019 and December 31, 2018, respectively. To date, the Company’s operations have been principally financed by proceeds received from the issuance of preferred and common stock, convertible debt and bank debt and, to a lesser extent, cash generated from product sales. It is anticipated that the Company will continue to generate operating losses and use cash in operating activities. The Company’s continuation as a going concern is dependent upon its ability to increase sales and/or raise additional funds through the capital markets. Whether and when the Company can attain profitability and positive cash flows from operating activities or obtain additional financing is uncertain.   The Company is actively generating additional scientific and clinical data confirming the beneficial attributes of silicon nitride and intends to publish the results in leading industry publications. The unique features of the Company’s silicon nitride material are not well known, and the Company believes that the publication of such data would help sales efforts as the Company approaches new prospects. The Company is also making additional changes to the sales strategy, including a focus on revenue growth by expanding the use of silicon nitride in other areas outside of spinal fusion applications.   The Company has common stock that is publicly traded and has been able to successfully raise capital when needed since the date of the Company’s initial public offering in February 2014. In March 2018, the Company closed on gross proceeds of $1.4 million, before payment of placement agent fees and costs on a warrant reprice and exercise transaction. Additionally, on May 14, 2018, the Company closed on a public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15 million, which excludes underwriting discounts and commissions and offering expenses payable by the Company. On June 4, 2019, the Company entered into an Equity Distribution Agreement, (the “Distribution Agreement”), with Maxim Group LLC (“Maxim”), pursuant to which the Company may sell from time to time, shares of its common stock, having an aggregate offering price of up to $1.6 million through Maxim, as agent (the “ATM Offering”). On September 12, 2019, the Company entered into an amendment to the Distribution Agreement with Maxim, which increased the maximum aggregate offering price of the shares of the Company’s common stock from $1.6 million to $2.5 million. Subject to the terms and conditions of the Distribution Agreement, Maxim will use its commercially reasonable efforts to sell the shares from time to time, based on the Company’s instructions. The Company has no obligation to sell any of the shares and may at any time suspend offers under the Distribution Agreement. The Offering will terminate upon the earlier of (i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020. The Company agrees to pay Maxim a transaction fee at a fixed rate of 4.25% of the gross sales price of shares sold under the Distribution Agreement and agreed to provide indemnification and contribution to Maxim with respect to certain liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2019 the Company raised approximately $1.3 million, net of fees, through the issuance of 457,878 shares of common stock under the Distribution Agreement with Maxim. The Company is eligible to raise an additional $1.2 million under this offering. In addition, during the nine months ended September 30, 2019, the Company converted 3,825 shares of preferred stock into 1,143,784 shares of common stock. The Company is engaged in discussions with investment and banking firms to examine financing alternatives, including options for a public offering of the Company’s preferred or common stock. On October 1, 2018, the Company sold the retail spine business. This sale will continue to provide cash flows from November 2019 totaling $1.0 million over the next seven months and $3.5 million for the following 18 months. The buyer also assumed the Company’s $2.5 million related party note payable.   Although the Company is seeking to obtain additional equity and/or debt financing, such funding is not assured and may not be available to the Company on favorable or acceptable terms and may involve significant restrictive covenants. Any additional equity financing is also not assured and, if available to the Company, will most likely be dilutive to its current stockholders. If the Company is not able to obtain additional debt or equity financing on a timely basis, the impact on the Company will be material and adverse.   These uncertainties create substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.   Significant Accounting Policies   Except as explained below, no material changes were made to the Company’s significant accounting policies as described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.   Accounting Pronouncements Adopted During the Nine Months Ended September 30, 2019   In August 2016, the FASB updated accounting guidance on the following eight specific cash flow classification issues: (1) debt prepayment or debt extinguishment costs; (2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; (3) contingent consideration payments made after a business combination; (4) proceeds from the settlement of insurance claims; (5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (6) distributions received from equity method investees; (7) beneficial interests in securitization transactions; and (8) separately identifiable cash flows and application of the predominance principle. Under prior U.S. GAAP, there was no specific guidance on the eight cash flow classification issues aforementioned. The Company adopted the new guidance effective January 1, 2019. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.   In February 2016, the FASB updated the accounting guidance related to leases as part of a joint project with the International Accounting Standards Board (“IASB”) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The Company adopted the new guidance effective January 1, 2019 (see Note 13), using the modified retrospective approach. Adoption of the new guidance resulted in the Company being required to record an additional operating lease right-of-use asset totaling approximately $0.7 million and liability totaling approximately $0.9 million (with $0.7 million incremental to adoption of the new guidance) on the date of adoption. Subsequent to the initial adoption of the new standard the Company amended the lease (see Note 13). The standard did not materially impact the consolidated net loss and had no impact on cash flows.   In May 2014, in addition to several amendments issued during 2016, the FASB updated the accounting guidance related to revenue from contracts with customers, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The Company adopted the new guidance effective January 1, 2019. The core principle of the new guidance is that a company should recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. The standard defines a five-step process to achieve this core principle and, in doing so, more judgment and estimates are often required within the revenue recognition process than were required under prior U.S. GAAP. The Company has one primary customer (see Note 12) and related contract that has one performance obligation to which revenue is allocated. Revenue under this contract is recognized when the product is shipped to the customer. The Company generally bills its customer upon shipment of the product and invoices are generally due within 30 days. The Company does provide certain rights of return, which historically have not been significant. The Company does not anticipate incurring significant incremental costs to obtain contracts with future customers. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.   New Accounting Pronouncements Not Yet Adopted   The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that no other pronouncements will have a significant effect on its financial statements.   Reclassification   Certain reclassifications were made to the nine months ended September 30, 2018, Statement of Operations to conform to the presentation for the nine months ended September 30, 2019, Statement of Operations. Research and development expenses in 2018 increased by $0.4, million offset by a decrease in general and administrative expenses by the same amount. The reclassification did not affect the 2018 net loss.

2. Basic and Diluted Net Loss per Common Share   Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share is calculated by dividing the net loss by the weighted-average number of common share equivalents outstanding for the period that are determined to be dilutive. Common stock equivalents are primarily comprised of preferred stock, warrants for the purchase of common stock and stock options. The Company had potentially dilutive securities, totaling approximately 0.5 million and 0.8 million as of September 30, 2019 and 2018, respectively.   Below are basic and diluted loss per share data for the three months ended September 30, 2019, which are in thousands except for share and per share data:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Basic Calculation</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Effect of Dilutive Warrant Securities</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Diluted Calculation</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Numerator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 53%; padding-left: 10pt">Loss from continuing operations</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(1,446</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(144</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(1,590</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(345</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(345</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(1,791</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(144</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(1,935</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Number of shares used in per common share calculations:</td> <td> </td> <td> </td> <td style="text-align: right">2,127,293</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,127,293</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Net loss per common share:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Loss from continuing operations</td> <td> </td> <td>$</td> <td style="text-align: right">(0.68</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.07</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.75</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(0.16</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(0.16</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.84</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.07</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.91</td> <td>)</td></tr> </table>   Below are basic and diluted loss per share data for the nine months ended September 30, 2019, which are in thousands except for share and per share data:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Basic Calculation</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Effect of Dilutive Warrant Securities</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Diluted Calculation</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Numerator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 53%; padding-left: 10pt">Loss from continuing operations</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(3,805</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(753</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(4,558</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(2,703</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(2,703</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(6,508</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(753</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(7,261</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Number of shares used in per common share calculations:</td> <td> </td> <td> </td> <td style="text-align: right">1,269,106</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,269,106</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Net loss per common share:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Loss from continuing operations</td> <td> </td> <td>$</td> <td style="text-align: right">(3.00</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.59</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(3.59</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(2.13</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(2.13</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(5.13</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.59</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(5.72</td> <td>)</td></tr> </table>   Below are basic and diluted loss per share data for the three months ended September 30, 2018, which are in thousands except for share and per share data:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Basic Calculation</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Effect of Dilutive Warrant Securities</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Diluted Calculation</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Numerator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 53%; padding-left: 10pt">Loss from continuing operations</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(2,967</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(4,485</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(7,452</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Income from discontinued operations</td> <td> </td> <td> </td> <td style="text-align: right">(280</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(280</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(6,353</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(6,353</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(9,600</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(4,485</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(14,085</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Number of shares used in per common share calculations:</td> <td> </td> <td> </td> <td style="text-align: right">418,638</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">54</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">418,692</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net loss per common share:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Loss from continuing operations</td> <td> </td> <td>$</td> <td style="text-align: right">(7.09</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(10.71</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(17.80</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Loss from discontinued operations</td> <td> </td> <td> </td> <td style="text-align: right">(0.67</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(0.67</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(15.17</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(15.17</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(22.93</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(10.71</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(33.64</td> <td>)</td></tr> </table>   Below are basic and diluted loss per share data for the nine months ended September 30, 2018, which are in thousands except for share and per share data:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Basic Calculation</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Effect of Dilutive Warrant Securities</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Diluted Calculation</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Numerator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 53%; padding-left: 10pt">Loss from continuing operations</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(8,634</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(6,396</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(15,030</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Income from discontinued operations</td> <td> </td> <td> </td> <td style="text-align: right">(324</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(324</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(13,686</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(13,686</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(22,644</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(6,396</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(29,040</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Number of shares used in per common share calculations:</td> <td> </td> <td> </td> <td style="text-align: right">243,543</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">59,933</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">303,476</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net loss per common share:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Loss from continuing operations</td> <td> </td> <td>$</td> <td style="text-align: right">(35.45</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(14.08</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(49.53</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Loss from discontinued operations</td> <td> </td> <td> </td> <td style="text-align: right">(1.33</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">0.26</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(1.07</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deemed dividend and accretion of a discount</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(56.20</td> <td>)</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">11.10</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(45.10</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Net loss attributable to common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(92.98</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(2.72</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(95.70</td> <td>)</td></tr> </table>

3. Inventories   Inventories consisted of the following (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Raw materials</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">625</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">624</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Intermediate goods</td> <td> </td> <td> </td> <td style="text-align: right">16</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>WIP</td> <td> </td> <td> </td> <td style="text-align: right">70</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">47</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Finished goods</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">5</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">711</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">676</td> <td> </td></tr> </table>   As of September 30, 2019, inventories totaling approximately $0.1 million and $0.6 million were classified as current and long-term, respectively. Inventories classified as current represent the carrying value of inventories as of September 30, 2019, that management estimates will be sold by September 30, 2020.

5. Fair Value Measurements   Financial Instruments Measured and Recorded at Fair Value on a Recurring Basis   The Company has issued certain warrants to purchase shares of common stock, which are considered derivative liabilities because they have registration rights which could require a cash settlement and are re-measured to fair value at each reporting period in accordance with accounting guidance. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 72px">Level 1 -</td> <td style="text-align: justify">quoted market prices for identical assets or liabilities in active markets.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>Level 2 -</td> <td style="text-align: justify">observable prices that are based on inputs not quoted on active markets but corroborated by market data.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>Level 3 -</td> <td style="text-align: justify">unobservable inputs reflecting management’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.</td></tr> </table>   The Company classifies assets and liabilities measured at fair value in their entirety based on the lowest level of input that is significant to their fair value measurement. No financial assets were measured on a recurring basis as of September 30, 2019 and December 31, 2018. The following tables set forth the financial liabilities measured at fair value on a recurring basis by level within the fair value hierarchy as of September 30, 2019 and December 31, 2018:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">Fair Value Measurements as of September 30, 2019</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">Description</td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 1</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 2</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 3</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Derivative liability</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 45%; padding-left: 10pt">Common stock warrants</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">769</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">769</td> <td style="width: 1%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">Fair Value Measurements as of December 31, 2018</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">Description</td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 1</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 2</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Level 3</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Derivative liability</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 45%; padding-left: 10pt">Common stock warrants</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">1,566</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">1,566</td> <td style="width: 1%"> </td></tr> </table>   The Company did not have any transfers of assets and liabilities between Level 1 and Level 2 of the fair value measurement hierarchy during the nine months ended September 30, 2019 and 2018.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Common Stock Warrants</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 81%">Balance at December 31, 2017</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">(1,357</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Issuances of warrants classified as derivatives</td> <td> </td> <td> </td> <td style="text-align: right">(7,577</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Change in fair value</td> <td> </td> <td> </td> <td style="text-align: right">6,500</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercise of warrants</td> <td> </td> <td> </td> <td style="text-align: right">575</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Other, net</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(212</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Balance at September 30, 2018</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(2,071</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Balance at December 31, 2018</td> <td> </td> <td>$</td> <td style="text-align: right">(1,566</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Change in fair value</td> <td> </td> <td> </td> <td style="text-align: right">754</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercise of warrants</td> <td> </td> <td> </td> <td style="text-align: right">44</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Other, net</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(1</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Balance at September 30, 2019</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(769</td> <td>)</td></tr> </table>    Common Stock Warrants   The Company has issued certain warrants to purchase shares of common stock, which are considered derivative liabilities because they have registration rights which could require a cash settlement and are re-measured to fair value at each reporting period in accordance with accounting guidance. At September 30, 2019 and December 31, 2018, approximately $0.8 million and $1.6 million, respectively, of the derivative liability was calculated using the Black-Scholes-Merton valuation model. At September 30, 2019 and December 31, 2018, no significant amount of the derivative liability was calculated using the Monte Carlo Simulation valuation model.   The assumptions used in estimating the common stock warrant liability using the Black-Scholes-Merton valuation model as of September 30, 2019 and December 31, 2018 were as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Weighted-average risk-free interest rate</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">1.56</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">2.51</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Weighted-average expected life (in years)</td> <td> </td> <td> </td> <td style="text-align: right">3.61</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.9</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected dividend yield</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Weighted-average expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">64</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">157</td> <td>%</td></tr> </table>   The assumptions used in estimating the common stock warrant liability using the Monte Carlo Simulation valuation model at September 30, 2019 and December 31, 2018 were as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Weighted-average risk-free interest rate</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">1.59</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">2.46</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Weighted-average expected life (in years)</td> <td> </td> <td> </td> <td style="text-align: right">2.16</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3.1</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected dividend yield</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Weighted average expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">65</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">68</td> <td>%</td></tr> </table>   In addition, if any time after the second anniversary of the issuance of the warrant, both: (1) the 30-day volume weighted average price of the Company’s stock exceeds $594.00; and (2) the average daily trading volume for such 30-day period exceeds $126 million, the Company may call this warrant for $3.60 per share. For those warrants that have a call provision, management believes the Monte Carlo Simulation valuation model provides a better estimate of fair value for the warrants issued during 2018 and 2017 than the Black-Scholes-Merton valuation model.   Other Financial Instruments   The Company’s recorded values of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded value of debt approximates the fair value as the interest rate approximates market interest rates.

6. Accrued Liabilities   Accrued liabilities consisted of the following (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Payroll and related expense</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">454</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">388</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Resterilization and repackaging costs</td> <td> </td> <td> </td> <td style="text-align: right">365</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">344</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Other</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">247</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">106</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,066</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">838</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

7. Debt   L2 Capital Debt   On January 31, 2018, the Company signed a promissory note in the aggregate principal amount of up to $0.84 million (the “L2 Note”) for an aggregate purchase price of up to $0.75 million and warrants to purchase up to an aggregate of 68,257 shares of common stock (the “Warrants”) at an exercise price of $3.31 per share. The maturity date was six months from date of funding. The L2 Note’s interest rate was 8% per year and a default interest rate of 18% per year.   On May 14, 2018, the Company closed on an underwritten public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million. Part of the proceeds from this offering were used to pay off the outstanding debt with L2 Capital. The total payoff was $1.1 million, with $0.7 million in principal and $0.4 million in interest.   Hercules and MEF I, LP/Anson Investments Debt Exchange   On January 3, 2018, the Company entered into an Assignment Agreement (the “Assignment Agreement”) with MEF I, LP and Anson Investments Master Fund (collectively the “Assignees” and each an “Assignee”), Hercules Technology III, L.P. (“HT III”) and Hercules Capital, Inc. (“HC” and, together with HT III, “Hercules”), pursuant to which Hercules assigned to the Assignees all amounts remaining due under the Loan and Security Agreement, dated June 30, 2014, as amended, between the Company and Hercules (the “Loan and Security Agreement”) and (2) the note (the “Hercules Note”) between the Company and Hercules evidencing the amounts due under the Loan and Security Agreement. The total amount assigned by Hercules to the Assignees in the aggregate was $2.3 million and was secured by the same collateral underlying the Loan and Security Agreement. Subsequently, the Company entered into an exchange agreement pursuant to which the Assignees agreed to exchange the Hercules Term Loan obligation acquired by them for two senior secured convertible promissory notes issued by the Company, each in the principal amount of $1.1 million for an aggregate principal amount of $2.2 million, (the “Exchange Notes”). The Exchange Notes were scheduled to mature on February 3, 2019 (the “Maturity Date”). The Exchange Notes had interest at a rate of 15% per annum. The Exchange Notes were secured by a first priority security interest in substantially all of the Company assets, including intellectual property, and contains covenants restricting payments to certain of our affiliates.   On May 14, 2018, the Company closed on an underwritten public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million. Part of the proceeds from this offering were used to pay off the outstanding debt with MEF I, L.P and Anson Investments. The total payoff was $1.6 million, with $1.4 million in principal and $0.2 million in interest.   North Stadium Term Loan – Related Party   On July 28, 2017, the Company entered into a $2.5 million term loan (the “North Stadium Loan”) with North Stadium Investments, LLC (“North Stadium”), a company owned and controlled by the Company’s Chief Executive Officer and Chairman of the Board. The North Stadium Loan bore interest at 10% per annum and required the Company to make monthly interest only payments from September 5, 2017 through July 5, 2018. All principal and unpaid interest (if any) under the North Stadium Loan was due and payable on July 28, 2018. The North Stadium Loan was secured by substantially all of the Company’s assets but was junior to security interest in assets encumbered by the Hercules Term Loan (see below). In connection with the North Stadium Loan the Company also issued North Stadium a warrant to purchase up to 1,834 shares of the Company’s common stock at a purchase price of $151.20 per share, subject to a 5-year term. The relative estimated value of the warrants on the date of grant approximated $0.2 million, which was being amortized as interest expense over the life of the term loan.   On October 1, 2018, CTL Medical assumed the North Stadium Term Loan debt as part of the sale of the retail spine business. As of December 31, 2018, the Company has been released by North Stadium from any and all obligations related to this debt.   Hercules Term Loan   On June 30, 2014, the Company entered into a Loan and Security Agreement with Hercules which provided the Company with a $20.0 million term loan. The Hercules Term Loan matured on January 1, 2018. The Hercules Term Loan included a $0.2 million closing fee, which was paid to Hercules on the closing date of the loan. The closing fee was recorded as a debt discount and was being amortized to interest expense over the life of the loan. The Hercules Term Loan also included a non-refundable final payment fee of $1.7 million. The final payment fee was being accrued and recorded to interest expense over the life of the loan.   On January 3, 2018, the Hercules Term Loan and all amounts owing thereunder was assigned to MEF I and Anson Investments. See discussion above under “Hercules and MEF I, LP/Anson Investments Debt Exchange” for a more detailed description of that transaction.   Equipment Loan   In September of 2019 the Company entered into a debt arrangement with a finance company to purchase equipment. The debt balance at September 30, 2019, totaled $0.02 million. The debt incurs interest at 12%, is collateralized by the equipment and is payable in monthly payments of $0.001 million (including interest) over 36 months.

8. Equity   Preferred Stock Conversion   From July through December of 2018, Series B Convertible Preferred shareholders of the Company converted 10,926 shares of Series B Convertible Preferred Stock into 569,966 shares of common stock.   During May 2018 and June 2018, Series B Convertible Preferred shareholders of the Company converted a total of 4,072 shares of Series B Convertible Preferred Stock into 102,886 shares of common stock.   During the nine months ended September 30, 2019, Series B Convertible Preferred shareholders of the Company converted 3,825 shares of Series B Convertible Preferred Stock into 1,143,784 shares of common stock.   August 2018 Warrant Exercise   During August 2018, pursuant to the cashless exercise provision contained in their warrant, L2 Capital exercised its warrants and was issued 8,069 shares of common stock. The L2 Capital warrant is no longer outstanding.   July 2018 Warrant Exercise   During May 2018, the Company closed on a public offering, consisting of both convertible preferred stock and warrants. During July 2018, 998 of the warrants were exercised and converted into 998 shares of common stock.   May 2018 Warrant Exercise (July 2016 Warrants)   During March 2018, the Company repriced 27,733 warrants dated July 8, 2016, from $360 to $63.75 (for further description see Warrant Reprice March 2018 below). During May 2018, an additional 4,861 of the repriced warrants were exercised resulting in gross proceeds to the Company of $0.3 million.   August 2019 Warrant Exercise (May 2018 Warrants)   During the nine months ended September 30, 2019, 35,874 warrants were exercised resulting in gross proceeds to the Company of approximately $0.1 million.   May 2018 Unit Offering   On May 14, 2018, the Company closed on an underwritten public offering of units (“the Units”), consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million, which excludes underwriting discounts and commissions and offering expenses payable by SINTX. The offering was priced at a public offering price of $1,000 per unit. Each unit consisted of one share of Series B Convertible Preferred Stock, with a stated value of $1,100, and warrants to purchase up to 25 shares of common stock (the “May 2018 Warrants”). The May 2018 Warrants are initially exercisable at an exercise price of $48 per share and expire 5 years from the date of issuance. The Series B Preferred Stock is convertible into shares of common stock by dividing the stated value of $1,100 by: (i) for the first 40 trading days following the closing of this offering, $43.54 (the “Conversion Price”), (ii) after 40 trading days but prior to the 81st trading day, the lesser of  (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the 41st trading day, and (iii) after 80 trading days, the lesser of  (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the date of the notice of conversion. In the case of (ii)(b) and (iii)(b) above, the share price shall not be less than $2.94 (the “Floor Price”). Each of the Conversion Price and Floor Price is subject to adjustment in certain circumstances.   The Company raised $15.0 million associated with the issuance of the Units, with $6.8 million, net of issuance costs of $0.6 million, allocated to the preferred stock and $6.9 million, net of issuance costs of $0.7 million, allocated to the warrants. In association with the warrants that were recorded as a derivative liability, the Company immediately expensed approximately $0.7 million of issuance costs. The 15,000 preferred shares were initially convertible into 378,997 shares of common stock and had an effective conversion rate of $43.50 per share based on the proceeds that were allocated to them. The conversion price was adjusted to $19.63, effective July 12, 2018, and was adjusted again on September 7, 2018 to $14.40. During the nine months ended September 30, 2019 the conversion price was adjusted down on several occasions and ultimately settled at $2.84 as of September 30, 2019.   Warrant Reprice March 2018   During the six months ended June 30, 2018 the Company entered into a warrant amendment agreement (the “Amendment Agreement”) with certain holders of previously issued Series E Common Stock Purchase Warrants (collectively, “Investors”). In connection with that certain Series E Common Stock Purchase Warrant between the Company and Investors dated July 8, 2016, the Company issued to Investors warrants to purchase up to 27,733 shares of common stock (the “Warrant Shares”) at an exercise price of $360.00 per share, (the “Investors Warrants”). Under the terms of the Amendment Agreement, in consideration of Investors exercising 22,279 of the Investors Warrants (the “Warrant Exercise”), the exercise price per share of the Investors Warrants was reduced to $63.75 per share. 22,278 of the Investors Warrants were exercised resulting in gross proceeds to the Company of $1.4 million before payment of placement agent fees and costs. In addition, and as further consideration, the Company issued to Investors new warrants to purchase up to the number of shares of common stock equal to 100% of the number of Warrant Shares issued pursuant to the Warrant Exercise at an exercise price per share equal to $60.00 per share.   2019 ATM Stock Offerings   During the nine months ended September 30, 2019, the Company entered into an ATM equity distribution agreement in which the Company may sell, from time to time, shares of common stock having an aggregate offering price of up to $2.5 million. The Company sold 457,878 shares during the nine months ended September 30, 2019, raising approximately $1.3 million net of issuance cost of $0.2 million. The Company is eligible to raise an additional $1.2 million under this offering.

9. Stock-Based Compensation   A summary of the Company’s outstanding stock option activity for the nine months ended September 30, 2019 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Options</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted- Average Exercise Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted- Average Remaining Contractual Life (Years)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Intrinsic Value</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%">As of December 31, 2018</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">377</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">7,653</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">6.0</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">-</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Granted</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Exercised</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Forfeited</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Expired</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">As of September 30, 2019</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">377</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">7,653</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">5.6</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercisable as of September 30, 2019</td> <td> </td> <td> </td> <td style="text-align: right">377</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">7,653</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5.6</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> </table>   The Company estimates the fair value of each stock option on the grant date using the Black-Scholes-Merton valuation model, which requires several estimates including an estimate of the fair value of the underlying common stock on grant date. The expected volatility was based on an average of the historical volatility of a peer group of similar companies. The expected term was calculated utilizing the simplified method. The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option.

10. Commitments and Contingencies   The Company has executed agreements with certain executive officers of the Company which, upon the occurrence of certain events related to a change in control, call for payments to the executives up to three times their annual salary and accelerated vesting of previously granted stock options.   From time to time, the Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. Management believes any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the Company’s consolidated financial position, operating results or cash flows.

11. Note Receivable   On October 1, 2018, the Company completed the sale of its spine business to CTL Medical. The sale included a $6 million noninterest bearing note receivable. The 36-month term of the note receivable requires 18 payments of $138,889 followed by 18 payments of $194,444, with maturity of the note receivable on October 1, 2021. The note receivable includes an imputed interest rate of 10%, which totaled $915,725 as of October 1, 2018, and has a 36-month amortization. As of September 30, 2019, the net carrying value of the note receivable was approximately $4.0 million.

12. Discontinued Operations   As explained in Note 1, on October 1, 2018, the Company completed the sale of its retail spine business to CTL Medical. The gain on the sale of the retail spine business is estimated to approximate $1.4 million, which was recognized during the quarter ended December 31, 2018.   The Company and CTL Medical entered in an asset purchase agreement whereby CTL Medical agreed to acquire all of the Company’s commercial spine business for total consideration of $8.5 million, which includes a $6.0 million (including interest) note receivable (See Note 7) and CTL Medical’s assumption of the Company’s $2.5 million related party note payable to North Stadium (see Note 11). As a result of the closing, CTL Medical is now the exclusive owner of SINTX’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies. The Company has agreed to pay the cost, if any, to re-sterilize and re-package select silicon nitride spinal inventories sold to CTL Medical if the sterilization date expires prior to CTL Medical selling the inventories to a third-party customer. This agreement extends for a total of 24 months, ending on September 30, 2020. The Company estimates the sterilization and repackaging cost to approximate $0.5 million. Manufacturing, R&D, and all intellectual property related to the core, non-spine, biomaterial technology of silicon nitride remains with the Company in Salt Lake City. The Company will serve as CTL’s exclusive OEM provider of silicon nitride products.

13. Leases   The Company leases office, warehouse and manufacturing space under a single operating lease, which lease originally expired during 2019 (see Note 1 under Accounting Pronouncements Adopted During the Nine Months Ended September 30, 2019). On June 7, 2019, the lease was amended to extend the rental period through 2024 and reduce the amount of space leased from 54,428 square feet to 29,534 square feet. The new rent is effective the earlier of January 1, 2020 or when the Company vacates the portion of the property that will not be part of the new lease. The amended lease has two five-year extension options. As of September 30, 2019, the operating lease right-of-use asset totaled approximately $2.5 million and the operating lease liability totaled approximately $2.4 million. Non-cash operating lease expense during the nine months ended September 30, 2019, totaled approximately $0.3 million. As of September 30, 2019, the weighted-average discount rate for the Company’s operating lease totaled 6.5%. During the three months ended September 30, 2019, the Company recorded a loss of approximately $0.12 million in association with the lease amendment.   Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease. The Company accounts for lease components separately from the non-lease components. The depreciable life of the assets and leasehold improvements are limited by the expected lease term.   Operating lease future minimum payments together with the present values as of September 30, 2019, are summarized as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 81%; text-align: justify">2019</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">245</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">2020</td> <td> </td> <td> </td> <td style="text-align: right">494</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">2021</td> <td> </td> <td> </td> <td style="text-align: right">509</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">2022</td> <td> </td> <td> </td> <td style="text-align: right">525</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">2023</td> <td> </td> <td> </td> <td style="text-align: right">540</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Thereafter</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">556</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify">Total future minimum lease payments</td> <td> </td> <td> </td> <td style="text-align: right">2,869</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify">Less amounts representing interests</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(435</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify">Present value of lease liability</td> <td> </td> <td> </td> <td style="text-align: right">2,434</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Current-portion of operating lease liability</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">475</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Long-term portion operating lease liability</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,959</td> <td> </td></tr> </table>

Organization   SINTX Technologies, Inc. (“SINTX” or “the Company”) (previously known as Amedica Corporation) was incorporated in the state of Delaware on December 10, 1996. SINTX is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The Company believes it is the first and only manufacturer to use silicon nitride in medical applications. The Company acquired US Spine, Inc. (“US Spine”), a Delaware spinal products corporation with operations in Florida, on September 20, 2010. The Company’s products are primarily sold in the United States.   As further explained in Note 12, On October 1, 2018, the Company completed the sale of its retail spine business to CTL Medical, a Dallas, Texas-based privately held medical device manufacturer. As a result of the sale, CTL Medical is now the exclusive owner of SINTX’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies. Manufacturing, R&D, and all intellectual property related to the core, non-spine, biomaterial technology of silicon nitride remains with the Company. The Company will serve as CTL’s exclusive OEM provider of silicon nitride products.   On October 30, 2018, the Company amended its Certificate of Incorporation with the State of Delaware to change its corporate name to SINTX Technologies, Inc. in order to better reflect its focus on silicon nitride science and technologies and pipeline of silicon nitride-based products in various biomedical applications. The Company also changed its trading symbol on the NASDAQ Capital Market to “SINT”. The Company also changed the name of its wholly owned subsidiary US Spine, Inc. to “ST Sub, Inc.”   The previous name, Amedica, has transferred to CTL Medical, which is now CTL-Amedica. The Company’s new corporate brand reflects both the Company’s core competence in the science and production of silicon nitride ceramics, as well as encouraging prospects for the future, as an OEM supplier of spine implants to CTL-Amedica, and several opportunities outside of spine. The Company will focus on developing silicon nitride in terms of product design, and future biomaterial formulations, for a variety of OEM customers.

Basis of Presentation   These unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and include all assets and liabilities of the Company and its wholly owned subsidiary, ST Sub, Inc. All material intercompany transactions and balances have been eliminated in consolidation. SEC rules and regulations allow the omission of certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, so long as the statements are not misleading. In the opinion of management, these financial statements and accompanying notes contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position and results of operations for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on March 11, 2019. The results of operations for the nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the year ending December 31, 2019. The Company’s significant accounting policies are set forth in Note 1 to the consolidated financial statements in its Annual Report on Form 10-K for the year ended December 31, 2018.

Use of Estimates   The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the periods then ended. Actual results could differ from those estimates. The most significant estimates relate to inventory, long-lived and intangible assets and the liability for preferred stock and common stock warrants.

Liquidity and Capital Resources   The condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern within one year from the date of issuance of these condensed consolidated financial statements.   For the nine months ended September 30, 2019 and 2018, the Company incurred net losses from continuing operations of approximately $3.8 million and $8.6 million, respectively, and used cash in continuing operations of approximately $4.3 million and $7.7 million, respectively. The Company had an accumulated deficit of approximately $233 million and $229 million as of September 30, 2019 and December 31, 2018, respectively. To date, the Company’s operations have been principally financed by proceeds received from the issuance of preferred and common stock, convertible debt and bank debt and, to a lesser extent, cash generated from product sales. It is anticipated that the Company will continue to generate operating losses and use cash in operating activities. The Company’s continuation as a going concern is dependent upon its ability to increase sales and/or raise additional funds through the capital markets. Whether and when the Company can attain profitability and positive cash flows from operating activities or obtain additional financing is uncertain.   The Company is actively generating additional scientific and clinical data confirming the beneficial attributes of silicon nitride and intends to publish the results in leading industry publications. The unique features of the Company’s silicon nitride material are not well known, and the Company believes that the publication of such data would help sales efforts as the Company approaches new prospects. The Company is also making additional changes to the sales strategy, including a focus on revenue growth by expanding the use of silicon nitride in other areas outside of spinal fusion applications.    The Company has common stock that is publicly traded and has been able to successfully raise capital when needed since the date of the Company’s initial public offering in February 2014. In March 2018, the Company closed on gross proceeds of $1.4 million, before payment of placement agent fees and costs on a warrant reprice and exercise transaction. Additionally, on May 14, 2018, the Company closed on a public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15 million, which excludes underwriting discounts and commissions and offering expenses payable by the Company. On June 4, 2019, the Company entered into an Equity Distribution Agreement, (the “Distribution Agreement”), with Maxim Group LLC (“Maxim”), pursuant to which the Company may sell from time to time, shares of its common stock, having an aggregate offering price of up to $1.6 million through Maxim, as agent (the “ATM Offering”). On September 12, 2019, the Company entered into an amendment to the Distribution Agreement with Maxim, which increased the maximum aggregate offering price of the shares of the Company’s common stock from $1.6 million to $2.5 million. Subject to the terms and conditions of the Distribution Agreement, Maxim will use its commercially reasonable efforts to sell the shares from time to time, based on the Company’s instructions. The Company has no obligation to sell any of the shares and may at any time suspend offers under the Distribution Agreement. The Offering will terminate upon the earlier of (i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020. The Company agrees to pay Maxim a transaction fee at a fixed rate of 4.25% of the gross sales price of shares sold under the Distribution Agreement and agreed to provide indemnification and contribution to Maxim with respect to certain liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2019 the Company raised approximately $1.3 million, net of fees, through the issuance of 457,878 shares of common stock under the Distribution Agreement with Maxim. The Company is eligible to raise an additional $1.2 million under this offering. In addition, during the nine months ended September 30, 2019, the Company converted 3,825 shares of preferred stock into 1,143,784 shares of common stock. The Company is engaged in discussions with investment and banking firms to examine financing alternatives, including options for a public offering of the Company’s preferred or common stock. On October 1, 2018, the Company sold the retail spine business. This sale will continue to provide cash flows from November 2019 totaling $1.0 million over the next seven months and $3.5 million for the following 18 months. The buyer also assumed the Company’s $2.5 million related party note payable.   Although the Company is seeking to obtain additional equity and/or debt financing, such funding is not assured and may not be available to the Company on favorable or acceptable terms and may involve significant restrictive covenants. Any additional equity financing is also not assured and, if available to the Company, will most likely be dilutive to its current stockholders. If the Company is not able to obtain additional debt or equity financing on a timely basis, the impact on the Company will be material and adverse.   These uncertainties create substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties. Significant Accounting Policies   Except as explained below, no material changes were made to the Company’s significant accounting policies as described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

Accounting Pronouncements Adopted During the Nine Months Ended September 30, 2019   In August 2016, the FASB updated accounting guidance on the following eight specific cash flow classification issues: (1) debt prepayment or debt extinguishment costs; (2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; (3) contingent consideration payments made after a business combination; (4) proceeds from the settlement of insurance claims; (5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (6) distributions received from equity method investees; (7) beneficial interests in securitization transactions; and (8) separately identifiable cash flows and application of the predominance principle. Under prior U.S. GAAP, there was no specific guidance on the eight cash flow classification issues aforementioned. The Company adopted the new guidance effective January 1, 2019. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.   In February 2016, the FASB updated the accounting guidance related to leases as part of a joint project with the International Accounting Standards Board (“IASB”) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The Company adopted the new guidance effective January 1, 2019 (see Note 13), using the modified retrospective approach. Adoption of the new guidance resulted in the Company being required to record an additional operating lease right-of-use asset totaling approximately $0.7 million and liability totaling approximately $0.9 million (with $0.7 million incremental to adoption of the new guidance) on the date of adoption. Subsequent to the initial adoption of the new standard the Company amended the lease (see Note 13). The standard did not materially impact the consolidated net loss and had no impact on cash flows.   In May 2014, in addition to several amendments issued during 2016, the FASB updated the accounting guidance related to revenue from contracts with customers, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The Company adopted the new guidance effective January 1, 2019. The core principle of the new guidance is that a company should recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. The standard defines a five-step process to achieve this core principle and, in doing so, more judgment and estimates are often required within the revenue recognition process than were required under prior U.S. GAAP. The Company has one primary customer (see Note 12) and related contract that has one performance obligation to which revenue is allocated. Revenue under this contract is recognized when the product is shipped to the customer. The Company generally bills its customer upon shipment of the product and invoices are generally due within 30 days. The Company does provide certain rights of return, which historically have not been significant. The Company does not anticipate incurring significant incremental costs to obtain contracts with future customers. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.

New Accounting Pronouncements Not Yet Adopted   The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that no other pronouncements will have a significant effect on its financial statements.

Intangible assets consisted of the following (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%">Trademarks</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">50</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">50</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Less: accumulated amortization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(7</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(4</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">43</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">46</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

This agreement extends for a total of 24 months, ending on September 30, 2020.

4000000

6000000

35874 36205 103000 1653000 103000 1653000 9000 9000 575000 575000 1600000 2500000 2500000 1600000 0.0425

457878

1300000

1200000

6000

15000

6162000

Reverse Stock Split   On July 26, 2019 the Company effected a 1 for 30 reverse stock split of the Company’s common stock. The par value and the authorized shares of the common and convertible preferred stock were not adjusted as a result of the reverse stock split. All common stock shares, equivalents, and per-share amounts for all periods presented in these consolidated financial statements have been adjusted retroactively to reflect the reverse stock split.   21000

1 for 30 reverse stock split

(i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020. 1200000

1.56

2.51

0.00

157

1.59

2.46

0.00

The 36-month term of the note receivable requires 18 payments of $138,889 followed by 18 payments of $194,444, with maturity of the note receivable on October 1, 2021.

915725

-3805000

-8634000

-1446000

-2967000

-324000

-280000

2500000

625000

624000

711000

676000

1000

500000

14. Subsequent Events   On November 1, 2019, the Company filed a Form S-1 Registration Statement with the United States Securities and Exchange Commission to distribute to holders of the Company’s common stock, Series B Preferred Stock, and holders of our May 2018 Warrants, as of the Record Date, non-transferable Subscription Rights to purchase Units at a price of $1,000 per Unit. The Subscription Rights will not be tradable. Each Unit consists of one share of our Preferred Stock and yet to be decided number of Warrants. The common stock to be issued upon conversion of the Preferred Stock or exercise of the Warrants, like our existing shares of common stock, will be traded on the NASDAQ Capital Market under the symbol “SINT.”

8000

400000000

Reclassification   Certain reclassifications were made to the nine months ended September 30, 2018, Statement of Operations to conform to the presentation for the nine months ended September 30, 2019, Statement of Operations. Research and development expenses in 2018 increased by $0.4, million offset by a decrease in general and administrative expenses by the same amount. The reclassification did not affect the 2018 net loss.

-0.59 -14.08 -0.07 -10.71 0.26 11.10 -0.59 -2.72 -0.07 -10.71

EX-101.SCH 6 sint-20190930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Organization and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Basic and Diluted Net Loss Per Common Share link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Note Receivable link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Basic and Diluted Net Loss Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Organization and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Basic and Diluted Net Loss Per Common Share (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Basic and Diluted Net Loss Per Common Share - Schedule of Basic and Diluted Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Inventories (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Inventories - Schedule of Components of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Fair Value Measurements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Fair Value Measurements - Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Hierarchy of Derivative Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Estimating Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Debt (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Note Receivable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Discontinued Operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Leases - Schedule of Operating Lease Future Minimum Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 sint-20190930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 sint-20190930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 sint-20190930_lab.xml XBRL LABEL FILE Indefinite Lived Intangible Assets By Major Class [Axis] Trademarks [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 1 [Member] Measurement Frequency [Axis] Fair Value, Measurements, Recurring [Member] Equity Components [Axis] Common Stock Warrants [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Debt Instrument [Axis] North Stadium Loan [Member] Related Party [Axis] North Stadium Investments, LLC [Member] Hercules Term Loan [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Loan and Security Agreement [Member] Valuation Approach and Technique [Axis] Monte Carlo Simulation Valuation Model [Member] Warrants [Member] Black-Scholes-Merton Valuation Model [Member] L2 Capital Debt [Member] Long-term Debt, Type [Axis] Senior Secured Convertible Promissory Notes One [Member] Senior Secured Convertible Promissory Notes Two [Member] Exchange Notes [Member] Award Date [Axis] Closing Date [Member] Preferred Stock [Member] Common Stock [Member] Convertible Preferred Stock and Warrants [Member] Sale of Stock [Axis] Public Offering [Member] Class of Stock [Axis] Series B Convertible Preferred Stock [Member] May 2018 Warrants [Member] MEF I, L.P. and Anson Investments [Member] August 2018 Warrant Exercise [Member] Secondary Offering [Member] July 2018 Warrant Exercise [Member] Public Offering [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] July Through December of 2018 [Member] Asset Purchase Agreement [Member] Receivable Type [Axis] Interest Note Receivable [Member] Short-term Debt, Type [Axis] Related Party Note Payable [Member] Series E Common Stock Purchase Warrant [Member] New Warrants [Member] Legal Entity [Axis] Retail Spine Business [Member] Warrant Derivative [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Scenario [Axis] Next Seven Months [Member] Following Eighteen Months [Member] Liability Class [Axis] Measurement Input Type [Axis] Weighted-Average Risk-Free Interest Rate [Member] Expected Dividend Yield [Member] Weighted-Average Expected Volatility [Member] May 2018 Warrant Exercise (July 2016 Warrants) [Member] Range [Axis] Minimum [Member] Maximum [Member] Equity Distribution Agreement [Member] ATM Equity Distribution Agreement [Member] Weighted-Average Expected Life (in years) [Member] Equipment Loan [Member] August 2019 Warrant Exercise (May 2018 Warrants) [Member] Holders [Member] Series B Preferred Stock [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Trade accounts receivable, net of allowance of $0 and $56, respectively Prepaid expenses and other current assets Inventories, net Notes receivable, current portion Total current assets Inventories, net Property and equipment, net Intangible assets, net Long-term note receivable, net of current portion Operating lease right-of-use-asset Other long-term assets Total assets Liabilities and stockholders' equity Current liabilities: Accounts payable Accrued liabilities Derivative liabilities, current portion Current portion of operating lease liability Current portion of debt Other current liabilities Total current liabilities Operating lease liability, net of current portion Derivative liabilities, net of current portion Long term debt Other long-term liabilities Total liabilities Commitments and contingencies Stockholders' equity: Convertible preferred stock, $0.01 par value, 130,000,000 shares authorized; 249 shares and 4,074 shares issued and outstanding at September 30, 2019 and December 31, 2018. Common stock, $0.01 par value, 250,000,000 shares authorized; 2,363,991 shares, and 726,455 shares issued and outstanding at September 30, 2019 and December 31, 2018. Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Allowance of trade accounts receivable Convertible preferred stock, par value Convertible preferred stock, shares authorized Convertible preferred stock, shares issued Convertible preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Product revenue Costs of revenue Gross profit Operating expenses: Research and development General and administrative Sales and marketing Goodwill impairment Total operating expenses Loss from operations Other income (expenses): Interest expense Interest income Change in fair value of derivative liabilities Loss on extinguishment of debt Offering costs Loss on extinguishment of derivative liabilities Other income, net Total other income, net Net loss from continuing operations before income taxes Provision for income taxes Loss from continuing operations Loss from discontinued operations Net loss Deemed dividend related to the beneficial conversion feature and accretion of a discount on series B preferred stock Net loss attributable to common stockholders Net loss per share - basic and diluted Basic - continuing operations Basic - discontinued operations Basic - deemed dividend and accretion of a discount on conversion of series B preferred stock Basic - attributable to common stockholders Diluted - continuing operations Diluted - discontinued operations Diluted - deemed dividend and accretion of a discount on conversion of series B preferred stock Diluted - attributable to common stockholders Weighted average common shares outstanding: Basic Diluted Statement [Table] Statement [Line Items] Balance Balance, shares Common stock issued from exercise of warrants Common stock issued from exercise of warrants, shares Issuance of common stock in exchange for reduction in debt Issuance of common stock in exchange for reduction in debt, shares Issuance of preferred stock from offering, net of issuance costs Issuance of preferred stock from offering, net of issuance costs, shares Warrants issued in association with debt Loss on extinguishment of derivative liabilities Deemed dividend related to adjustment of the exercise price of warrants issued with debt EX-101.PRE 10 sint-20190930_pre.xml XBRL PRESENTATION FILE XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 149 385 1 false 58 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://sintx.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://sintx.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://sintx.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://sintx.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://sintx.com/role/StatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://sintx.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://sintx.com/role/StatementsOfCashFlowsParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) Statements 7 false false R8.htm 00000008 - Disclosure - Organization and Summary of Significant Accounting Policies Sheet http://sintx.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies Organization and Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Basic and Diluted Net Loss Per Common Share Sheet http://sintx.com/role/BasicAndDilutedNetLossPerCommonShare Basic and Diluted Net Loss Per Common Share Notes 9 false false R10.htm 00000010 - Disclosure - Inventories Sheet http://sintx.com/role/Inventories Inventories Notes 10 false false R11.htm 00000011 - Disclosure - Intangible Assets Sheet http://sintx.com/role/IntangibleAssets Intangible Assets Notes 11 false false R12.htm 00000012 - Disclosure - Fair Value Measurements Sheet http://sintx.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 00000013 - Disclosure - Accrued Liabilities Sheet http://sintx.com/role/AccruedLiabilities Accrued Liabilities Notes 13 false false R14.htm 00000014 - Disclosure - Debt Sheet http://sintx.com/role/Debt Debt Notes 14 false false R15.htm 00000015 - Disclosure - Equity Sheet http://sintx.com/role/Equity Equity Notes 15 false false R16.htm 00000016 - Disclosure - Stock-Based Compensation Sheet http://sintx.com/role/Stock-basedCompensation Stock-Based Compensation Notes 16 false false R17.htm 00000017 - Disclosure - Commitments and Contingencies Sheet http://sintx.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 00000018 - Disclosure - Note Receivable Sheet http://sintx.com/role/NoteReceivable Note Receivable Notes 18 false false R19.htm 00000019 - Disclosure - Discontinued Operations Sheet http://sintx.com/role/DiscontinuedOperations Discontinued Operations Notes 19 false false R20.htm 00000020 - Disclosure - Leases Sheet http://sintx.com/role/Leases Leases Notes 20 false false R21.htm 00000021 - Disclosure - Subsequent Events Sheet http://sintx.com/role/SubsequentEvents Subsequent Events Notes 21 false false R22.htm 00000022 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) Sheet http://sintx.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies Organization and Summary of Significant Accounting Policies (Policies) Policies http://sintx.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies 22 false false R23.htm 00000023 - Disclosure - Basic and Diluted Net Loss Per Common Share (Tables) Sheet http://sintx.com/role/BasicAndDilutedNetLossPerCommonShareTables Basic and Diluted Net Loss Per Common Share (Tables) Tables http://sintx.com/role/BasicAndDilutedNetLossPerCommonShare 23 false false R24.htm 00000024 - Disclosure - Inventories (Tables) Sheet http://sintx.com/role/InventoriesTables Inventories (Tables) Tables http://sintx.com/role/Inventories 24 false false R25.htm 00000025 - Disclosure - Intangible Assets (Tables) Sheet http://sintx.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://sintx.com/role/IntangibleAssets 25 false false R26.htm 00000026 - Disclosure - Fair Value Measurements (Tables) Sheet http://sintx.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://sintx.com/role/FairValueMeasurements 26 false false R27.htm 00000027 - Disclosure - Accrued Liabilities (Tables) Sheet http://sintx.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://sintx.com/role/AccruedLiabilities 27 false false R28.htm 00000028 - Disclosure - Stock-Based Compensation (Tables) Sheet http://sintx.com/role/Stock-basedCompensationTables Stock-Based Compensation (Tables) Tables http://sintx.com/role/Stock-basedCompensation 28 false false R29.htm 00000029 - Disclosure - Leases (Tables) Sheet http://sintx.com/role/LeasesTables Leases (Tables) Tables http://sintx.com/role/Leases 29 false false R30.htm 00000030 - Disclosure - Organization and Summary of Significant Accounting Policies (Details Narrative) Sheet http://sintx.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Organization and Summary of Significant Accounting Policies (Details Narrative) Details http://sintx.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies 30 false false R31.htm 00000031 - Disclosure - Basic and Diluted Net Loss Per Common Share (Details Narrative) Sheet http://sintx.com/role/BasicAndDilutedNetLossPerCommonShareDetailsNarrative Basic and Diluted Net Loss Per Common Share (Details Narrative) Details http://sintx.com/role/BasicAndDilutedNetLossPerCommonShareTables 31 false false R32.htm 00000032 - Disclosure - Basic and Diluted Net Loss Per Common Share - Schedule of Basic and Diluted Loss Per Share (Details) Sheet http://sintx.com/role/BasicAndDilutedNetLossPerCommonShare-ScheduleOfBasicAndDilutedLossPerShareDetails Basic and Diluted Net Loss Per Common Share - Schedule of Basic and Diluted Loss Per Share (Details) Details 32 false false R33.htm 00000033 - Disclosure - Inventories (Details Narrative) Sheet http://sintx.com/role/InventoriesDetailsNarrative Inventories (Details Narrative) Details http://sintx.com/role/InventoriesTables 33 false false R34.htm 00000034 - Disclosure - Inventories - Schedule of Components of Inventory (Details) Sheet http://sintx.com/role/Inventories-ScheduleOfComponentsOfInventoryDetails Inventories - Schedule of Components of Inventory (Details) Details 34 false false R35.htm 00000035 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details) Sheet http://sintx.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails Intangible Assets - Schedule of Intangible Assets (Details) Details 35 false false R36.htm 00000036 - Disclosure - Fair Value Measurements (Details Narrative) Sheet http://sintx.com/role/FairValueMeasurementsDetailsNarrative Fair Value Measurements (Details Narrative) Details http://sintx.com/role/FairValueMeasurementsTables 36 false false R37.htm 00000037 - Disclosure - Fair Value Measurements - Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy (Details) Sheet http://sintx.com/role/FairValueMeasurements-ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails Fair Value Measurements - Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy (Details) Details 37 false false R38.htm 00000038 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Hierarchy of Derivative Liability (Details) Sheet http://sintx.com/role/FairValueMeasurements-ScheduleOfFairValueMeasurementHierarchyOfDerivativeLiabilityDetails Fair Value Measurements - Schedule of Fair Value Measurement Hierarchy of Derivative Liability (Details) Details 38 false false R39.htm 00000039 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Estimating Fair Value (Details) Sheet http://sintx.com/role/FairValueMeasurements-ScheduleOfAssumptionsUsedInEstimatingFairValueDetails Fair Value Measurements - Schedule of Assumptions Used in Estimating Fair Value (Details) Details 39 false false R40.htm 00000040 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details) Sheet http://sintx.com/role/AccruedLiabilities-ScheduleOfAccruedLiabilitiesDetails Accrued Liabilities - Schedule of Accrued Liabilities (Details) Details 40 false false R41.htm 00000041 - Disclosure - Debt (Details Narrative) Sheet http://sintx.com/role/DebtDetailsNarrative Debt (Details Narrative) Details http://sintx.com/role/Debt 41 false false R42.htm 00000042 - Disclosure - Equity (Details Narrative) Sheet http://sintx.com/role/EquityDetailsNarrative Equity (Details Narrative) Details http://sintx.com/role/Equity 42 false false R43.htm 00000043 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) Sheet http://sintx.com/role/Stock-basedCompensation-SummaryOfStockOptionActivityDetails Stock-Based Compensation - Summary of Stock Option Activity (Details) Details 43 false false R44.htm 00000044 - Disclosure - Note Receivable (Details Narrative) Sheet http://sintx.com/role/NoteReceivableDetailsNarrative Note Receivable (Details Narrative) Details http://sintx.com/role/NoteReceivable 44 false false R45.htm 00000045 - Disclosure - Discontinued Operations (Details Narrative) Sheet http://sintx.com/role/DiscontinuedOperationsDetailsNarrative Discontinued Operations (Details Narrative) Details http://sintx.com/role/DiscontinuedOperations 45 false false R46.htm 00000046 - Disclosure - Leases (Details Narrative) Sheet http://sintx.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://sintx.com/role/LeasesTables 46 false false R47.htm 00000047 - Disclosure - Leases - Schedule of Operating Lease Future Minimum Payments (Details) Sheet http://sintx.com/role/Leases-ScheduleOfOperatingLeaseFutureMinimumPaymentsDetails Leases - Schedule of Operating Lease Future Minimum Payments (Details) Details 47 false false R48.htm 00000048 - Disclosure - Subsequent Events (Details Narrative) Sheet http://sintx.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://sintx.com/role/SubsequentEvents 48 false false All Reports Book All Reports sint-20190930.xml sint-20190930.xsd sint-20190930_cal.xml sint-20190930_def.xml sint-20190930_lab.xml sint-20190930_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 12 R33.htm IDEA: XBRL DOCUMENT

Inventories (Details Narrative) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Inventories, current	$ 86	$ 52
Inventories, non - current	$ 625	$ 624

XML 13 R37.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy (Details) - Fair Value, Measurements, Recurring [Member] - Common Stock Warrants [Member] - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	$ 769	$ 1,566
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	$ 769	$ 1,566

XML 14 R18.htm IDEA: XBRL DOCUMENT

Note Receivable

9 Months Ended

Sep. 30, 2019

Receivables [Abstract]

Note Receivable

11. Note Receivable

XML 15 R14.htm IDEA: XBRL DOCUMENT

Debt

9 Months Ended

Sep. 30, 2019

Debt Disclosure [Abstract]

Debt

7. Debt

L2 Capital Debt

Hercules and MEF I, LP/Anson Investments Debt Exchange

On May 14, 2018, the Company closed on an underwritten public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million. Part of the proceeds from this offering were used to pay off the outstanding debt with MEF I, L.P and Anson Investments. The total payoff was $1.6 million, with $1.4 million in principal and $0.2 million in interest.

North Stadium Term Loan – Related Party

Hercules Term Loan

Equipment Loan

XML 16 R10.htm IDEA: XBRL DOCUMENT

Inventories

9 Months Ended

Sep. 30, 2019

Inventory Disclosure [Abstract]

Inventories

3. Inventories

Inventories consisted of the following (in thousands):

	September 30, 2019		December 31, 2018
Raw materials	$	625	$	624
Intermediate goods		16		-
WIP		70		47
Finished goods		-		5
	$	711	$	676

EXCEL 17 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 18 R5.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands

Preferred Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Accumulated Deficit [Member]

Total

Balance at Dec. 31, 2017 $ 1 $ 226,070 $ (220,629) $ 5,442

Balance, shares at Dec. 31, 2017 100,935

Common stock issued from exercise of warrants 1,653 1,653

Common stock issued from exercise of warrants, shares 36,205

Issuance of common stock in exchange for reduction in debt 1,453 1,453

Issuance of common stock in exchange for reduction in debt, shares 19,348

Issuance of preferred stock from offering, net of issuance costs 6,748 6,748

Issuance of preferred stock from offering, net of issuance costs, shares 15,000

Warrants issued in association with debt 98 98

Loss on extinguishment of derivative liabilities 1,040 1,040

Deemed dividend related to adjustment of the exercise price of warrants issued with debt (9) (9)

Accretion of change in warrant exercise price 9 9

Common stock issued due to conversion of preferred stock $ 5 (5)

Common stock issued due to conversion of preferred stock, shares (10,598) 544,911

Accretion of convertible preferred stock discount 13,687 13,687

Deemed dividend related to the issuance of preferred stock (13,687) (13,687)

Extinguishment of derivative liabilities 575 575

Stock-based compensation 39 39

Net loss (8,958) (8,958)

Balance at Sep. 30, 2018 $ 6 237,671 (229,587) 8,090

Balance, shares at Sep. 30, 2018 4,402 701,399

Balance at Dec. 31, 2018 $ 7 237,673 (229,281) 8,399

Balance, shares at Dec. 31, 2018 4,074 726,455

Common stock issued from exercise of warrants 103 103

Common stock issued from exercise of warrants, shares 35,874

Issuance of common stock in exchange for reduction in debt

Common stock issued due to conversion of preferred stock $ 12 (12)

Common stock issued due to conversion of preferred stock, shares (3,825) 1,143,784

Stock-based compensation 2 2

Common Stock Issued for Cash $ 5 1,280 $ 1,285

Common Stock Issued for Cash, shares 457,878 457,878

Removal of derivative liability upon exercise of warrant 44 $ 44

Net loss (3,805) (3,805)

Balance at Sep. 30, 2019 $ 24 $ 239,090 $ (233,086) $ 6,028

Balance, shares at Sep. 30, 2019 249 2,363,991

X

- Definition
Accretion of change in warrant exercise price.
+ References
No definition available.
+ Details

Name: SINT_AccretionOfChangeInWarrantExercisePrice

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Accretion of convertible preferred stock discount.
+ References
No definition available.
+ Details

Name: SINT_AdjustmentToAdditionalPaidInCapitalAccretionOfConvertiblePreferredStockDiscount

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Deemed dividend related to adjustment of the exercise price of warrants issued with debt.
+ References
No definition available.
+ Details

Name: SINT_AdjustmentToAdditionalPaidInCapitalDeemedDividendRelatedToAdjustmentOfExercisePriceOfWarrantsIssuedWithDebt

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Deemed dividend related to the issuance of preferred stock.
+ References
No definition available.
+ Details

Name: SINT_AdjustmentToAdditionalPaidInCapitalDeemedDividendRelatedToIssuanceOfPreferredStock

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Removal of derivative liability upon Exercise of warrant.
+ References
No definition available.
+ Details

Name: SINT_AdjustmentToAdditonalPaidInCapitalRemovalOfDerivativeLiabilityUponExerciseOfWarrant

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Adjustments to additional paid in capital related to (gain) loss on extinguishment of derivative liability.
+ References
No definition available.
+ Details

Name: SINT_AdjustmentsToAdditionalPaidInCapitalRelatedToGainLossOnExtinguishmentOfDerivativeLiability

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Common stock issued from exercise of warrants.
+ References
No definition available.
+ Details

Name: SINT_CommonStockIssuedFromExerciseOfWarrants

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Common stock issued from exercise of warrants, shares.
+ References
No definition available.
+ Details

Name: SINT_CommonStockIssuedFromExerciseOfWarrantsShares

Namespace Prefix: SINT_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Extinguishment of derivative liabilities.
+ References
No definition available.
+ Details

Name: SINT_ExtinguishmentOfDerivativeLiabilities

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Issuance of common stock in exchange for reduction in debt.
+ References
No definition available.
+ Details

Name: SINT_IssuanceOfCommonStockInExchangeForReductionInDebt

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Issuance of common stock in exchange for reduction in debt, shares.
+ References
No definition available.
+ Details

Name: SINT_IssuanceOfCommonStockInExchangeForReductionInDebtShares

Namespace Prefix: SINT_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Issuance of preferred stock from offering, net of issuance costs.
+ References
No definition available.
+ Details

Name: SINT_IssuanceOfPreferredStockFromOfferingNetOfIssuanceCosts

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Issuance of preferred stock from offering, net of issuance costs, shares.
+ References
No definition available.
+ Details

Name: SINT_IssuanceOfPreferredStockFromOfferingNetOfIssuanceCostsShares

Namespace Prefix: SINT_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 25
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109126253&loc=d3e4724-112606

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The gross value of stock issued during the period upon the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 19 R26.htm IDEA: XBRL DOCUMENT v3.19.3

Fair Value Measurements (Tables)
9 Months Ended

Sep. 30, 2019

Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy

The following tables set forth the financial liabilities measured at fair value on a recurring basis by level within the fair value hierarchy as of September 30, 2019 and December 31, 2018:

Fair Value Measurements as of September 30, 2019

Description Level 1 Level 2 Level 3 Total

Derivative liability

Common stock warrants $ - $ - $ 769 $ 769

Fair Value Measurements as of December 31, 2018

Description Level 1 Level 2 Level 3 Total

Derivative liability

Common stock warrants $ - $ - $ 1,566 $ 1,566

Schedule of Fair Value Measurement Hierarchy of Derivative Liability

The Company did not have any transfers of assets and liabilities between Level 1 and Level 2 of the fair value measurement hierarchy during the nine months ended September 30, 2019 and 2018.

Common Stock
Warrants

Balance at December 31, 2017 $ (1,357 )

Issuances of warrants classified as derivatives (7,577 )

Change in fair value 6,500

Exercise of warrants 575

Other, net (212 )

Balance at September 30, 2018 $ (2,071 )

Balance at December 31, 2018 $ (1,566 )

Change in fair value 754

Exercise of warrants 44

Other, net (1 )

Balance at September 30, 2019 $ (769 )

Black-Scholes-Merton Valuation Model [Member]

Schedule of Assumptions Used in Estimating Fair Value

The assumptions used in estimating the common stock warrant liability using the Black-Scholes-Merton valuation model as of September 30, 2019 and December 31, 2018 were as follows:

September 30, 2019 December 31, 2018

Weighted-average risk-free interest rate 1.56 % 2.51 %

Weighted-average expected life (in years) 3.61 0.9

Expected dividend yield - % - %

Weighted-average expected volatility 64 % 157 %

Monte Carlo Simulation Valuation Model [Member]

Schedule of Assumptions Used in Estimating Fair Value

The assumptions used in estimating the common stock warrant liability using the Monte Carlo Simulation valuation model at September 30, 2019 and December 31, 2018 were as follows:

September 30, 2019 December 31, 2018

Weighted-average risk-free interest rate 1.59 % 2.46 %

Weighted-average expected life (in years) 2.16 3.1

Expected dividend yield - % - %

Weighted average expected volatility 65 % 68 %

X

- Definition
Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258
+ Details

Name: us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (k)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920
+ Details

Name: us-gaap_ScheduleOfAssumptionsUsedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ValuationTechniqueAxis=SINT_BlackScholesMertonValuationModelMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=SINT_MonteCarloSimulationValuationModelMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 20 R1.htm IDEA: XBRL DOCUMENT v3.19.3

Document and Entity Information - shares
9 Months Ended

Sep. 30, 2019

Nov. 12, 2019

Document And Entity Information

Entity Registrant Name Sintx Technologies, Inc.

Entity Central Index Key 0001269026

Document Type 10-Q

Document Period End Date Sep. 30, 2019

Amendment Flag false

Current Fiscal Year End Date --12-31

Entity Current Reporting Status Yes

Entity Interactive Data Current Yes

Entity Filer Category Non-accelerated Filer

Entity Small Business Flag true

Entity Emerging Growth Company false

Entity Ex Transition Period false

Entity Shell Company false

Entity Common Stock, Shares Outstanding 2,434,008

Document Fiscal Period Focus Q3

Document Fiscal Year Focus 2019

X

- References
No definition available.
+ Details

Name: SINT_DocumentAndEntityInformationAbstract

Namespace Prefix: SINT_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details

Name: dei_EntityExTransitionPeriod

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-T
-Number 232
-Section 405
+ Details

Name: dei_EntityInteractiveDataCurrent

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityShellCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a Smaller Reporting Company (SRC).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

XML 21 R22.htm IDEA: XBRL DOCUMENT v3.19.3

Organization and Summary of Significant Accounting Policies (Policies)
9 Months Ended

Sep. 30, 2019

Accounting Policies [Abstract]

Organization

Organization

SINTX Technologies, Inc. (“SINTX” or “the Company”) (previously known as Amedica Corporation) was incorporated in the state of Delaware on December 10, 1996. SINTX is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The Company believes it is the first and only manufacturer to use silicon nitride in medical applications. The Company acquired US Spine, Inc. (“US Spine”), a Delaware spinal products corporation with operations in Florida, on September 20, 2010. The Company’s products are primarily sold in the United States.

As further explained in Note 12, On October 1, 2018, the Company completed the sale of its retail spine business to CTL Medical, a Dallas, Texas-based privately held medical device manufacturer. As a result of the sale, CTL Medical is now the exclusive owner of SINTX’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies. Manufacturing, R&D, and all intellectual property related to the core, non-spine, biomaterial technology of silicon nitride remains with the Company. The Company will serve as CTL’s exclusive OEM provider of silicon nitride products.

On October 30, 2018, the Company amended its Certificate of Incorporation with the State of Delaware to change its corporate name to SINTX Technologies, Inc. in order to better reflect its focus on silicon nitride science and technologies and pipeline of silicon nitride-based products in various biomedical applications. The Company also changed its trading symbol on the NASDAQ Capital Market to “SINT”. The Company also changed the name of its wholly owned subsidiary US Spine, Inc. to “ST Sub, Inc.”

The previous name, Amedica, has transferred to CTL Medical, which is now CTL-Amedica. The Company’s new corporate brand reflects both the Company’s core competence in the science and production of silicon nitride ceramics, as well as encouraging prospects for the future, as an OEM supplier of spine implants to CTL-Amedica, and several opportunities outside of spine. The Company will focus on developing silicon nitride in terms of product design, and future biomaterial formulations, for a variety of OEM customers.

Reverse Stock Split
Reverse Stock Split

On July 26, 2019 the Company effected a 1 for 30 reverse stock split of the Company’s common stock. The par value and the authorized shares of the common and convertible preferred stock were not adjusted as a result of the reverse stock split. All common stock shares, equivalents, and per-share amounts for all periods presented in these consolidated financial statements have been adjusted retroactively to reflect the reverse stock split.

Basis of Presentation

Basis of Presentation

These unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and include all assets and liabilities of the Company and its wholly owned subsidiary, ST Sub, Inc. All material intercompany transactions and balances have been eliminated in consolidation. SEC rules and regulations allow the omission of certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, so long as the statements are not misleading. In the opinion of management, these financial statements and accompanying notes contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position and results of operations for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on March 11, 2019. The results of operations for the nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the year ending December 31, 2019. The Company’s significant accounting policies are set forth in Note 1 to the consolidated financial statements in its Annual Report on Form 10-K for the year ended December 31, 2018.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the periods then ended. Actual results could differ from those estimates. The most significant estimates relate to inventory, long-lived and intangible assets and the liability for preferred stock and common stock warrants.

Liquidity and Capital Resources

Liquidity and Capital Resources

The condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern within one year from the date of issuance of these condensed consolidated financial statements.

For the nine months ended September 30, 2019 and 2018, the Company incurred net losses from continuing operations of approximately $3.8 million and $8.6 million, respectively, and used cash in continuing operations of approximately $4.3 million and $7.7 million, respectively. The Company had an accumulated deficit of approximately $233 million and $229 million as of September 30, 2019 and December 31, 2018, respectively. To date, the Company’s operations have been principally financed by proceeds received from the issuance of preferred and common stock, convertible debt and bank debt and, to a lesser extent, cash generated from product sales. It is anticipated that the Company will continue to generate operating losses and use cash in operating activities. The Company’s continuation as a going concern is dependent upon its ability to increase sales and/or raise additional funds through the capital markets. Whether and when the Company can attain profitability and positive cash flows from operating activities or obtain additional financing is uncertain.

The Company is actively generating additional scientific and clinical data confirming the beneficial attributes of silicon nitride and intends to publish the results in leading industry publications. The unique features of the Company’s silicon nitride material are not well known, and the Company believes that the publication of such data would help sales efforts as the Company approaches new prospects. The Company is also making additional changes to the sales strategy, including a focus on revenue growth by expanding the use of silicon nitride in other areas outside of spinal fusion applications.

The Company has common stock that is publicly traded and has been able to successfully raise capital when needed since the date of the Company’s initial public offering in February 2014. In March 2018, the Company closed on gross proceeds of $1.4 million, before payment of placement agent fees and costs on a warrant reprice and exercise transaction. Additionally, on May 14, 2018, the Company closed on a public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15 million, which excludes underwriting discounts and commissions and offering expenses payable by the Company. On June 4, 2019, the Company entered into an Equity Distribution Agreement, (the “Distribution Agreement”), with Maxim Group LLC (“Maxim”), pursuant to which the Company may sell from time to time, shares of its common stock, having an aggregate offering price of up to $1.6 million through Maxim, as agent (the “ATM Offering”). On September 12, 2019, the Company entered into an amendment to the Distribution Agreement with Maxim, which increased the maximum aggregate offering price of the shares of the Company’s common stock from $1.6 million to $2.5 million. Subject to the terms and conditions of the Distribution Agreement, Maxim will use its commercially reasonable efforts to sell the shares from time to time, based on the Company’s instructions. The Company has no obligation to sell any of the shares and may at any time suspend offers under the Distribution Agreement. The Offering will terminate upon the earlier of (i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020. The Company agrees to pay Maxim a transaction fee at a fixed rate of 4.25% of the gross sales price of shares sold under the Distribution Agreement and agreed to provide indemnification and contribution to Maxim with respect to certain liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2019 the Company raised approximately $1.3 million, net of fees, through the issuance of 457,878 shares of common stock under the Distribution Agreement with Maxim. The Company is eligible to raise an additional $1.2 million under this offering. In addition, during the nine months ended September 30, 2019, the Company converted 3,825 shares of preferred stock into 1,143,784 shares of common stock. The Company is engaged in discussions with investment and banking firms to examine financing alternatives, including options for a public offering of the Company’s preferred or common stock. On October 1, 2018, the Company sold the retail spine business. This sale will continue to provide cash flows from November 2019 totaling $1.0 million over the next seven months and $3.5 million for the following 18 months. The buyer also assumed the Company’s $2.5 million related party note payable.

Although the Company is seeking to obtain additional equity and/or debt financing, such funding is not assured and may not be available to the Company on favorable or acceptable terms and may involve significant restrictive covenants. Any additional equity financing is also not assured and, if available to the Company, will most likely be dilutive to its current stockholders. If the Company is not able to obtain additional debt or equity financing on a timely basis, the impact on the Company will be material and adverse.

These uncertainties create substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Significant Accounting Policies

Significant Accounting Policies

Except as explained below, no material changes were made to the Company’s significant accounting policies as described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

Accounting Pronouncements Adopted During the Quarter Ended March 31, 2019

Accounting Pronouncements Adopted During the Nine Months Ended September 30, 2019

In August 2016, the FASB updated accounting guidance on the following eight specific cash flow classification issues: (1) debt prepayment or debt extinguishment costs; (2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; (3) contingent consideration payments made after a business combination; (4) proceeds from the settlement of insurance claims; (5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (6) distributions received from equity method investees; (7) beneficial interests in securitization transactions; and (8) separately identifiable cash flows and application of the predominance principle. Under prior U.S. GAAP, there was no specific guidance on the eight cash flow classification issues aforementioned. The Company adopted the new guidance effective January 1, 2019. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.

In February 2016, the FASB updated the accounting guidance related to leases as part of a joint project with the International Accounting Standards Board (“IASB”) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The Company adopted the new guidance effective January 1, 2019 (see Note 13), using the modified retrospective approach. Adoption of the new guidance resulted in the Company being required to record an additional operating lease right-of-use asset totaling approximately $0.7 million and liability totaling approximately $0.9 million (with $0.7 million incremental to adoption of the new guidance) on the date of adoption. Subsequent to the initial adoption of the new standard the Company amended the lease (see Note 13). The standard did not materially impact the consolidated net loss and had no impact on cash flows.

In May 2014, in addition to several amendments issued during 2016, the FASB updated the accounting guidance related to revenue from contracts with customers, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The Company adopted the new guidance effective January 1, 2019. The core principle of the new guidance is that a company should recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. The standard defines a five-step process to achieve this core principle and, in doing so, more judgment and estimates are often required within the revenue recognition process than were required under prior U.S. GAAP. The Company has one primary customer (see Note 12) and related contract that has one performance obligation to which revenue is allocated. Revenue under this contract is recognized when the product is shipped to the customer. The Company generally bills its customer upon shipment of the product and invoices are generally due within 30 days. The Company does provide certain rights of return, which historically have not been significant. The Company does not anticipate incurring significant incremental costs to obtain contracts with future customers. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.

New Accounting Pronouncements Not Yet Adopted

New Accounting Pronouncements Not Yet Adopted

The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that no other pronouncements will have a significant effect on its financial statements.

Reclassification

Reclassification

Certain reclassifications were made to the nine months ended September 30, 2018, Statement of Operations to conform to the presentation for the nine months ended September 30, 2019, Statement of Operations. Research and development expenses in 2018 increased by $0.4, million offset by a decrease in general and administrative expenses by the same amount. The reclassification did not affect the 2018 net loss.

X

- Definition
Liquidity and capital resources [Policy Text Block]
+ References
No definition available.
+ Details

Name: SINT_LiquidityAndCapitalResourcePolicyTextblock

Namespace Prefix: SINT_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
New Accounting Pronouncements Not Yet Adopted [Policy Text Block]
+ References
No definition available.
+ Details

Name: SINT_NewAccountingPronouncementsNotYetAdoptedPolicyTextBlock

Namespace Prefix: SINT_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Organization [Policy Text Block]
+ References
No definition available.
+ Details

Name: SINT_OrganizationPolicytextBlock

Namespace Prefix: SINT_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Reverse stock split [Policy Text Block]
+ References
No definition available.
+ Details

Name: SINT_ReverseStockSplitPolicyTextBlock

Namespace Prefix: SINT_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Significant Accounting Policies [Policy Text Block]
+ References
No definition available.
+ Details

Name: SINT_SignificantAccountingPoliciesPolicyTextBlock

Namespace Prefix: SINT_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755
+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustmentDescription

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.19.3

Basic and Diluted Net Loss Per Common Share
9 Months Ended

Sep. 30, 2019

Earnings Per Share [Abstract]

Basic and Diluted Net Loss Per Common Share

2. Basic and Diluted Net Loss per Common Share

Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share is calculated by dividing the net loss by the weighted-average number of common share equivalents outstanding for the period that are determined to be dilutive. Common stock equivalents are primarily comprised of preferred stock, warrants for the purchase of common stock and stock options. The Company had potentially dilutive securities, totaling approximately 0.5 million and 0.8 million as of September 30, 2019 and 2018, respectively.

Below are basic and diluted loss per share data for the three months ended September 30, 2019, which are in thousands except for share and per share data:

Basic Calculation
Effect of

Dilutive
Warrant
Securities
Diluted Calculation

Numerator:

Loss from continuing operations $ (1,446 ) $ (144 ) $ (1,590 )

Deemed dividend and accretion of a discount (345 ) - (345 )

Net loss attributable to common stockholders $ (1,791 ) $ (144 ) $ (1,935 )

Denominator:

Number of shares used in per common share calculations: 2,127,293 - 2,127,293

Net loss per common share:

Loss from continuing operations $ (0.68 ) $ (0.07 ) $ (0.75 )

Deemed dividend and accretion of a discount (0.16 ) - (0.16 )

Net loss attributable to common stockholders $ (0.84 ) $ (0.07 ) $ (0.91 )

Below are basic and diluted loss per share data for the nine months ended September 30, 2019, which are in thousands except for share and per share data:

Basic Calculation
Effect of

Dilutive
Warrant
Securities
Diluted Calculation

Numerator:

Loss from continuing operations $ (3,805 ) $ (753 ) $ (4,558 )

Deemed dividend and accretion of a discount (2,703 ) - (2,703 )

Net loss attributable to common stockholders $ (6,508 ) $ (753 ) $ (7,261 )

Denominator:

Number of shares used in per common share calculations: 1,269,106 - 1,269,106

Net loss per common share:

Loss from continuing operations $ (3.00 ) $ (0.59 ) $ (3.59 )

Deemed dividend and accretion of a discount (2.13 ) - (2.13 )

Net loss attributable to common stockholders $ (5.13 ) $ (0.59 ) $ (5.72 )

Below are basic and diluted loss per share data for the three months ended September 30, 2018, which are in thousands except for share and per share data:

Basic Calculation Effect of Dilutive
Warrant
Securities Diluted Calculation

Numerator:

Loss from continuing operations $ (2,967 ) $ (4,485 ) $ (7,452 )

Income from discontinued operations (280 ) - (280 )

Deemed dividend and accretion of a discount (6,353 ) - (6,353 )

Net loss attributable to common stockholders $ (9,600 ) $ (4,485 ) $ (14,085 )

Denominator:

Number of shares used in per common share calculations: 418,638 54 418,692

Net loss per common share:

Loss from continuing operations $ (7.09 ) $ (10.71 ) $ (17.80 )

Loss from discontinued operations (0.67 ) - (0.67 )

Deemed dividend and accretion of a discount (15.17 ) - (15.17 )

Net loss attributable to common stockholders $ (22.93 ) $ (10.71 ) $ (33.64 )

Below are basic and diluted loss per share data for the nine months ended September 30, 2018, which are in thousands except for share and per share data:

Basic Calculation Effect of Dilutive
Warrant
Securities Diluted Calculation

Numerator:

Loss from continuing operations $ (8,634 ) $ (6,396 ) $ (15,030 )

Income from discontinued operations (324 ) - (324 )

Deemed dividend and accretion of a discount (13,686 ) - (13,686 )

Net loss attributable to common stockholders $ (22,644 ) $ (6,396 ) $ (29,040 )

Denominator:

Number of shares used in per common share calculations: 243,543 59,933 303,476

Net loss per common share:

Loss from continuing operations $ (35.45 ) $ (14.08 ) $ (49.53 )

Loss from discontinued operations (1.33 ) 0.26 (1.07 )

Deemed dividend and accretion of a discount (56.20 ) 11.10 (45.10 )

Net loss attributable to common stockholders $ (92.98 ) $ (2.72 ) $ (95.70 )

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-URI http://asc.fasb.org/topic&trid=2144383
+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 23 R43.htm IDEA: XBRL DOCUMENT v3.19.3

Stock-Based Compensation - Summary of Stock Option Activity (Details)
9 Months Ended

Sep. 30, 2019

USD ($)

$ / shares

shares

Share-based Payment Arrangement [Abstract]

Options, Outstanding at beginning of period | shares 377

Options, Granted | shares

Options, Exercised | shares

Options, Forfeited | shares

Options, Expired | shares

Options, Outstanding at end of period | shares 377

Options, Exercisable at end of period | shares 377

Weighted Average Exercise Price, Outstanding at beginning of period | $ / shares $ 7,653

Weighted Average Exercise Price, Granted | $ / shares

Weighted Average Exercise Price, Exercised | $ / shares

Weighted Average Exercise Price, Forfeited | $ / shares

Weighted Average Exercise Price, Expired | $ / shares

Weighted Average Exercise Price, Outstanding at end of period | $ / shares 7,653

Weighted Average Exercise Price, Exercisable at end of period | $ / shares $ 7,653

Weighted Average Remaining Contractual Terms (Years), Outstanding at beginning 6 years

Weighted Average Remaining Contractual Terms (Years), Outstanding at ending 5 years 7 months 6 days

Weighted Average Remaining Contractual Terms (Years), Exercisable 5 years 7 months 6 days

Intrinsic Value, Outstanding at beginning of period | $

Intrinsic Value, Outstanding at end of period | $

Intrinsic Value, Exercisable at end of period | $

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: SINT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm

Namespace Prefix: SINT_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(4)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Net number of share options (or share units) granted during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 24 R47.htm IDEA: XBRL DOCUMENT v3.19.3

Leases - Schedule of Operating Lease Future Minimum Payments (Details) - USD ($)
$ in Thousands

Sep. 30, 2019

Jan. 02, 2019

Dec. 31, 2018

Leases [Abstract]

2019 $ 245

2020 494

2021 509

2022 525

2023 540

Thereafter 556

Total future minimum lease payments 2,869

Less amounts representing interests (435)

Present value of lease liability 2,343 $ 900

Current-portion of operating lease liability 475 $ 169

Long-term portion operating lease liability $ 1,959

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 25 R8.htm IDEA: XBRL DOCUMENT v3.19.3

Organization and Summary of Significant Accounting Policies
9 Months Ended

Sep. 30, 2019

Accounting Policies [Abstract]

Organization and Summary of Significant Accounting Policies

1. Organization and Summary of Significant Accounting Policies

Organization

SINTX Technologies, Inc. (“SINTX” or “the Company”) (previously known as Amedica Corporation) was incorporated in the state of Delaware on December 10, 1996. SINTX is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The Company believes it is the first and only manufacturer to use silicon nitride in medical applications. The Company acquired US Spine, Inc. (“US Spine”), a Delaware spinal products corporation with operations in Florida, on September 20, 2010. The Company’s products are primarily sold in the United States.

As further explained in Note 12, On October 1, 2018, the Company completed the sale of its retail spine business to CTL Medical, a Dallas, Texas-based privately held medical device manufacturer. As a result of the sale, CTL Medical is now the exclusive owner of SINTX’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies. Manufacturing, R&D, and all intellectual property related to the core, non-spine, biomaterial technology of silicon nitride remains with the Company. The Company will serve as CTL’s exclusive OEM provider of silicon nitride products.

On October 30, 2018, the Company amended its Certificate of Incorporation with the State of Delaware to change its corporate name to SINTX Technologies, Inc. in order to better reflect its focus on silicon nitride science and technologies and pipeline of silicon nitride-based products in various biomedical applications. The Company also changed its trading symbol on the NASDAQ Capital Market to “SINT”. The Company also changed the name of its wholly owned subsidiary US Spine, Inc. to “ST Sub, Inc.”

The previous name, Amedica, has transferred to CTL Medical, which is now CTL-Amedica. The Company’s new corporate brand reflects both the Company’s core competence in the science and production of silicon nitride ceramics, as well as encouraging prospects for the future, as an OEM supplier of spine implants to CTL-Amedica, and several opportunities outside of spine. The Company will focus on developing silicon nitride in terms of product design, and future biomaterial formulations, for a variety of OEM customers.

Reverse Stock Split

On July 26, 2019 the Company effected a 1 for 30 reverse stock split of the Company’s common stock. The par value and the authorized shares of the common and convertible preferred stock were not adjusted as a result of the reverse stock split. All common stock shares, equivalents, and per-share amounts for all periods presented in these consolidated financial statements have been adjusted retroactively to reflect the reverse stock split.

Basis of Presentation

These unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and include all assets and liabilities of the Company and its wholly owned subsidiary, ST Sub, Inc. All material intercompany transactions and balances have been eliminated in consolidation. SEC rules and regulations allow the omission of certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, so long as the statements are not misleading. In the opinion of management, these financial statements and accompanying notes contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position and results of operations for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on March 11, 2019. The results of operations for the nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the year ending December 31, 2019. The Company’s significant accounting policies are set forth in Note 1 to the consolidated financial statements in its Annual Report on Form 10-K for the year ended December 31, 2018.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the periods then ended. Actual results could differ from those estimates. The most significant estimates relate to inventory, long-lived and intangible assets and the liability for preferred stock and common stock warrants.

Liquidity and Capital Resources

The condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern within one year from the date of issuance of these condensed consolidated financial statements.

For the nine months ended September 30, 2019 and 2018, the Company incurred net losses from continuing operations of approximately $3.8 million and $8.6 million, respectively, and used cash in continuing operations of approximately $4.3 million and $7.7 million, respectively. The Company had an accumulated deficit of approximately $233 million and $229 million as of September 30, 2019 and December 31, 2018, respectively. To date, the Company’s operations have been principally financed by proceeds received from the issuance of preferred and common stock, convertible debt and bank debt and, to a lesser extent, cash generated from product sales. It is anticipated that the Company will continue to generate operating losses and use cash in operating activities. The Company’s continuation as a going concern is dependent upon its ability to increase sales and/or raise additional funds through the capital markets. Whether and when the Company can attain profitability and positive cash flows from operating activities or obtain additional financing is uncertain.

The Company is actively generating additional scientific and clinical data confirming the beneficial attributes of silicon nitride and intends to publish the results in leading industry publications. The unique features of the Company’s silicon nitride material are not well known, and the Company believes that the publication of such data would help sales efforts as the Company approaches new prospects. The Company is also making additional changes to the sales strategy, including a focus on revenue growth by expanding the use of silicon nitride in other areas outside of spinal fusion applications.

The Company has common stock that is publicly traded and has been able to successfully raise capital when needed since the date of the Company’s initial public offering in February 2014. In March 2018, the Company closed on gross proceeds of $1.4 million, before payment of placement agent fees and costs on a warrant reprice and exercise transaction. Additionally, on May 14, 2018, the Company closed on a public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15 million, which excludes underwriting discounts and commissions and offering expenses payable by the Company. On June 4, 2019, the Company entered into an Equity Distribution Agreement, (the “Distribution Agreement”), with Maxim Group LLC (“Maxim”), pursuant to which the Company may sell from time to time, shares of its common stock, having an aggregate offering price of up to $1.6 million through Maxim, as agent (the “ATM Offering”). On September 12, 2019, the Company entered into an amendment to the Distribution Agreement with Maxim, which increased the maximum aggregate offering price of the shares of the Company’s common stock from $1.6 million to $2.5 million. Subject to the terms and conditions of the Distribution Agreement, Maxim will use its commercially reasonable efforts to sell the shares from time to time, based on the Company’s instructions. The Company has no obligation to sell any of the shares and may at any time suspend offers under the Distribution Agreement. The Offering will terminate upon the earlier of (i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020. The Company agrees to pay Maxim a transaction fee at a fixed rate of 4.25% of the gross sales price of shares sold under the Distribution Agreement and agreed to provide indemnification and contribution to Maxim with respect to certain liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2019 the Company raised approximately $1.3 million, net of fees, through the issuance of 457,878 shares of common stock under the Distribution Agreement with Maxim. The Company is eligible to raise an additional $1.2 million under this offering. In addition, during the nine months ended September 30, 2019, the Company converted 3,825 shares of preferred stock into 1,143,784 shares of common stock. The Company is engaged in discussions with investment and banking firms to examine financing alternatives, including options for a public offering of the Company’s preferred or common stock. On October 1, 2018, the Company sold the retail spine business. This sale will continue to provide cash flows from November 2019 totaling $1.0 million over the next seven months and $3.5 million for the following 18 months. The buyer also assumed the Company’s $2.5 million related party note payable.

Although the Company is seeking to obtain additional equity and/or debt financing, such funding is not assured and may not be available to the Company on favorable or acceptable terms and may involve significant restrictive covenants. Any additional equity financing is also not assured and, if available to the Company, will most likely be dilutive to its current stockholders. If the Company is not able to obtain additional debt or equity financing on a timely basis, the impact on the Company will be material and adverse.

These uncertainties create substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Significant Accounting Policies

Except as explained below, no material changes were made to the Company’s significant accounting policies as described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

Accounting Pronouncements Adopted During the Nine Months Ended September 30, 2019

In August 2016, the FASB updated accounting guidance on the following eight specific cash flow classification issues: (1) debt prepayment or debt extinguishment costs; (2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; (3) contingent consideration payments made after a business combination; (4) proceeds from the settlement of insurance claims; (5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (6) distributions received from equity method investees; (7) beneficial interests in securitization transactions; and (8) separately identifiable cash flows and application of the predominance principle. Under prior U.S. GAAP, there was no specific guidance on the eight cash flow classification issues aforementioned. The Company adopted the new guidance effective January 1, 2019. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.

In February 2016, the FASB updated the accounting guidance related to leases as part of a joint project with the International Accounting Standards Board (“IASB”) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The Company adopted the new guidance effective January 1, 2019 (see Note 13), using the modified retrospective approach. Adoption of the new guidance resulted in the Company being required to record an additional operating lease right-of-use asset totaling approximately $0.7 million and liability totaling approximately $0.9 million (with $0.7 million incremental to adoption of the new guidance) on the date of adoption. Subsequent to the initial adoption of the new standard the Company amended the lease (see Note 13). The standard did not materially impact the consolidated net loss and had no impact on cash flows.

In May 2014, in addition to several amendments issued during 2016, the FASB updated the accounting guidance related to revenue from contracts with customers, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The Company adopted the new guidance effective January 1, 2019. The core principle of the new guidance is that a company should recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. The standard defines a five-step process to achieve this core principle and, in doing so, more judgment and estimates are often required within the revenue recognition process than were required under prior U.S. GAAP. The Company has one primary customer (see Note 12) and related contract that has one performance obligation to which revenue is allocated. Revenue under this contract is recognized when the product is shipped to the customer. The Company generally bills its customer upon shipment of the product and invoices are generally due within 30 days. The Company does provide certain rights of return, which historically have not been significant. The Company does not anticipate incurring significant incremental costs to obtain contracts with future customers. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.

New Accounting Pronouncements Not Yet Adopted

The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that no other pronouncements will have a significant effect on its financial statements.

Reclassification

Certain reclassifications were made to the nine months ended September 30, 2018, Statement of Operations to conform to the presentation for the nine months ended September 30, 2019, Statement of Operations. Research and development expenses in 2018 increased by $0.4, million offset by a decrease in general and administrative expenses by the same amount. The reclassification did not affect the 2018 net loss.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-URI http://asc.fasb.org/topic&trid=2122394

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R4.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Sep. 30, 2019

Sep. 30, 2018

Income Statement [Abstract]

Product revenue $ 173 $ 437

Costs of revenue 151 364

Gross profit 22 73

Operating expenses:

Research and development 869 549 2,557 2,383

General and administrative 714 654 2,166 2,912

Sales and marketing 139 303 42

Goodwill impairment 6,162 6,162

Total operating expenses 1,722 7,365 5,026 11,499

Loss from operations (1,700) (7,365) (4,953) (11,499)

Other income (expenses):

Interest expense (1) (83) (3) (1,367)

Interest income 111 349

Change in fair value of derivative liabilities 144 4,480 754 6,500

Loss on extinguishment of debt (340)

Offering costs (682)

Loss on extinguishment of derivative liabilities (1,252)

Other income, net 1 48 6

Total other income, net 254 4,398 1,148 2,865

Net loss from continuing operations before income taxes (1,446) (2,967) (3,805) (8,634)

Provision for income taxes

Loss from continuing operations (1,446) (2,967) (3,805) (8,634)

Loss from discontinued operations (280) (324)

Net loss (1,446) (3,247) (3,805) (8,958)

Deemed dividend related to the beneficial conversion feature and accretion of a discount on series B preferred stock (345) (6,353) (2,703) (13,686)

Net loss attributable to common stockholders $ (1,791) $ (9,600) $ (6,508) $ (22,644)

Net loss per share - basic and diluted

Basic - continuing operations $ (0.68) $ (7.09) $ (3.00) $ (35.45)

Basic - discontinued operations (0.67) (1.33)

Basic - deemed dividend and accretion of a discount on conversion of series B preferred stock (0.16) (15.17) (2.13) (56.20)

Basic - attributable to common stockholders (0.84) (22.93) (5.13) (92.98)

Diluted - continuing operations (0.75) (17.80) (3.59) (49.53)

Diluted - discontinued operations (0.67) (1.07)

Diluted - deemed dividend and accretion of a discount on conversion of series B preferred stock (0.16) (15.17) (2.13) (45.10)

Diluted - attributable to common stockholders $ (0.91) $ (33.64) $ (5.72) $ (95.70)

Weighted average common shares outstanding:

Basic 2,127,293 418,638 1,269,106 243,543

Diluted 2,127,293 418,692 1,269,106 303,476

X

- Definition
Basic - deemed dividend and accretion of a discount on conversion of series B preferred stock.
+ References
No definition available.
+ Details

Name: SINT_BasicDeemedDividendAndAccretionOfDiscountOnConversionOfSeriesBPreferredStock

Namespace Prefix: SINT_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Diluted deemed dividend and accretion of a discount on conversion of series B preferred stock.
+ References
No definition available.
+ Details

Name: SINT_DilutedDeemedDividendAndAccretionOfDiscountOnConversionOfSeriesBPreferredStock

Namespace Prefix: SINT_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Gains (Losses) on Extinguishment of Derivative Instruments.
+ References
No definition available.
+ Details

Name: SINT_GainsLossesonExtinguishmentofDerivativeInstruments

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959
+ Details

Name: us-gaap_DerivativeGainLossOnDerivativeNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.
+ References
No definition available.
+ Details

Name: us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.
+ References
No definition available.
+ Details

Name: us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 50
-Section 40
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 50
-Section 40
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(20))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-03(13))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-03(13))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(12))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of interest expense classified as other.
+ References
No definition available.
+ Details

Name: us-gaap_InterestExpenseOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of interest income earned from interest bearing assets classified as other.
+ References
No definition available.
+ Details

Name: us-gaap_InterestIncomeOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.14)
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260
+ Details

Name: us-gaap_NoninterestExpenseOfferingCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.
+ References
No definition available.
+ Details

Name: us-gaap_PreferredStockDividendsIncomeStatementImpact

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
+ References
No definition available.
+ Details

Name: us-gaap_SellingAndMarketingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 27 R27.htm IDEA: XBRL DOCUMENT v3.19.3

Accrued Liabilities (Tables)
9 Months Ended

Sep. 30, 2019

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

September 30, 2019 December 31, 2018

Payroll and related expense $ 454 $ 388

Resterilization and repackaging costs 365 344

Other 247 106

$ 1,066 $ 838

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of accrued liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R23.htm IDEA: XBRL DOCUMENT v3.19.3

Basic and Diluted Net Loss Per Common Share (Tables)
9 Months Ended

Sep. 30, 2019

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Loss Per Share

Below are basic and diluted loss per share data for the three months ended September 30, 2019, which are in thousands except for share and per share data:

Basic Calculation
Effect of

Dilutive
Warrant
Securities
Diluted Calculation

Numerator:

Loss from continuing operations $ (1,446 ) $ (144 ) $ (1,590 )

Deemed dividend and accretion of a discount (345 ) - (345 )

Net loss attributable to common stockholders $ (1,791 ) $ (144 ) $ (1,935 )

Denominator:

Number of shares used in per common share calculations: 2,127,293 - 2,127,293

Net loss per common share:

Loss from continuing operations $ (0.68 ) $ (0.07 ) $ (0.75 )

Deemed dividend and accretion of a discount (0.16 ) - (0.16 )

Net loss attributable to common stockholders $ (0.84 ) $ (0.07 ) $ (0.91 )

Below are basic and diluted loss per share data for the nine months ended September 30, 2019, which are in thousands except for share and per share data:

Basic Calculation
Effect of

Dilutive
Warrant
Securities
Diluted Calculation

Numerator:

Loss from continuing operations $ (3,805 ) $ (753 ) $ (4,558 )

Deemed dividend and accretion of a discount (2,703 ) - (2,703 )

Net loss attributable to common stockholders $ (6,508 ) $ (753 ) $ (7,261 )

Denominator:

Number of shares used in per common share calculations: 1,269,106 - 1,269,106

Net loss per common share:

Loss from continuing operations $ (3.00 ) $ (0.59 ) $ (3.59 )

Deemed dividend and accretion of a discount (2.13 ) - (2.13 )

Net loss attributable to common stockholders $ (5.13 ) $ (0.59 ) $ (5.72 )

Below are basic and diluted loss per share data for the three months ended September 30, 2018, which are in thousands except for share and per share data:

Basic Calculation Effect of Dilutive
Warrant
Securities Diluted Calculation

Numerator:

Loss from continuing operations $ (2,967 ) $ (4,485 ) $ (7,452 )

Income from discontinued operations (280 ) - (280 )

Deemed dividend and accretion of a discount (6,353 ) - (6,353 )

Net loss attributable to common stockholders $ (9,600 ) $ (4,485 ) $ (14,085 )

Denominator:

Number of shares used in per common share calculations: 418,638 54 418,692

Net loss per common share:

Loss from continuing operations $ (7.09 ) $ (10.71 ) $ (17.80 )

Loss from discontinued operations (0.67 ) - (0.67 )

Deemed dividend and accretion of a discount (15.17 ) - (15.17 )

Net loss attributable to common stockholders $ (22.93 ) $ (10.71 ) $ (33.64 )

Below are basic and diluted loss per share data for the nine months ended September 30, 2018, which are in thousands except for share and per share data:

Basic Calculation Effect of Dilutive
Warrant
Securities Diluted Calculation

Numerator:

Loss from continuing operations $ (8,634 ) $ (6,396 ) $ (15,030 )

Income from discontinued operations (324 ) - (324 )

Deemed dividend and accretion of a discount (13,686 ) - (13,686 )

Net loss attributable to common stockholders $ (22,644 ) $ (6,396 ) $ (29,040 )

Denominator:

Number of shares used in per common share calculations: 243,543 59,933 303,476

Net loss per common share:

Loss from continuing operations $ (35.45 ) $ (14.08 ) $ (49.53 )

Loss from discontinued operations (1.33 ) 0.26 (1.07 )

Deemed dividend and accretion of a discount (56.20 ) 11.10 (45.10 )

Net loss attributable to common stockholders $ (92.98 ) $ (2.72 ) $ (95.70 )

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R42.htm IDEA: XBRL DOCUMENT v3.19.3

Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended 9 Months Ended

May 14, 2018

Aug. 31, 2018

Jul. 31, 2018

May 31, 2018

Jun. 30, 2018

Sep. 30, 2019

Sep. 30, 2018

Dec. 31, 2018

Sep. 07, 2018

Jul. 12, 2018

Mar. 31, 2018

Gross proceeds of warrants exercise $ 103 $ 1,652

Proceeds from public offering $ 15,000

Preferred stock stated value $ 0.01 $ 0.01

Common stock state value 0.01 $ 0.01

Conversion price per share $ 43.50 2.84 $ 14.40 $ 19.63

Share price $ 594.00

Proceeds from issuance of units $ 6,800 $ 6,749

Preferred stock issuance costs $ 600

ATM Equity Distribution Agreement [Member]

Sale of stock, shares 457,878

Sale of stock value $ 1,300

Payments of stock issuance costs 200

Additional offering value 1,200

Maximum [Member] | ATM Equity Distribution Agreement [Member]

Common stock offering price $ 2,500

Public Offering [Member]

Stock issued price per shares $ 1,000

Debt conversion, description The Series B Preferred Stock is convertible into shares of common stock by dividing the stated value of $1,100 by: (i) for the first 40 trading days following the closing of this offering, $43.54 (the "Conversion Price"), (ii) after 40 trading days but prior to the 81st trading day, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the 41st trading day, and (iii) after 80 trading days, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the date of the notice of conversion. In the case of (ii)(b) and (iii)(b) above, the share price shall not be less than $2.94 (the "Floor Price"). Each of the Conversion Price and Floor Price is subject to adjustment in certain circumstances.

Conversion price per share $ 43.54

Debt instrument trading percentage 87.50%

Share price $ 2.94

August 2018 Warrant Exercise [Member] | Secondary Offering [Member]

Warrants converted into shares of common stock 8,069

July 2018 Warrant Exercise [Member] | Public Offering [Member]

Warrants converted into shares of common stock 998

Warrant exercise 998

May 2018 Warrant Exercise (July 2016 Warrants) [Member]

Warrants to purchase of common stock shares 4,861 27,733

Gross proceeds of warrants exercise $ 300

May 2018 Warrant Exercise (July 2016 Warrants) [Member] | Maximum [Member]

Warrants exercise price $ 360

May 2018 Warrant Exercise (July 2016 Warrants) [Member] | Minimum [Member]

Warrants exercise price $ 63.75

August 2019 Warrant Exercise (May 2018 Warrants) [Member]

Warrants to purchase of common stock shares 35,874

Gross proceeds of warrants exercise $ 100

Convertible Preferred Stock and Warrants [Member]

Proceeds from public offering $ 15,000

May 2018 Warrants [Member]

Warrants to purchase of common stock shares 25

Warrants exercise price $ 48

Warrant term 5 years

Number of warrants issued 6,900

Warrants issuance cost $ 700

Series E Common Stock Purchase Warrant [Member]

Warrant exercise 22,279

Warrants to purchase of common stock shares 27,733

Gross proceeds of warrants exercise $ 1,400

Series E Common Stock Purchase Warrant [Member] | Maximum [Member]

Warrants exercise price $ 360.00

Series E Common Stock Purchase Warrant [Member] | Minimum [Member]

Warrants exercise price 63.75

New Warrants [Member]

Warrants exercise price $ 60.00

Percentage of warrant shares issued for new warrants 100.00%

Series B Convertible Preferred Stock [Member]

Convertible preferred stock shares conversion 4,072 4,072 3,825

Preferred stock stated value $ 1,100

Common stock state value $ 1,100

Common Stock [Member]

Convertible preferred stock shares conversion 378,997 102,886 102,886 1,143,784

Preferred Stock [Member]

Convertible preferred stock shares conversion 15,000

July Through December of 2018 [Member] | Series B Convertible Preferred Stock [Member]

Convertible preferred stock shares conversion 10,926

July Through December of 2018 [Member] | Common Stock [Member]

Convertible preferred stock shares conversion 569,966

X

- Definition
Additional offering value.
+ References
No definition available.
+ Details

Name: SINT_AdditionalOfferingValue

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Common stock offering price.
+ References
No definition available.
+ Details

Name: SINT_CommonStockOfferingPrice

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of warrants issued.
+ References
No definition available.
+ Details

Name: SINT_NumberOfWarrantsIssued

Namespace Prefix: SINT_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of warrant shares issued for new warrants.
+ References
No definition available.
+ Details

Name: SINT_PercentageOfWarrantSharesIssuedForNewWarrants

Namespace Prefix: SINT_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Preferred stock issuance costs.
+ References
No definition available.
+ Details

Name: SINT_PreferredStockIssuanceCosts

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Warrant Exercise.
+ References
No definition available.
+ Details

Name: SINT_WarrantExercise

Namespace Prefix: SINT_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Warrants converted into shares of common stock.
+ References
No definition available.
+ Details

Name: SINT_WarrantsConvertedIntoSharesOfCommonStock

Namespace Prefix: SINT_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Warrants issuance cost.
+ References
No definition available.
+ Details

Name: SINT_WarrantsIssuanceCost

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.
+ References
No definition available.
+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued for each share of convertible preferred stock that is converted.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644
+ Details

Name: us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
No definition available.
+ Details

Name: us-gaap_DebtConversionDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The price per share of the conversion feature embedded in the debt instrument.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 5
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870
+ Details

Name: us-gaap_DebtInstrumentConvertibleConversionPrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow for cost incurred directly with the issuance of an equity security.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfStockIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The cash inflow associated with the amount received from entity's first offering of stock to the public.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceInitialPublicOffering

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock warrants.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromWarrantExercises

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockConsiderationReceivedPerTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Per share or per unit amount of equity securities issued.
+ References
No definition available.
+ Details

Name: us-gaap_SharesIssuedPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_WarrantsAndRightsOutstandingTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_TypeOfArrangementAxis=SINT_ATMEquityDistributionAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_AugustTwoThousandEighteenWarrantExerciseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=SINT_SecondaryOfferingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_JulyTwoThousandEighteenWarrantExerciseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=SINT_PublicOfferingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_MayTwoThousandEighteenWarrantExerciseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_AugustTwoThousandNineteenWarrantExerciseMayTwoThousandEighteenWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_ConvertiblePreferredStockAndWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_MayTwoThousandEighteenWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_SeriesECommonStockPurchaseWarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_NewWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=SINT_SeriesBConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardDateAxis=SINT_JulyThroughDecemberOfTwoThousandAndEighteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 30 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 31 R46.htm IDEA: XBRL DOCUMENT v3.19.3

Leases (Details Narrative)
$ in Thousands
3 Months Ended 9 Months Ended

Jun. 07, 2019

ft²

Sep. 30, 2019

USD ($)

Sep. 30, 2019

USD ($)

Sep. 30, 2018

USD ($)

Jan. 02, 2019

USD ($)

Dec. 31, 2018

USD ($)

Leases [Abstract]

Lease expired, description The Company leases office, warehouse and manufacturing space under a single operating lease, which lease originally expired during 2019

Lease extended period, description On June 7, 2019, the lease was amended to extend the rental period through 2024 The amended lease has two five-year extension options.

Area of lease | ft² 54,428

Reduction of lease area | ft² 29,534

Operating lease right-of-use asset $ 2,440 $ 2,440 $ 700

Operating lease liability $ 2,343 2,343 $ 900

Non-cash lease expense $ 264

Operating lease weighted-average discount rate 6.50% 6.50%

Loss on amendment lease $ 120

X

- Definition
Loss on amendent lease.
+ References
No definition available.
+ Details

Name: SINT_LesseeOperatingLeaseLossOnAmendentLease

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Reduction of lease area.
+ References
No definition available.
+ Details

Name: SINT_ReductionOfLeaseArea

Namespace Prefix: SINT_

Data Type: num:areaItemType

Balance Type: na

Period Type: instant

X

- Definition
Area of land held.
+ References
No definition available.
+ Details

Name: us-gaap_AreaOfLand

Namespace Prefix: us-gaap_

Data Type: num:areaItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of lessee's operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseOptionToExtend

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of operating lease expense. Excludes sublease income.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977
+ Details

Name: us-gaap_OperatingLeaseExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average discount rate for operating lease calculated at point in time.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (g)(4)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971
+ Details

Name: us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

XML 32 R32.htm IDEA: XBRL DOCUMENT v3.19.3

Basic and Diluted Net Loss Per Common Share - Schedule of Basic and Diluted Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Sep. 30, 2019

Sep. 30, 2018

Earnings Per Share [Abstract]

Loss from continuing operations, basic calculation $ (1,446) $ (2,967) $ (3,805) $ (8,634)

Income from discontinued operations (280) (324)

Deemed dividend and accretion of a discount, basic calculation (345) (6,353) (2,703) (13,686)

Net loss attributable to common stockholders, basic calculation (1,791) (9,600) (6,508) (22,644)

Loss from continuing operations, effect of dilutive warrant securities (144) (4,485) (753) (6,396)

Net loss attributable to common stockholders, effect of dilutive warrant securities (144) (4,485) (753) (6,396)

Loss from continuing operations, diluted calculation (1,590) (7,452) (4,558) (15,030)

Income from discontinued operations, diluted calculation (280) (324)

Deemed dividend and accretion of a discount, diluted calculation (345) (6,353) (2,703) (13,686)

Net loss attributable to common stockholders, diluted calculation $ (1,935) $ (14,085) $ (7,261) $ (29,040)

Number of shares used in per common share calculations, basic calculation 2,127,293 418,638 1,269,106 243,543

Number of shares used in per common share calculations, effect of dilutive warrant securities 54 59,933

Number of shares used in per common share calculations, diluted calculation 2,127,293 418,692 1,269,106 303,476

Loss from continuing operations, basic calculation $ (0.68) $ (7.09) $ (3.00) $ (35.45)

Loss from discontinued operations, basic calculation (0.67) (1.33)

Deemed dividend and accretion of a discount, basic calculation (0.16) (15.17) (2.13) (56.20)

Net loss attributable to common stockholders, basic calculation (0.84) (22.93) (5.13) (92.98)

Loss from continuing operations, Effect of Dilutive Warrant Securities (0.07) (10.71) (0.59) (14.08)

Loss from discontinued operations, Effect of Dilutive Warrant Securities 0.26

Deemed dividend and accretion of a discount, Effect of Dilutive Warrant Securities 11.10

Net loss attributable to common stockholders, Effect of Dilutive Warrant Securities (0.07) (10.71) (0.59) (2.72)

Loss from continuing operations, diluted calculation (0.75) (17.80) (3.59) (49.53)

Loss from discontinued operations, diluted calculation (0.67) (1.07)

Deemed dividend and accretion of a discount, diluted calculation (0.16) (15.17) (2.13) (45.10)

Net loss attributable to common stockholders, diluted calculation $ (0.91) $ (33.64) $ (5.72) $ (95.70)

X

- Definition
Deemed dividend and accretion of a discount, basic calculation.
+ References
No definition available.
+ Details

Name: SINT_DeemedDividendAndAccretionOfDiscountBasic

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Deemed dividend and accretion of a discount, basic calculation per share.
+ References
No definition available.
+ Details

Name: SINT_DeemedDividendAndAccretionOfDiscountBasicCalculationPerShare

Namespace Prefix: SINT_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Deemed dividend and accretion of a discount, diluted calculation.
+ References
No definition available.
+ Details

Name: SINT_DeemedDividendAndAccretionOfDiscountDilutedCalculation

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Deemed dividend and accretion of a discount, diluted calculation per share.
+ References
No definition available.
+ Details

Name: SINT_DeemedDividendAndAccretionOfDiscountDilutedCalculationPerShare

Namespace Prefix: SINT_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Deemed dividend and accretion of a discount, Effect of Dilutive Warrant Securities.
+ References
No definition available.
+ Details

Name: SINT_DeemedDividendAndAccretionOfDiscountEffectOfDilutiveWarrantSecurities

Namespace Prefix: SINT_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss from continuing operations, effect of dilutive warrant securities.
+ References
No definition available.
+ Details

Name: SINT_LossFromContinuingOperationsEffectOfDilutiveWarrantSecurities

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss from continuing operations, Effect of Dilutive Warrant Securities.
+ References
No definition available.
+ Details

Name: SINT_LossFromContinuingOperationsEffectOfDilutiveWarrantsSecurities

Namespace Prefix: SINT_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss from discontinued operations, Effect of Dilutive Warrant Securities.
+ References
No definition available.
+ Details

Name: SINT_LossFromDiscontinuedOperationsEffectOfDilutiveWarrantSecurities

Namespace Prefix: SINT_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Net loss attributable to common stockholders, Effect of Dilutive Warrant Securities.
+ References
No definition available.
+ Details

Name: SINT_NetLossAttributableToCommonStockholdersEffectOfDilutiveWarrantSecurities

Namespace Prefix: SINT_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.
+ References
No definition available.
+ Details

Name: us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(20))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-03(13))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-03(13))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1278-109256

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(12))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(14))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 5.E)
-URI http://asc.fasb.org/extlink&oid=116822174&loc=d3e355146-122828

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1278-109256
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256
+ Details

Name: us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256
+ Details

Name: us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1278-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (b)(5)
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1278-109256

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (b)(5)
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 33 R36.htm IDEA: XBRL DOCUMENT v3.19.3

Fair Value Measurements (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands

Sep. 30, 2019

Dec. 31, 2018

Weighted average price stock exceeds $ 594.00

Average daily trading value $ 126,000

Warrants [Member]

Weighted average price stock exceeds $ 3.60

Black-Scholes-Merton Valuation Model [Member]

Derivative liability $ 800 $ 1,600

Monte Carlo Simulation Valuation Model [Member]

Derivative liability

X

- Definition
Average daily trading value.
+ References
No definition available.
+ Details

Name: SINT_AverageDailyTradingValue

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313
+ Details

Name: us-gaap_DerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_WarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=SINT_BlackScholesMertonValuationModelMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=SINT_MonteCarloSimulationValuationModelMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 34 R15.htm IDEA: XBRL DOCUMENT v3.19.3

Equity
9 Months Ended

Sep. 30, 2019

Equity [Abstract]

Equity

8. Equity

Preferred Stock Conversion

From July through December of 2018, Series B Convertible Preferred shareholders of the Company converted 10,926 shares of Series B Convertible Preferred Stock into 569,966 shares of common stock.

During May 2018 and June 2018, Series B Convertible Preferred shareholders of the Company converted a total of 4,072 shares of Series B Convertible Preferred Stock into 102,886 shares of common stock.

During the nine months ended September 30, 2019, Series B Convertible Preferred shareholders of the Company converted 3,825 shares of Series B Convertible Preferred Stock into 1,143,784 shares of common stock.

August 2018 Warrant Exercise

During August 2018, pursuant to the cashless exercise provision contained in their warrant, L2 Capital exercised its warrants and was issued 8,069 shares of common stock. The L2 Capital warrant is no longer outstanding.

July 2018 Warrant Exercise

During May 2018, the Company closed on a public offering, consisting of both convertible preferred stock and warrants. During July 2018, 998 of the warrants were exercised and converted into 998 shares of common stock.

May 2018 Warrant Exercise (July 2016 Warrants)

During March 2018, the Company repriced 27,733 warrants dated July 8, 2016, from $360 to $63.75 (for further description see Warrant Reprice March 2018 below). During May 2018, an additional 4,861 of the repriced warrants were exercised resulting in gross proceeds to the Company of $0.3 million.

August 2019 Warrant Exercise (May 2018 Warrants)

During the nine months ended September 30, 2019, 35,874 warrants were exercised resulting in gross proceeds to the Company of approximately $0.1 million.

May 2018 Unit Offering

On May 14, 2018, the Company closed on an underwritten public offering of units (“the Units”), consisting of convertible preferred stock and warrants, for gross proceeds of $15.0 million, which excludes underwriting discounts and commissions and offering expenses payable by SINTX. The offering was priced at a public offering price of $1,000 per unit. Each unit consisted of one share of Series B Convertible Preferred Stock, with a stated value of $1,100, and warrants to purchase up to 25 shares of common stock (the “May 2018 Warrants”). The May 2018 Warrants are initially exercisable at an exercise price of $48 per share and expire 5 years from the date of issuance. The Series B Preferred Stock is convertible into shares of common stock by dividing the stated value of $1,100 by: (i) for the first 40 trading days following the closing of this offering, $43.54 (the “Conversion Price”), (ii) after 40 trading days but prior to the 81st trading day, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the 41st trading day, and (iii) after 80 trading days, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the date of the notice of conversion. In the case of (ii)(b) and (iii)(b) above, the share price shall not be less than $2.94 (the “Floor Price”). Each of the Conversion Price and Floor Price is subject to adjustment in certain circumstances.

The Company raised $15.0 million associated with the issuance of the Units, with $6.8 million, net of issuance costs of $0.6 million, allocated to the preferred stock and $6.9 million, net of issuance costs of $0.7 million, allocated to the warrants. In association with the warrants that were recorded as a derivative liability, the Company immediately expensed approximately $0.7 million of issuance costs. The 15,000 preferred shares were initially convertible into 378,997 shares of common stock and had an effective conversion rate of $43.50 per share based on the proceeds that were allocated to them. The conversion price was adjusted to $19.63, effective July 12, 2018, and was adjusted again on September 7, 2018 to $14.40. During the nine months ended September 30, 2019 the conversion price was adjusted down on several occasions and ultimately settled at $2.84 as of September 30, 2019.

Warrant Reprice March 2018

During the six months ended June 30, 2018 the Company entered into a warrant amendment agreement (the “Amendment Agreement”) with certain holders of previously issued Series E Common Stock Purchase Warrants (collectively, “Investors”). In connection with that certain Series E Common Stock Purchase Warrant between the Company and Investors dated July 8, 2016, the Company issued to Investors warrants to purchase up to 27,733 shares of common stock (the “Warrant Shares”) at an exercise price of $360.00 per share, (the “Investors Warrants”). Under the terms of the Amendment Agreement, in consideration of Investors exercising 22,279 of the Investors Warrants (the “Warrant Exercise”), the exercise price per share of the Investors Warrants was reduced to $63.75 per share. 22,278 of the Investors Warrants were exercised resulting in gross proceeds to the Company of $1.4 million before payment of placement agent fees and costs. In addition, and as further consideration, the Company issued to Investors new warrants to purchase up to the number of shares of common stock equal to 100% of the number of Warrant Shares issued pursuant to the Warrant Exercise at an exercise price per share equal to $60.00 per share.

2019 ATM Stock Offerings

During the nine months ended September 30, 2019, the Company entered into an ATM equity distribution agreement in which the Company may sell, from time to time, shares of common stock having an aggregate offering price of up to $2.5 million. The Company sold 457,878 shares during the nine months ended September 30, 2019, raising approximately $1.3 million net of issuance cost of $0.2 million. The Company is eligible to raise an additional $1.2 million under this offering.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R11.htm IDEA: XBRL DOCUMENT v3.19.3

Intangible Assets
9 Months Ended

Sep. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

4. Intangible Assets

Intangible assets consisted of the following (in thousands):

September 30, 2019 December 31, 2018

Trademarks $ 50 $ 50

Less: accumulated amortization (7 ) (4 )

$ 43 $ 46

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all or part of the information related to intangible assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-URI http://asc.fasb.org/topic&trid=2144416
+ Details

Name: us-gaap_IntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R19.htm IDEA: XBRL DOCUMENT v3.19.3

Discontinued Operations
9 Months Ended

Sep. 30, 2019

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

12. Discontinued Operations

As explained in Note 1, on October 1, 2018, the Company completed the sale of its retail spine business to CTL Medical. The gain on the sale of the retail spine business is estimated to approximate $1.4 million, which was recognized during the quarter ended December 31, 2018.

The Company and CTL Medical entered in an asset purchase agreement whereby CTL Medical agreed to acquire all of the Company’s commercial spine business for total consideration of $8.5 million, which includes a $6.0 million (including interest) note receivable (See Note 7) and CTL Medical’s assumption of the Company’s $2.5 million related party note payable to North Stadium (see Note 11). As a result of the closing, CTL Medical is now the exclusive owner of SINTX’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies. The Company has agreed to pay the cost, if any, to re-sterilize and re-package select silicon nitride spinal inventories sold to CTL Medical if the sterilization date expires prior to CTL Medical selling the inventories to a third-party customer. This agreement extends for a total of 24 months, ending on September 30, 2020. The Company estimates the sterilization and repackaging cost to approximate $0.5 million. Manufacturing, R&D, and all intellectual property related to the core, non-spine, biomaterial technology of silicon nitride remains with the Company in Salt Lake City. The Company will serve as CTL’s exclusive OEM provider of silicon nitride products.

X

- References
No definition available.
+ Details

Name: us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-URI http://asc.fasb.org/topic&trid=2155823

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=2122178
+ Details

Name: us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R29.htm IDEA: XBRL DOCUMENT v3.19.3

Leases (Tables)
9 Months Ended

Sep. 30, 2019

Leases [Abstract]

Schedule of Operating Lease Future Minimum Payments

Operating lease future minimum payments together with the present values as of September 30, 2019, are summarized as follows:

September 30, 2019

2019 $ 245

2020 494

2021 509

2022 525

2023 540

Thereafter 556

Total future minimum lease payments 2,869

Less amounts representing interests (435 )

Present value of lease liability 2,434

Current-portion of operating lease liability 475

Long-term portion operating lease liability $ 1,959

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R25.htm IDEA: XBRL DOCUMENT v3.19.3

Intangible Assets (Tables)
9 Months Ended

Sep. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

Intangible assets consisted of the following (in thousands):

September 30, 2019 December 31, 2018

Trademarks $ 50 $ 50

Less: accumulated amortization (7 ) (4 )

$ 43 $ 46

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R6.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Cash flow from operating activities

Net loss from continuing operations $ (3,805) $ (8,958)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation expense 79 75

Non-cash lease expense 264

Amortization of intangible assets 4

Amortization of lease incentive for tenant improvements 25

Non-cash interest income (344)

Non-cash interest expense 956

Loss on extinguishment of debt 340

Stock based compensation 2 40

Change in fair value of derivative liabilities (754) (6,500)

Loss on extinguishment of derivative liabilities 1,252

Loss on disposal of equipment 54

Loss on impairment of goodwill 6,162

Bad debt expense (3)

Changes in operating assets and liabilities:

Trade accounts receivable 154

Prepaid expenses and other current assets 33 (246)

Inventories (35) (47)

Accounts payable and accrued liabilities 83 (899)

Net cash used in operating activities - continuing operations (4,322) (7,746)

Net cash used in operating activities - discontinued operations (207)

Net cash used in operating activities (4,322) (7,953)

Cash flows from investing activities

Purchase of property and equipment (141) (152)

Proceeds from notes receivable, net of imputed interest 1,111

Proceeds from sale of property and equipment 8

Purchase of intangible asset (50)

Net cash used in investing activities 970 (194)

Cash flows from financing activities

Proceeds from issuance of stock in connection with exercise of warrants, net of issuance costs 103 1,652

Proceeds from issuance of common stock, net of fees ($245) 1,285

Proceeds from issuance of preferred stock, net of issuance costs ($668) 6,749

Proceeds from issuance of warrant derivative liabilities, net of issuance costs ($682) 7,577

Payments on operating lease liability (557)

Proceeds from issuance of debt 705

Payments on debt (2,282)

Net cash provided by financing activities 831 14,401

Net increase (decrease) in cash and cash equivalents (2,521) 6,254

Cash and cash equivalents at beginning of period 5,447 539

Cash and cash equivalents at end of period 2,926 6,793

Noncash investing and financing activities

Right-of-use assets and assumption of operating lease liability 2,704

Reduction of derivative liability due to exercise of warrants 44

Hercules and MEF I, LP/Anson Investments Debt Exchange 2,265

Issuance of common stock in exchange for reduction in debt 1,453

Extinguishment of derivative liabilities through exercise of warrants 565

Warrants issued in association with debt 98

Issuance of debt for equipment 21

Supplemental cash flow information

Cash paid for interest $ 2 $ 405

X

- Definition
Extinguishment of derivative liabilities through exercise of warrants.
+ References
No definition available.
+ Details

Name: SINT_ExtinguishmentOfDerivativeLiabilitiesThroughExerciseOfWarrants

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Gains (Losses) on Extinguishment of Derivative Instruments.
+ References
No definition available.
+ Details

Name: SINT_GainsLossesonExtinguishmentofDerivativeInstruments

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Issuance of debt for equipment.
+ References
No definition available.
+ Details

Name: SINT_IssuanceOfDebtForEquipment

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Payments on operating lease liability.
+ References
No definition available.
+ Details

Name: SINT_PaymentsOnOperatingLeaseLiability

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Reduction of derivative liability due to exercise of warrants.
+ References
No definition available.
+ Details

Name: SINT_ReductionOfDerivativeLiabilityDueToExerciseOfWarrants

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Right-of-Use Assets and assumption of operating lease liability.
+ References
No definition available.
+ Details

Name: SINT_RightofuseAssetsAndAssumptionOfOperatingLeaseLiability

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Warrants issued in association with debt.
+ References
No definition available.
+ Details

Name: SINT_WarrantsIssuedInAssociationWithDebt

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of amortization of lease incentive costs incurred by the lessor for the benefit of the lessee.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77902458&loc=d3e40010-112707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 25
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=77902458&loc=d3e40019-112707
+ Details

Name: us-gaap_AmortizationOfLeaseIncentives

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585
+ Details

Name: us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760
+ Details

Name: us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959
+ Details

Name: us-gaap_DerivativeGainLossOnDerivativeNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_GainLossOnSaleOfPropertyPlantEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 50
-Section 40
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 50
-Section 40
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in prepaid expenses, and assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The fair value of notes issued in noncash investing and financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586
+ Details

Name: us-gaap_NotesIssued1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of operating lease expense. Excludes sublease income.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977
+ Details

Name: us-gaap_OperatingLeaseExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expense or loss included in net income that result in no cash flow, classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_OtherNoncashExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income or gain included in net income that result in no cash inflow (outflow), classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_OtherNoncashIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfWarrants

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the proceeds from sale of notes receivable, as well as principal collections from a borrowing supported by a written promise to pay an obligation (note receivable).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock warrants.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromWarrantExercises

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expense (reversal of expense) for expected credit loss on accounts receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 20
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(5))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of noncash expense for share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The fair value of stock issued in noncash financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586
+ Details

Name: us-gaap_StockIssued1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 40 R21.htm IDEA: XBRL DOCUMENT v3.19.3

Subsequent Events
9 Months Ended

Sep. 30, 2019

Subsequent Events [Abstract]

Subsequent Events

14. Subsequent Events

On November 1, 2019, the Company filed a Form S-1 Registration Statement with the United States Securities and Exchange Commission to distribute to holders of the Company’s common stock, Series B Preferred Stock, and holders of our May 2018 Warrants, as of the Record Date, non-transferable Subscription Rights to purchase Units at a price of $1,000 per Unit. The Subscription Rights will not be tradable. Each Unit consists of one share of our Preferred Stock and yet to be decided number of Warrants. The common stock to be issued upon conversion of the Preferred Stock or exercise of the Warrants, like our existing shares of common stock, will be traded on the NASDAQ Capital Market under the symbol “SINT.”

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R2.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands

Sep. 30, 2019

Dec. 31, 2018

Current assets:

Cash and cash equivalents $ 2,926 $ 5,447

Trade accounts receivable, net of allowance of $0 and $56, respectively 113 263

Prepaid expenses and other current assets 137 171

Inventories, net 86 52

Notes receivable, current portion 1,603 1,084

Total current assets 4,865 7,017

Inventories, net 625 624

Property and equipment, net 207 124

Intangible assets, net 43 46

Long-term note receivable, net of current portion 2,383 3,669

Operating lease right-of-use-asset 2,440

Other long-term assets 35 35

Total assets 10,598 11,515

Current liabilities:

Accounts payable 166 301

Accrued liabilities 1,066 838

Derivative liabilities, current portion 317 1,062

Current portion of operating lease liability 475 169

Current portion of debt 6

Other current liabilities 23 10

Total current liabilities 2,053 2,380

Operating lease liability, net of current portion 1,959

Derivative liabilities, net of current portion 452 504

Long term debt 15

Other long-term liabilities 91 232

Total liabilities 4,570 3,116

Commitments and contingencies

Stockholders' equity:

Convertible preferred stock, $0.01 par value, 130,000,000 shares authorized; 249 shares and 4,074 shares issued and outstanding at September 30, 2019 and December 31, 2018.

Common stock, $0.01 par value, 250,000,000 shares authorized; 2,363,991 shares, and 726,455 shares issued and outstanding at September 30, 2019 and December 31, 2018. 24 7

Additional paid-in capital 239,090 237,673

Accumulated deficit (233,086) (229,281)

Total stockholders' equity 6,028 8,399

Total liabilities and stockholders' equity $ 10,598 $ 11,515

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312
+ Details

Name: us-gaap_DerivativeLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312
+ Details

Name: us-gaap_DerivativeLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(d))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(7))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765
+ Details

Name: us-gaap_NotesAndLoansReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_NotesAndLoansReceivableNetNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6904-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 42 R40.htm IDEA: XBRL DOCUMENT v3.19.3

Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Thousands

Sep. 30, 2019

Dec. 31, 2018

Payables and Accruals [Abstract]

Payroll and related expense $ 454 $ 388

Resterilization and repackaging costs 365 344

Other 247 106

Total accrued liabilities $ 1,066 $ 838

X

- Definition
Resterilization and repackaging costs.
+ References
No definition available.
+ Details

Name: SINT_ResterilizationAndRepackagingCosts

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765
+ Details

Name: us-gaap_OtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R44.htm IDEA: XBRL DOCUMENT v3.19.3

Note Receivable (Details Narrative) - USD ($)
9 Months Ended

Oct. 02, 2018

Sep. 30, 2019

Receivables [Abstract]

Non interest note receivable $ 6,000,000 $ 4,000,000

Debt description The 36-month term of the note receivable requires 18 payments of $138,889 followed by 18 payments of $194,444, with maturity of the note receivable on October 1, 2021.

Payments of notes receivable $ 138,889 $ 194,444

Maturity date of note receivable Oct. 01, 2021

Debt instrument imputed interest percentage 10.00%

Imputed interest $ 915,725

Imputed interest, description The note receivable includes an imputed interest rate of 10%, which totaled $915,725 as of October 1, 2018, and has a 36-month amortization.

X

- Definition
Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(13))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823
+ Details

Name: us-gaap_DebtInstrumentDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after allowance for credit loss, of accounts and financing receivables, classified as noncurrent. Includes, but is not limited to, notes and loan receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireNotesReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The description of the receivable with imputed interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399
+ Details

Name: us-gaap_ReceivableWithImputedInterestDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of the unamortized amount of the premium on the note or receivable which is added to the face amount of the receivable or loan. The discount or premium is defined as the difference between the present value and the face amount.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399
+ Details

Name: us-gaap_ReceivableWithImputedInterestPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ReceivablesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R48.htm IDEA: XBRL DOCUMENT v3.19.3

Subsequent Events (Details Narrative)

Nov. 02, 2019

$ / shares

Subsequent Event [Member] | Holders [Member] | Series B Preferred Stock [Member]

Purchase price per units $ 1,000

X

- Definition
Per share or per unit amount of equity securities issued.
+ References
No definition available.
+ Details

Name: us-gaap_SharesIssuedPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SINT_HoldersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 45 R17.htm IDEA: XBRL DOCUMENT v3.19.3

Commitments and Contingencies
9 Months Ended

Sep. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

10. Commitments and Contingencies

The Company has executed agreements with certain executive officers of the Company which, upon the occurrence of certain events related to a change in control, call for payments to the executives up to three times their annual salary and accelerated vesting of previously granted stock options.

From time to time, the Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. Management believes any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the Company’s consolidated financial position, operating results or cash flows.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R13.htm IDEA: XBRL DOCUMENT v3.19.3

Accrued Liabilities
9 Months Ended

Sep. 30, 2019

Payables and Accruals [Abstract]

Accrued Liabilities

6. Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

September 30, 2019 December 31, 2018

Payroll and related expense $ 454 $ 388

Resterilization and repackaging costs 365 344

Other 247 106

$ 1,066 $ 838

X

- Definition
The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 R30.htm IDEA: XBRL DOCUMENT v3.19.3

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended

Sep. 12, 2019

Jul. 26, 2019

Jun. 04, 2019

Jan. 02, 2019

May 14, 2018

Nov. 30, 2019

Nov. 30, 2019

Mar. 31, 2018

Sep. 30, 2019

Sep. 30, 2018

Sep. 30, 2019

Sep. 30, 2018

Dec. 31, 2018

Reverse stock split, description 1 for 30 reverse stock split

Loss from continuing operations $ (1,446) $ (2,967) $ (3,805) $ (8,634)

Net cash used in operating activities (4,322) (7,746)

Accumulated deficit (233,086) (233,086) $ (229,281)

Proceeds from issuance of private placement $ 1,400

Proceeds from issuance of public offering $ 15,000

Common stock issued for cash $ 1,285

Common stock issued for cash, shares 457,878

Operating lease asset $ 700 2,440 $ 2,440

Operating lease liability 900 2,343 2,343

Right-of-use assets and assumption of operating lease liability $ 700 2,704

Increase in research and development expenses $ 400,000

Retail Spine Business [Member]

Related party note payable assumed amount $ 2,500 2,500

Subsequent Event [Member] | Retail Spine Business [Member] | Next Seven Months [Member]

Proceeds from sales of business $ 1,000

Subsequent Event [Member] | Retail Spine Business [Member] | Following Eighteen Months [Member]

Proceeds from sales of business $ 3,500

Preferred Stock [Member]

Common stock issued for cash

Common stock issued for cash, shares

Issuance of common stock due to conversion of preferred stock, shares (3,825) (10,598)

Common Stock [Member]

Common stock issued for cash $ 5

Common stock issued for cash, shares 457,878

Issuance of common stock due to conversion of preferred stock, shares 1,143,784 544,911

Equity Distribution Agreement [Member]

Common stock offering price, description (i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020.

Percentage of maximum transaction fee 4.25%

Additional common stock offering price $ 1,200

Equity Distribution Agreement [Member] | Maximum [Member]

Common stock offering price 2,500 $ 1,600

Equity Distribution Agreement [Member] | Minimum [Member]

Common stock offering price $ 1,600

X

- Definition
Additional common stock offering price
+ References
No definition available.
+ Details

Name: SINT_AdditionalCommonStockOfferingPrice

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Common stock offering price.
+ References
No definition available.
+ Details

Name: SINT_CommonStockOfferingPrice

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Common stock offering price, description.
+ References
No definition available.
+ Details

Name: SINT_CommonStockOfferingPriceDescription

Namespace Prefix: SINT_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Increase in research and development expenses.
+ References
No definition available.
+ Details

Name: SINT_IncreaseInResearchAndDevelopmentExpenses

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Percentage of maximum transaction fee.
+ References
No definition available.
+ Details

Name: SINT_PercentageOfMaximumTransactionFee

Namespace Prefix: SINT_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Right-of-Use Assets and assumption of operating lease liability.
+ References
No definition available.
+ Details

Name: SINT_RightofuseAssetsAndAssumptionOfOperatingLeaseLiability

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount for notes payable (written promise to pay), due to related parties.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cash inflow associated with the amount received from entity's first offering of stock to the public.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceInitialPublicOffering

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfPrivatePlacement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770
+ Details

Name: us-gaap_StockholdersEquityReverseStockSplit

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: dei_LegalEntityAxis=SINT_RetailSpineBusinessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementScenarioAxis=SINT_NextSevenMonthsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementScenarioAxis=SINT_FollowingEighteenMonthsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=SINT_EquityDistributionAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 49 R34.htm IDEA: XBRL DOCUMENT v3.19.3

Inventories - Schedule of Components of Inventory (Details) - USD ($)
$ in Thousands

Sep. 30, 2019

Dec. 31, 2018

Inventory Disclosure [Abstract]

Raw materials $ 625 $ 624

Intermediate goods 16

WIP 70 47

Finished goods 5

Inventory $ 711 $ 676

X

- Definition
Intermediate goods.
+ References
No definition available.
+ Details

Name: SINT_InventoryIntermediateGoods

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryFinishedGoods

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(4),(5))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryRawMaterialsAndSupplies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryWorkInProcess

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 50 R38.htm IDEA: XBRL DOCUMENT v3.19.3

Fair Value Measurements - Schedule of Fair Value Measurement Hierarchy of Derivative Liability (Details) - Common Stock Warrants [Member] - USD ($)
$ in Thousands
9 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Beginning balance $ (1,566) $ (1,357)

Issuances of warrants classified as derivatives (7,577)

Change in fair value 754 6,500

Exercise of warrants 44 575

Other, net (1) (212)

Ending balance $ (769) $ (2,071)

X

- Definition
Amount of exercise of warrants of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
No definition available.
+ Details

Name: SINT_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfWarrants

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1a)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_CommonStockWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

ZIP 51 0001493152-19-017023-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-19-017023-xbrl.zip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�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
DA(_,CF>>[OICO> M*'3I)BI_!^:VL>,M]E>B4$*)]V:$STTEP-:HM(=6<5C0[7+D45[BU(*"#CTE M)1#499)DLK.HH<]A6ROCB@D2][0MG8#%?+9W(L MC9/#82B4?F0>SI]([/H)N5F6.P;!_N@ W\6^L(<%]Q\,@!=IPC[2K2M[[(_. MFB#S6)F@FW1-8K:YCVUZ:CQY1BL M=\:>!,8];3 )C'G>. ^;Y>.LNNV8TYWL9LNE\CEA<^T\2?T-_6ZXVCN.9?<; M'_K=;U2^.V,?GOGA;/_I:B>O%QKFV!EP!]@N*'*()"GQ5^UP52+E38G%8LG5 MC2$F 1=!YK]LF>89G-.'T5S[KKPJ49F[S0+DR0LYV:O>=,O%C@NTW2#EXN#\ MMS:<]?UFDTUPO+*Y3UNF>[)Y)5(><\)YO22$XF9Z;DSPPK%M"Z=ML,>BGH:Y6!&P$O'2UL"&U9.,_L M9,O@XT-T D!DBY0(,^MMLPVB9T)N"7\+M"+K4ZKD5(W$+ %(D8T] *EF$AQ4 M'(;\A+?T4$9B^LG\.59F(O[WIW?-W0DC MM>RM7\[-;HSJ'8>HO0V%$"99%D0.P&M!$%N+3EQ9%QW)-.DRI/J3L?')+P^[ MVDX(A:[AVQ&N6!_9M;-17O")*>P 1*Q64E"JC)B)2;DZ/G6V/MT-L ]+ QTZ M6V*?6U2:4CVT2%@U=&3\&XG=C&[YF.?H*G)"J7Q%C;$S)W5$+&?8D)3/G]PU M>QCU.DJ)/ JULR7V=8:.?"6LFHJ..K^XO%HX],P2)E%X&3[2DS]/@9,'1:FH ML&.A=(0.%($A *ZC.%W3]=SS,[4-$36&FFDK[+2<8U-&Y%OF;_F65"7CSI90 M 1M[P%7+BHAYM^Y-^$XM [8[L0%"JC]051%!39RQDH:>5L9X/45?NR5D,[)-^I-2+!&Z[*$43T-ZLS608/KS[1;@>U-<8< 0(UJ!7- M$+%GA_FHNV O')?,-U$FBU834TRE1KZ*9T/.%_;911:[:R*R)$,+8#>KY<$I>%6 _#M+,;[.NG$6"5B,<. M9!=QY!+B)1>4>?;6BQ,R^[(H$P9X$;K\;X3^AO^5GM@EKUJ4"0T#^\6^R )C M/XX [5 &EJ?US!TZ[/77!\GAI-T2.U(.#)B(23L@:)J2_/6;(MFGM"QP"RL@ M!X+U9W2PM,1A(X*?G)3[-IE? @I;G08[&K(G5EV,VP&0%941T-'J4H!P[OTSRZ]:I>]R%70*,O2K9OW'8V3\VS$U&QY#HNLD);H^TG?X MOAX%SS8"D[_WX[N+?"/%S$5RX@1!%(7ECZ(3LG!\#XJ<3H_H-Y\]H=67V@2P M[PDP'$7;G#8"_K%K_N2O6<.RYH^;6?,YL65Y\_F@U/GRS78V9&E/,D^^6^"O M^?&6Q6E8G!__!XV104Z(?XV1&2UTX']GP?/].HZRU?J,N"2_;[W_'MVOHRSA M29[>.3LL$R)/ ^S1#W;H 2#$IK=T[-C'[F9X<<.:^^*EEDI"8L?MJ9 MCBCL,%R5]\!40?T=3;&#GM2XB,=N$PK *;.[%AXP1XZ-A32 P;!_5NS,;7YN MI=JSC4)VK0M)ZKQ%HJWJ"&=P!%T%CX'!A!?;%@&%)%N< Q9]6QY:;S,&CD3I#SRH&[ M3"[X3 M/]\Y[+DDR"6!F,2R-)%0] :VWT 5ZOZ@B%EWM "L<@> M\%R;N[*;H3 MH)^T97Q//S[]OJWIMCIC[[D*7A^QD<(]<*D*5;DMK]=?7ZJ]Z%Y3WGXKD+#])8_\A MXQ(#U8"%D4)]O\9*;XQ0"59'2'9L:X17:]S.)ZP4#/$^;Z,P;YA0?L2SL5=G MV &W\(IF_45ER)%6WD 4(^.E1*)\-#?+RBV08%["R;&#;V$%)77%81:5,JQ M+OQ]*_LK^W4.VRICIE=O\MQQU_6V$M,VO.O)E/<;38P6:X6MA3OQJP".5;AS MHM<8U4)X#6,'K!/8IIID%4 1\R\+XK+6X65(;9H3U*_H8'@KNIA,14%ML4Q? M$ZH[=V[:%B3F/U/X"+M))E..4,FV'0MWH_JH$]_$>7UA7@9,#164'CUV SY# M=00R_>GY6N(0QLM+P9N5J-H[3\Y(XL;^-I6ZG"0DZ&DH6J6YI'S;88^K<<7: MQAA$/)URAQJR>!GSR8@W%MXI)E[ MGL^$Z03E>L"=J8+U3]@:O30E;/E3<-LQCP[Z# ?7G*.'9B;(T5VVV?!L\7SA MYG<4<_8PZ/[1CAT+M;?JBTCO]6/+GQVB-C).\1VI0\7S,3_*A_E;2N:T MM?D=[(P)*W6U&PP[-J2[C1CQSC)^U,VG 3\L59;2I RVE"E3C[ZPTS?,*$QO MH5JB% ,5_B**E\1/,W;>-FZ".C^&G;%BI1V2P**_:G[(5\V0K!A#TU\QSY^V M?NY'.(#.=GX,.PG'2IV5P/*JLYC'DB_'^(E#5FILIZ1&.9NYDI<8*(7G5U]IT_IWP4M+>_)'$SHK4$@\/8GGE \#.\;%2MS7A M^X-XCX3%DCH]%H;T?LQ!8.=)X>C^^#!.Q/^@8GR7&8RLPIKC0$_\LE.->Z'Y M0C2YPV>#I,O:(T%/"G@%HIS[W1'0B^OQ"3H<: MWCISR8M3/B"^.O$$'B,#'JNISE;C8/K MRU!L\6(E$H"DV ?*8-#3:ZU4[ &X6J38XQP]+BF??ICXKBBS9/S33O.3Z)FQ M5NZ4E1C]06X,)Z3*&KX.?6B[C3\U<1M;);-_++C]QMNL(,U-Q M/S! ^F%G8T0KAV%;A:S>2;FKE]O MR)F!$OP:DWV(L.S8[->KZH$+P I(L//DX,@I^;8#GG+1N8_F[K?,CPG7L#V; M8I34E-@Y:G"PH%*P [.Z:GUR4O9ZR_,9W5) YU2=!COIJ^^DZN)\^K4@ZSS2 M+1JA<*2WE,>\(/&^Q!44;7D?V.E3?=&'2&;ZVK"7SN]^NK[<;+/\$33.^B(F M&S^3U,R'46.G(\$U0$<:=MAJZ8A!NR%X#]A).B/A"-LK'?1,R(.X)6:L(0YVW:O"\#=!<-8MP2>"IM+4#(M [WUW#K]XB]48A M*6%(B/OC*GI\XQ$_1X#^H2EX^J,O5V3E!.=4I=)GP>/JM%6KT11$W37NBO/@ M<"+.!W 6L9O;;OG66R +MTMN+;>D4.T'S*1@..0<5EQ8B&CV?O6_CI-V1 M'0A*M;$!I#:+9LS9/$E(NLAB=^TD9+Z*"?^^U*+)2;"=KSUUL%91%2 3.\Q? M[7J&W\U0EB_\T E=/USM3[LGS_L_,R656\EAO=HQ%4'&=!BC%?>T%8X>-C+A M?J[E *FVM@.R,919Z.^ILFO&DE)+XQ>>I!/BL"J"]8@ J4V%$MMS9=+6MMK+ M+UK"L,.8WJVC.&67WLS?K[:2@N9VS"78>;^;@\K%BTUHJ$R;D, 21&3:I0+& M])&6AX4MG#A]9M-TX3PK#9:"!OMR3Z$]]9,N@'L[+-1'RL)5E"0W8?ZF1GDR M%T\*,05R*!+X#0H5SW8@4X[J--H\T!T+$V+MK1-^\,CO@25!J7J]8,^)F.\P0 M96HD"2FN4,,5'QDH5D-)B+S:=V/1C#F&<6_'@M\UV#S1X3[B)E92C1Q"B[VX M]T:L6PAV@#:/B7.SO')DX%3;8"_M(!#:3!E:QF^)EW'7.?T:&QC[L/!TV-44 M>\&6BU,\;IM4N#[9;ED:]LWR,QTIN[,0:[6"#/NX#E)T$.N](V_I-LV&N-LZ MDU>^\T WC^DS%-D* 79T;0],6^S:..?.GUCRHR1(3] <.TJV!QX-5FU$HU&) M@HZ=U]Y7\U[/\.[/B0[/R2U:\W/I"7 R[9;<4;E[/QV.OL%]0P)S@'\21 M1&L-Z7.JC@D]F=FQ(IH?P190-M=>UGNSVW/1F:[+P5JYF!L++>YJ$^Z>O@*8%[WR9DG@\C!O= M3<(G-$A4TT)[., 3\2OI"J2_&S=*G0#?C2OE]W/H%5X8XIT_N;3I?,/^UE,; MQ-U-PETU2%3Z>F+;F\('=_@C><"T'?X3+9PB8/!455!.18?]8N(0=$^%!>)> M%LB0PH$ 4O1G!8=@+:T'. ;FIWNV[V>6 M=V19L%R33[5/6TQA0[&.2=9148'P6C#%M@0J4P531I_0@'0V$<&4\!#Q,$:% M%2.8*)/:Q"26X"+7,S5 (Z6V&4%(5:9"T!S[MDNI9W)4;,Q\JR;I58LXL%SP M_6_D%DZG#TLF%\3HZ;!E1YF8ZKC4!0O:;>T 1U\E)<"93?#]6Q30;N5UJAIM ML&V86$>J(56=C-EAL79S]S1PDN1F>9=&[E?%%DQ,8H?*ZVV*VUS843&E.BZ5 M^>EJ:QD6(OUJP-+%B1U[+A+[)#E9E*XA/D+ESDM&A&V[Q K6G"IJUBTQ9NQA MG^0R23)JDME+PPL2\Y])$!*33*7T@)+K@WDVB]^P?['GE>A/_C]02P$"% ,4 M " !\?VU/@'F-#].S "7V @ $0 @ $ &UL4$L! A0#% @ ?']M3[HK!""&)0 ^6L" !4 M ( !]]D '-I;G0M,C Q.3 Y,S!?9&5F+GAM;%!+ 0(4 Q0 ( 'Q_;4^: MX'!.F&4 -'!!0 5 " ;#_ !S:6YT+3(P,3DP.3,P7VQA M8BYX;6Q02P$"% ,4 " !\?VU/8HXS3 v3.19.3

Stock-Based Compensation
9 Months Ended

Sep. 30, 2019

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

9. Stock-Based Compensation

A summary of the Company’s outstanding stock option activity for the nine months ended September 30, 2019 is as follows:

Options
Weighted-
Average

Exercise Price

Weighted-

Average
Remaining
Contractual
Life
(Years)
Intrinsic
Value

As of December 31, 2018 377 $ 7,653 6.0 $ -

Granted - - - -

Exercised - - - -

Forfeited - - - -

Expired - - - -

As of September 30, 2019 377 $ 7,653 5.6 $ -

Exercisable as of September 30, 2019 377 $ 7,653 5.6 $ -

The Company estimates the fair value of each stock option on the grant date using the Black-Scholes-Merton valuation model, which requires several estimates including an estimate of the fair value of the underlying common stock on grant date. The expected volatility was based on an average of the historical volatility of a peer group of similar companies. The expected term was calculated utilizing the simplified method. The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option.

X

- Definition
The entire disclosure for share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 54 R12.htm IDEA: XBRL DOCUMENT v3.19.3

Fair Value Measurements
9 Months Ended

Sep. 30, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements

5. Fair Value Measurements

Financial Instruments Measured and Recorded at Fair Value on a Recurring Basis

The Company has issued certain warrants to purchase shares of common stock, which are considered derivative liabilities because they have registration rights which could require a cash settlement and are re-measured to fair value at each reporting period in accordance with accounting guidance. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows:

Level 1 - quoted market prices for identical assets or liabilities in active markets.

Level 2 - observable prices that are based on inputs not quoted on active markets but corroborated by market data.

Level 3 - unobservable inputs reflecting management’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

The Company classifies assets and liabilities measured at fair value in their entirety based on the lowest level of input that is significant to their fair value measurement. No financial assets were measured on a recurring basis as of September 30, 2019 and December 31, 2018. The following tables set forth the financial liabilities measured at fair value on a recurring basis by level within the fair value hierarchy as of September 30, 2019 and December 31, 2018:

Fair Value Measurements as of September 30, 2019

Description Level 1 Level 2 Level 3 Total

Derivative liability

Common stock warrants $ - $ - $ 769 $ 769

Fair Value Measurements as of December 31, 2018

Description Level 1 Level 2 Level 3 Total

Derivative liability

Common stock warrants $ - $ - $ 1,566 $ 1,566

The Company did not have any transfers of assets and liabilities between Level 1 and Level 2 of the fair value measurement hierarchy during the nine months ended September 30, 2019 and 2018.

Common Stock
Warrants

Balance at December 31, 2017 $ (1,357 )

Issuances of warrants classified as derivatives (7,577 )

Change in fair value 6,500

Exercise of warrants 575

Other, net (212 )

Balance at September 30, 2018 $ (2,071 )

Balance at December 31, 2018 $ (1,566 )

Change in fair value 754

Exercise of warrants 44

Other, net (1 )

Balance at September 30, 2019 $ (769 )

Common Stock Warrants

The Company has issued certain warrants to purchase shares of common stock, which are considered derivative liabilities because they have registration rights which could require a cash settlement and are re-measured to fair value at each reporting period in accordance with accounting guidance. At September 30, 2019 and December 31, 2018, approximately $0.8 million and $1.6 million, respectively, of the derivative liability was calculated using the Black-Scholes-Merton valuation model. At September 30, 2019 and December 31, 2018, no significant amount of the derivative liability was calculated using the Monte Carlo Simulation valuation model.

The assumptions used in estimating the common stock warrant liability using the Black-Scholes-Merton valuation model as of September 30, 2019 and December 31, 2018 were as follows:

September 30, 2019 December 31, 2018

Weighted-average risk-free interest rate 1.56 % 2.51 %

Weighted-average expected life (in years) 3.61 0.9

Expected dividend yield - % - %

Weighted-average expected volatility 64 % 157 %

The assumptions used in estimating the common stock warrant liability using the Monte Carlo Simulation valuation model at September 30, 2019 and December 31, 2018 were as follows:

September 30, 2019 December 31, 2018

Weighted-average risk-free interest rate 1.59 % 2.46 %

Weighted-average expected life (in years) 2.16 3.1

Expected dividend yield - % - %

Weighted average expected volatility 65 % 68 %

In addition, if any time after the second anniversary of the issuance of the warrant, both: (1) the 30-day volume weighted average price of the Company’s stock exceeds $594.00; and (2) the average daily trading volume for such 30-day period exceeds $126 million, the Company may call this warrant for $3.60 per share. For those warrants that have a call provision, management believes the Monte Carlo Simulation valuation model provides a better estimate of fair value for the warrants issued during 2018 and 2017 than the Black-Scholes-Merton valuation model.

Other Financial Instruments

The Company’s recorded values of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded value of debt approximates the fair value as the interest rate approximates market interest rates.

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 55 R39.htm IDEA: XBRL DOCUMENT v3.19.3

Fair Value Measurements - Schedule of Assumptions Used in Estimating Fair Value (Details) - Common Stock Warrants [Member]

Sep. 30, 2019

Dec. 31, 2018

Black-Scholes-Merton Valuation Model [Member] | Weighted-Average Risk-Free Interest Rate [Member]

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Fair value assumptions, measurement input, percentages 1.56 2.51

Black-Scholes-Merton Valuation Model [Member] | Weighted-Average Expected Life (in years) [Member]

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Fair value assumptions, measurement input, term 3 years 7 months 10 days 10 months 25 days

Black-Scholes-Merton Valuation Model [Member] | Expected Dividend Yield [Member]

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Fair value assumptions, measurement input, percentages 0.00 0.00

Black-Scholes-Merton Valuation Model [Member] | Weighted-Average Expected Volatility [Member]

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Fair value assumptions, measurement input, percentages 64 157

Monte Carlo Simulation Valuation Model [Member] | Weighted-Average Risk-Free Interest Rate [Member]

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Fair value assumptions, measurement input, percentages 1.59 2.46

Monte Carlo Simulation Valuation Model [Member] | Weighted-Average Expected Life (in years) [Member]

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Fair value assumptions, measurement input, term 2 years 1 month 27 days 3 years 1 month 6 days

Monte Carlo Simulation Valuation Model [Member] | Expected Dividend Yield [Member]

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Fair value assumptions, measurement input, percentages 0.00 0.00

Monte Carlo Simulation Valuation Model [Member] | Weighted-Average Expected Volatility [Member]

Fair Value Measurement Inputs and Valuation Techniques [Line Items]

Fair value assumptions, measurement input, percentages 65 68

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_WarrantsAndRightsOutstandingMeasurementInput

Namespace Prefix: us-gaap_

Data Type: xbrli:decimalItemType

Balance Type: na

Period Type: instant

X

- Definition
Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_WarrantsAndRightsOutstandingTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_FairValueByLiabilityClassAxis=SINT_CommonStockWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=SINT_BlackScholesMertonValuationModelMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=SINT_MonteCarloSimulationValuationModelMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 R31.htm IDEA: XBRL DOCUMENT v3.19.3

Basic and Diluted Net Loss Per Common Share (Details Narrative) - shares
9 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Earnings Per Share [Abstract]

Potentially dilutive securities 500,000 800,000

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 57 R35.htm IDEA: XBRL DOCUMENT v3.19.3

Intangible Assets - Schedule of Intangible Assets (Details) - Trademarks [Member] - USD ($)
$ in Thousands

Sep. 30, 2019

Dec. 31, 2018

Finite-Lived Intangible Assets [Line Items]

Intangible assets, gross $ 50 $ 50

Less accumulated amortization (7) (4)

Intangible assets, net $ 43 $ 46

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 928
-SubTopic 340
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 58 R24.htm IDEA: XBRL DOCUMENT v3.19.3

Inventories (Tables)
9 Months Ended

Sep. 30, 2019

Inventory Disclosure [Abstract]

Schedule of Components of Inventory

Inventories consisted of the following (in thousands):

September 30, 2019 December 31, 2018

Raw materials $ 625 $ 624

Intermediate goods 16 -

WIP 70 47

Finished goods - 5

$ 711 $ 676

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(c))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766
+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 59 R7.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
9 Months Ended

Sep. 30, 2019

Sep. 30, 2018

Common Stock [Member]

Fee & issuance costs $ 245

Preferred Stock [Member]

Fee & issuance costs $ 668

Warrant Derivative [Member]

Fee & issuance costs $ 682

X

- Definition
The cash outflow for cost incurred directly with the issuance of an equity security.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfStockIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SINT_WarrantDerivativeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 60 R20.htm IDEA: XBRL DOCUMENT v3.19.3

Leases
9 Months Ended

Sep. 30, 2019

Leases [Abstract]

Leases

13. Leases

The Company leases office, warehouse and manufacturing space under a single operating lease, which lease originally expired during 2019 (see Note 1 under Accounting Pronouncements Adopted During the Nine Months Ended September 30, 2019). On June 7, 2019, the lease was amended to extend the rental period through 2024 and reduce the amount of space leased from 54,428 square feet to 29,534 square feet. The new rent is effective the earlier of January 1, 2020 or when the Company vacates the portion of the property that will not be part of the new lease. The amended lease has two five-year extension options. As of September 30, 2019, the operating lease right-of-use asset totaled approximately $2.5 million and the operating lease liability totaled approximately $2.4 million. Non-cash operating lease expense during the nine months ended September 30, 2019, totaled approximately $0.3 million. As of September 30, 2019, the weighted-average discount rate for the Company’s operating lease totaled 6.5%. During the three months ended September 30, 2019, the Company recorded a loss of approximately $0.12 million in association with the lease amendment.

Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease. The Company accounts for lease components separately from the non-lease components. The depreciable life of the assets and leasehold improvements are limited by the expected lease term.

Operating lease future minimum payments together with the present values as of September 30, 2019, are summarized as follows:

September 30, 2019

2019 $ 245

2020 494

2021 509

2022 525

2023 540

Thereafter 556

Total future minimum lease payments 2,869

Less amounts representing interests (435 )

Present value of lease liability 2,434

Current-portion of operating lease liability 475

Long-term portion operating lease liability $ 1,959

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=77888251
+ Details

Name: us-gaap_LesseeOperatingLeasesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 61 R3.htm IDEA: XBRL DOCUMENT v3.19.3

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands

Sep. 30, 2019

Dec. 31, 2018

Statement of Financial Position [Abstract]

Allowance of trade accounts receivable $ 0 $ 56

Convertible preferred stock, par value $ 0.01 $ 0.01

Convertible preferred stock, shares authorized 130,000,000 130,000,000

Convertible preferred stock, shares issued 249 4,074

Convertible preferred stock, shares outstanding 249 4,074

Common stock, par value $ 0.01 $ 0.01

Common stock, shares authorized 250,000,000 250,000,000

Common stock, shares issued 2,363,991 726,455

Common stock, shares outstanding 2,363,991 726,455

X

- Definition
Amount of allowance for credit loss on accounts receivable, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 62 R28.htm IDEA: XBRL DOCUMENT v3.19.3

Stock-Based Compensation (Tables)
9 Months Ended

Sep. 30, 2019

Share-based Payment Arrangement [Abstract]

Summary of Stock Option Activity

A summary of the Company’s outstanding stock option activity for the nine months ended September 30, 2019 is as follows:

Options
Weighted-
Average

Exercise Price

Weighted-

Average
Remaining
Contractual
Life
(Years)
Intrinsic
Value

As of December 31, 2018 377 $ 7,653 6.0 $ -

Granted - - - -

Exercised - - - -

Forfeited - - - -

Expired - - - -

As of September 30, 2019 377 $ 7,653 5.6 $ -

Exercisable as of September 30, 2019 377 $ 7,653 5.6 $ -

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 63 R41.htm IDEA: XBRL DOCUMENT v3.19.3

Debt (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended

May 14, 2018

Jan. 03, 2018

Jul. 28, 2017

Jun. 30, 2014

Sep. 30, 2019

Sep. 30, 2019

Sep. 30, 2018

Oct. 02, 2018

Jan. 31, 2018

Percentage of loan bear interest rate 10.00%

Total payoff amount $ 2,282

Debt maturity date Oct. 01, 2021

L2 Capital Debt [Member]

Debt principal amount $ 700 $ 840

Debt purchase price $ 750

Warrant to purchase shares of common stock 68,257

Warrant exercise price per share $ 3.31

Percentage of loan bear interest rate 8.00%

Percentage of default interest rate 18.00%

Gross proceeds of convertible preferred stock and warrants 15,000

Total payoff amount 1,100

Interest amount 400

Hercules Term Loan [Member]

Debt principal amount $ 2,300

Hercules Term Loan [Member] | Closing Date [Member]

Term loan fee amount $ 200

Final payment fee for debt 1,700

Hercules Term Loan [Member] | Loan and Security Agreement [Member]

Debt principal amount $ 20,000

Debt maturity date Jan. 01, 2018

Hercules Term Loan [Member] | Senior Secured Convertible Promissory Notes One [Member]

Debt principal amount 1,100

Hercules Term Loan [Member] | Senior Secured Convertible Promissory Notes Two [Member]

Debt principal amount $ 2,200

Exchange Notes [Member]

Percentage of loan bear interest rate 15.00%

Debt maturity date Feb. 03, 2019

MEF I, L.P. and Anson Investments [Member]

Debt principal amount 1,400

Gross proceeds of convertible preferred stock and warrants 15,000

Total payoff amount 1,600

Interest amount $ 200

North Stadium Loan [Member] | North Stadium Investments, LLC [Member]

Debt principal amount $ 2,500

Warrant to purchase shares of common stock 1,834

Warrant exercise price per share $ 151.20

Percentage of loan bear interest rate 10.00%

Debt maturity date Jul. 28, 2018

Warrant term 5 years

Fair value of warrants $ 200

Equipment Loan [Member]

Debt principal amount $ 20 $ 20

Percentage of loan bear interest rate 12.00% 12.00%

Debt monthly payments $ 1

X

- Definition
Debt purchase price.
+ References
No definition available.
+ Details

Name: SINT_DebtPurchasePrice

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of the fee that accompanies borrowing money under the debt instrument.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentFeeAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Increase for accrued, but unpaid interest on the debt instrument for the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_DebtInstrumentIncreaseAccruedInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateEffectivePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the required periodic payments including both interest and principal payments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823
+ Details

Name: us-gaap_DebtInstrumentPeriodicPayment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expense (income) related to adjustment to fair value of warrant liability.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section 25
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875
+ Details

Name: us-gaap_FairValueAdjustmentOfWarrants

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholder, which takes precedence over common stockholders in the event of liquidation and from issuance of rights to purchase common shares at a predetermined price.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_WarrantsAndRightsOutstandingTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_DebtInstrumentAxis=SINT_L2CapitalDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=SINT_HerculesTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardDateAxis=SINT_ClosingDateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=SINT_LoanAndSecurityAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=SINT_SeniorSecuredConvertiblePromissoryNotesOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=SINT_SeniorSecuredConvertiblePromissoryNotesTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=SINT_ExchangeNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=SINT_MEFILPandAnsonInvestmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=SINT_NorthStadiumLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SINT_NorthStadiumInvestmentsLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=SINT_EquipmentLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 64 R45.htm IDEA: XBRL DOCUMENT v3.19.3

Discontinued Operations (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended

Oct. 02, 2018

Dec. 31, 2018

Asset Purchase Agreement [Member]

Total consideration $ 8,500

Agreement extension description This agreement extends for a total of 24 months, ending on September 30, 2020.

Sterilization and repackaging cost $ 500

Asset Purchase Agreement [Member] | Related Party Note Payable [Member]

Total consideration 2,500

Asset Purchase Agreement [Member] | Interest Note Receivable [Member]

Total consideration $ 6,000

Retail Spine Business [Member]

Gain on the sale of business $ 1,400

X

- Definition
Agreement extension description.
+ References
No definition available.
+ Details

Name: SINT_AgreementExtensionDescription

Namespace Prefix: SINT_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sterilization and repackaging cost.
+ References
No definition available.
+ Details

Name: SINT_SterilizationAndRepackagingCost

Namespace Prefix: SINT_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477
+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferred1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684
+ Details

Name: us-gaap_GainLossOnSaleOfBusiness

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_TypeOfArrangementAxis=SINT_AssetPurchaseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=SINT_RelatedPartyNotePayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=SINT_NoninterestBearingNoteReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=SINT_RetailSpineBusinessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2017		$ 1	$ 226,070	$ (220,629)	$ 5,442
Balance, shares at Dec. 31, 2017		100,935
Common stock issued from exercise of warrants			1,653		1,653
Common stock issued from exercise of warrants, shares		36,205
Issuance of common stock in exchange for reduction in debt			1,453		1,453
Issuance of common stock in exchange for reduction in debt, shares		19,348
Issuance of preferred stock from offering, net of issuance costs			6,748		6,748
Issuance of preferred stock from offering, net of issuance costs, shares	15,000
Warrants issued in association with debt			98		98
Loss on extinguishment of derivative liabilities			1,040		1,040
Deemed dividend related to adjustment of the exercise price of warrants issued with debt			(9)		(9)
Accretion of change in warrant exercise price			9		9
Common stock issued due to conversion of preferred stock		$ 5	(5)
Common stock issued due to conversion of preferred stock, shares	(10,598)	544,911
Accretion of convertible preferred stock discount			13,687		13,687
Deemed dividend related to the issuance of preferred stock			(13,687)		(13,687)
Extinguishment of derivative liabilities			575		575
Stock-based compensation			39		39
Net loss				(8,958)	(8,958)
Balance at Sep. 30, 2018		$ 6	237,671	(229,587)	8,090
Balance, shares at Sep. 30, 2018	4,402	701,399
Balance at Dec. 31, 2018		$ 7	237,673	(229,281)	8,399
Balance, shares at Dec. 31, 2018	4,074	726,455
Common stock issued from exercise of warrants			103		103
Common stock issued from exercise of warrants, shares		35,874
Issuance of common stock in exchange for reduction in debt
Common stock issued due to conversion of preferred stock		$ 12	(12)
Common stock issued due to conversion of preferred stock, shares	(3,825)	1,143,784
Stock-based compensation			2		2
Common Stock Issued for Cash		$ 5	1,280		$ 1,285
Common Stock Issued for Cash, shares		457,878			457,878
Removal of derivative liability upon exercise of warrant			44		$ 44
Net loss				(3,805)	(3,805)
Balance at Sep. 30, 2019		$ 24	$ 239,090	$ (233,086)	$ 6,028
Balance, shares at Sep. 30, 2019	249	2,363,991

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2019	Nov. 12, 2019
Document And Entity Information
Entity Registrant Name	Sintx Technologies, Inc.
Entity Central Index Key	0001269026
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,434,008
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019

Organization and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Organization	Organization SINTX Technologies, Inc. (“SINTX” or “the Company”) (previously known as Amedica Corporation) was incorporated in the state of Delaware on December 10, 1996. SINTX is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The Company believes it is the first and only manufacturer to use silicon nitride in medical applications. The Company acquired US Spine, Inc. (“US Spine”), a Delaware spinal products corporation with operations in Florida, on September 20, 2010. The Company’s products are primarily sold in the United States. As further explained in Note 12, On October 1, 2018, the Company completed the sale of its retail spine business to CTL Medical, a Dallas, Texas-based privately held medical device manufacturer. As a result of the sale, CTL Medical is now the exclusive owner of SINTX’s portfolio of metal and silicon nitride spine products, which are presently sold under the brand names of Taurus, Preference, and Valeo, with access to future silicon nitride spine technologies. Manufacturing, R&D, and all intellectual property related to the core, non-spine, biomaterial technology of silicon nitride remains with the Company. The Company will serve as CTL’s exclusive OEM provider of silicon nitride products. On October 30, 2018, the Company amended its Certificate of Incorporation with the State of Delaware to change its corporate name to SINTX Technologies, Inc. in order to better reflect its focus on silicon nitride science and technologies and pipeline of silicon nitride-based products in various biomedical applications. The Company also changed its trading symbol on the NASDAQ Capital Market to “SINT”. The Company also changed the name of its wholly owned subsidiary US Spine, Inc. to “ST Sub, Inc.” The previous name, Amedica, has transferred to CTL Medical, which is now CTL-Amedica. The Company’s new corporate brand reflects both the Company’s core competence in the science and production of silicon nitride ceramics, as well as encouraging prospects for the future, as an OEM supplier of spine implants to CTL-Amedica, and several opportunities outside of spine. The Company will focus on developing silicon nitride in terms of product design, and future biomaterial formulations, for a variety of OEM customers.
Reverse Stock Split	Reverse Stock Split On July 26, 2019 the Company effected a 1 for 30 reverse stock split of the Company’s common stock. The par value and the authorized shares of the common and convertible preferred stock were not adjusted as a result of the reverse stock split. All common stock shares, equivalents, and per-share amounts for all periods presented in these consolidated financial statements have been adjusted retroactively to reflect the reverse stock split.
Basis of Presentation	Basis of Presentation These unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and include all assets and liabilities of the Company and its wholly owned subsidiary, ST Sub, Inc. All material intercompany transactions and balances have been eliminated in consolidation. SEC rules and regulations allow the omission of certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, so long as the statements are not misleading. In the opinion of management, these financial statements and accompanying notes contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position and results of operations for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on March 11, 2019. The results of operations for the nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the year ending December 31, 2019. The Company’s significant accounting policies are set forth in Note 1 to the consolidated financial statements in its Annual Report on Form 10-K for the year ended December 31, 2018.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the periods then ended. Actual results could differ from those estimates. The most significant estimates relate to inventory, long-lived and intangible assets and the liability for preferred stock and common stock warrants.
Liquidity and Capital Resources	Liquidity and Capital Resources The condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern within one year from the date of issuance of these condensed consolidated financial statements. For the nine months ended September 30, 2019 and 2018, the Company incurred net losses from continuing operations of approximately $3.8 million and $8.6 million, respectively, and used cash in continuing operations of approximately $4.3 million and $7.7 million, respectively. The Company had an accumulated deficit of approximately $233 million and $229 million as of September 30, 2019 and December 31, 2018, respectively. To date, the Company’s operations have been principally financed by proceeds received from the issuance of preferred and common stock, convertible debt and bank debt and, to a lesser extent, cash generated from product sales. It is anticipated that the Company will continue to generate operating losses and use cash in operating activities. The Company’s continuation as a going concern is dependent upon its ability to increase sales and/or raise additional funds through the capital markets. Whether and when the Company can attain profitability and positive cash flows from operating activities or obtain additional financing is uncertain. The Company is actively generating additional scientific and clinical data confirming the beneficial attributes of silicon nitride and intends to publish the results in leading industry publications. The unique features of the Company’s silicon nitride material are not well known, and the Company believes that the publication of such data would help sales efforts as the Company approaches new prospects. The Company is also making additional changes to the sales strategy, including a focus on revenue growth by expanding the use of silicon nitride in other areas outside of spinal fusion applications. The Company has common stock that is publicly traded and has been able to successfully raise capital when needed since the date of the Company’s initial public offering in February 2014. In March 2018, the Company closed on gross proceeds of $1.4 million, before payment of placement agent fees and costs on a warrant reprice and exercise transaction. Additionally, on May 14, 2018, the Company closed on a public offering of units, consisting of convertible preferred stock and warrants, for gross proceeds of $15 million, which excludes underwriting discounts and commissions and offering expenses payable by the Company. On June 4, 2019, the Company entered into an Equity Distribution Agreement, (the “Distribution Agreement”), with Maxim Group LLC (“Maxim”), pursuant to which the Company may sell from time to time, shares of its common stock, having an aggregate offering price of up to $1.6 million through Maxim, as agent (the “ATM Offering”). On September 12, 2019, the Company entered into an amendment to the Distribution Agreement with Maxim, which increased the maximum aggregate offering price of the shares of the Company’s common stock from $1.6 million to $2.5 million. Subject to the terms and conditions of the Distribution Agreement, Maxim will use its commercially reasonable efforts to sell the shares from time to time, based on the Company’s instructions. The Company has no obligation to sell any of the shares and may at any time suspend offers under the Distribution Agreement. The Offering will terminate upon the earlier of (i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020. The Company agrees to pay Maxim a transaction fee at a fixed rate of 4.25% of the gross sales price of shares sold under the Distribution Agreement and agreed to provide indemnification and contribution to Maxim with respect to certain liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2019 the Company raised approximately $1.3 million, net of fees, through the issuance of 457,878 shares of common stock under the Distribution Agreement with Maxim. The Company is eligible to raise an additional $1.2 million under this offering. In addition, during the nine months ended September 30, 2019, the Company converted 3,825 shares of preferred stock into 1,143,784 shares of common stock. The Company is engaged in discussions with investment and banking firms to examine financing alternatives, including options for a public offering of the Company’s preferred or common stock. On October 1, 2018, the Company sold the retail spine business. This sale will continue to provide cash flows from November 2019 totaling $1.0 million over the next seven months and $3.5 million for the following 18 months. The buyer also assumed the Company’s $2.5 million related party note payable. Although the Company is seeking to obtain additional equity and/or debt financing, such funding is not assured and may not be available to the Company on favorable or acceptable terms and may involve significant restrictive covenants. Any additional equity financing is also not assured and, if available to the Company, will most likely be dilutive to its current stockholders. If the Company is not able to obtain additional debt or equity financing on a timely basis, the impact on the Company will be material and adverse. These uncertainties create substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.
Significant Accounting Policies	Significant Accounting Policies Except as explained below, no material changes were made to the Company’s significant accounting policies as described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.
Accounting Pronouncements Adopted During the Quarter Ended March 31, 2019	Accounting Pronouncements Adopted During the Nine Months Ended September 30, 2019 In August 2016, the FASB updated accounting guidance on the following eight specific cash flow classification issues: (1) debt prepayment or debt extinguishment costs; (2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; (3) contingent consideration payments made after a business combination; (4) proceeds from the settlement of insurance claims; (5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (6) distributions received from equity method investees; (7) beneficial interests in securitization transactions; and (8) separately identifiable cash flows and application of the predominance principle. Under prior U.S. GAAP, there was no specific guidance on the eight cash flow classification issues aforementioned. The Company adopted the new guidance effective January 1, 2019. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption. In February 2016, the FASB updated the accounting guidance related to leases as part of a joint project with the International Accounting Standards Board (“IASB”) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The Company adopted the new guidance effective January 1, 2019 (see Note 13), using the modified retrospective approach. Adoption of the new guidance resulted in the Company being required to record an additional operating lease right-of-use asset totaling approximately $0.7 million and liability totaling approximately $0.9 million (with $0.7 million incremental to adoption of the new guidance) on the date of adoption. Subsequent to the initial adoption of the new standard the Company amended the lease (see Note 13). The standard did not materially impact the consolidated net loss and had no impact on cash flows. In May 2014, in addition to several amendments issued during 2016, the FASB updated the accounting guidance related to revenue from contracts with customers, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The Company adopted the new guidance effective January 1, 2019. The core principle of the new guidance is that a company should recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. The standard defines a five-step process to achieve this core principle and, in doing so, more judgment and estimates are often required within the revenue recognition process than were required under prior U.S. GAAP. The Company has one primary customer (see Note 12) and related contract that has one performance obligation to which revenue is allocated. Revenue under this contract is recognized when the product is shipped to the customer. The Company generally bills its customer upon shipment of the product and invoices are generally due within 30 days. The Company does provide certain rights of return, which historically have not been significant. The Company does not anticipate incurring significant incremental costs to obtain contracts with future customers. The guidance in this standard did not have a material impact on the financial statements of the Company upon adoption.
New Accounting Pronouncements Not Yet Adopted	New Accounting Pronouncements Not Yet Adopted The Company has reviewed all recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that no other pronouncements will have a significant effect on its financial statements.
Reclassification	Reclassification Certain reclassifications were made to the nine months ended September 30, 2018, Statement of Operations to conform to the presentation for the nine months ended September 30, 2019, Statement of Operations. Research and development expenses in 2018 increased by $0.4, million offset by a decrease in general and administrative expenses by the same amount. The reclassification did not affect the 2018 net loss.

Stock-Based Compensation - Summary of Stock Option Activity (Details)	9 Months Ended
	Sep. 30, 2019 USD ($) $ / shares shares
Share-based Payment Arrangement [Abstract]
Options, Outstanding at beginning of period \| shares	377
Options, Granted \| shares
Options, Exercised \| shares
Options, Forfeited \| shares
Options, Expired \| shares
Options, Outstanding at end of period \| shares	377
Options, Exercisable at end of period \| shares	377
Weighted Average Exercise Price, Outstanding at beginning of period \| $ / shares	$ 7,653
Weighted Average Exercise Price, Granted \| $ / shares
Weighted Average Exercise Price, Exercised \| $ / shares
Weighted Average Exercise Price, Forfeited \| $ / shares
Weighted Average Exercise Price, Expired \| $ / shares
Weighted Average Exercise Price, Outstanding at end of period \| $ / shares	7,653
Weighted Average Exercise Price, Exercisable at end of period \| $ / shares	$ 7,653
Weighted Average Remaining Contractual Terms (Years), Outstanding at beginning	6 years
Weighted Average Remaining Contractual Terms (Years), Outstanding at ending	5 years 7 months 6 days
Weighted Average Remaining Contractual Terms (Years), Exercisable	5 years 7 months 6 days
Intrinsic Value, Outstanding at beginning of period \| $
Intrinsic Value, Outstanding at end of period \| $
Intrinsic Value, Exercisable at end of period \| $

Leases - Schedule of Operating Lease Future Minimum Payments (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Jan. 02, 2019	Dec. 31, 2018
Leases [Abstract]
2019	$ 245
2020	494
2021	509
2022	525
2023	540
Thereafter	556
Total future minimum lease payments	2,869
Less amounts representing interests	(435)
Present value of lease liability	2,343	$ 900
Current-portion of operating lease liability	475		$ 169
Long-term portion operating lease liability	$ 1,959

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Product revenue	$ 173		$ 437
Costs of revenue	151		364
Gross profit	22		73
Operating expenses:
Research and development	869	549	2,557	2,383
General and administrative	714	654	2,166	2,912
Sales and marketing	139		303	42
Goodwill impairment		6,162		6,162
Total operating expenses	1,722	7,365	5,026	11,499
Loss from operations	(1,700)	(7,365)	(4,953)	(11,499)
Other income (expenses):
Interest expense	(1)	(83)	(3)	(1,367)
Interest income	111		349
Change in fair value of derivative liabilities	144	4,480	754	6,500
Loss on extinguishment of debt				(340)
Offering costs				(682)
Loss on extinguishment of derivative liabilities				(1,252)
Other income, net		1	48	6
Total other income, net	254	4,398	1,148	2,865
Net loss from continuing operations before income taxes	(1,446)	(2,967)	(3,805)	(8,634)
Provision for income taxes
Loss from continuing operations	(1,446)	(2,967)	(3,805)	(8,634)
Loss from discontinued operations		(280)		(324)
Net loss	(1,446)	(3,247)	(3,805)	(8,958)
Deemed dividend related to the beneficial conversion feature and accretion of a discount on series B preferred stock	(345)	(6,353)	(2,703)	(13,686)
Net loss attributable to common stockholders	$ (1,791)	$ (9,600)	$ (6,508)	$ (22,644)
Net loss per share - basic and diluted
Basic - continuing operations	$ (0.68)	$ (7.09)	$ (3.00)	$ (35.45)
Basic - discontinued operations		(0.67)		(1.33)
Basic - deemed dividend and accretion of a discount on conversion of series B preferred stock	(0.16)	(15.17)	(2.13)	(56.20)
Basic - attributable to common stockholders	(0.84)	(22.93)	(5.13)	(92.98)
Diluted - continuing operations	(0.75)	(17.80)	(3.59)	(49.53)
Diluted - discontinued operations		(0.67)		(1.07)
Diluted - deemed dividend and accretion of a discount on conversion of series B preferred stock	(0.16)	(15.17)	(2.13)	(45.10)
Diluted - attributable to common stockholders	$ (0.91)	$ (33.64)	$ (5.72)	$ (95.70)
Weighted average common shares outstanding:
Basic	2,127,293	418,638	1,269,106	243,543
Diluted	2,127,293	418,692	1,269,106	303,476

Equity (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended			6 Months Ended	9 Months Ended
	May 14, 2018	Aug. 31, 2018	Jul. 31, 2018	May 31, 2018	Jun. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Sep. 07, 2018	Jul. 12, 2018	Mar. 31, 2018
Gross proceeds of warrants exercise						$ 103	$ 1,652
Proceeds from public offering	$ 15,000
Preferred stock stated value						$ 0.01		$ 0.01
Common stock state value						0.01		$ 0.01
Conversion price per share	$ 43.50					2.84			$ 14.40	$ 19.63
Share price						$ 594.00
Proceeds from issuance of units	$ 6,800						$ 6,749
Preferred stock issuance costs	$ 600
ATM Equity Distribution Agreement [Member]
Sale of stock, shares						457,878
Sale of stock value						$ 1,300
Payments of stock issuance costs						200
Additional offering value						1,200
Maximum [Member] \| ATM Equity Distribution Agreement [Member]
Common stock offering price						$ 2,500
Public Offering [Member]
Stock issued price per shares	$ 1,000
Debt conversion, description	The Series B Preferred Stock is convertible into shares of common stock by dividing the stated value of $1,100 by: (i) for the first 40 trading days following the closing of this offering, $43.54 (the "Conversion Price"), (ii) after 40 trading days but prior to the 81st trading day, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the 41st trading day, and (iii) after 80 trading days, the lesser of (a) the Conversion Price and (b) 87.5% of the lowest volume weighted average price for our Common Stock as reported at the close of trading on the market reporting trade prices for the Common Stock during the five trading days prior to the date of the notice of conversion. In the case of (ii)(b) and (iii)(b) above, the share price shall not be less than $2.94 (the "Floor Price"). Each of the Conversion Price and Floor Price is subject to adjustment in certain circumstances.
Conversion price per share	$ 43.54
Debt instrument trading percentage	87.50%
Share price	$ 2.94
August 2018 Warrant Exercise [Member] \| Secondary Offering [Member]
Warrants converted into shares of common stock		8,069
July 2018 Warrant Exercise [Member] \| Public Offering [Member]
Warrants converted into shares of common stock			998
Warrant exercise			998
May 2018 Warrant Exercise (July 2016 Warrants) [Member]
Warrants to purchase of common stock shares				4,861							27,733
Gross proceeds of warrants exercise				$ 300
May 2018 Warrant Exercise (July 2016 Warrants) [Member] \| Maximum [Member]
Warrants exercise price											$ 360
May 2018 Warrant Exercise (July 2016 Warrants) [Member] \| Minimum [Member]
Warrants exercise price											$ 63.75
August 2019 Warrant Exercise (May 2018 Warrants) [Member]
Warrants to purchase of common stock shares						35,874
Gross proceeds of warrants exercise						$ 100
Convertible Preferred Stock and Warrants [Member]
Proceeds from public offering	$ 15,000
May 2018 Warrants [Member]
Warrants to purchase of common stock shares	25
Warrants exercise price	$ 48
Warrant term	5 years
Number of warrants issued	6,900
Warrants issuance cost	$ 700
Series E Common Stock Purchase Warrant [Member]
Warrant exercise					22,279
Warrants to purchase of common stock shares					27,733
Gross proceeds of warrants exercise					$ 1,400
Series E Common Stock Purchase Warrant [Member] \| Maximum [Member]
Warrants exercise price					$ 360.00
Series E Common Stock Purchase Warrant [Member] \| Minimum [Member]
Warrants exercise price					63.75
New Warrants [Member]
Warrants exercise price					$ 60.00
Percentage of warrant shares issued for new warrants					100.00%
Series B Convertible Preferred Stock [Member]
Convertible preferred stock shares conversion				4,072	4,072	3,825
Preferred stock stated value	$ 1,100
Common stock state value	$ 1,100
Common Stock [Member]
Convertible preferred stock shares conversion	378,997			102,886	102,886	1,143,784
Preferred Stock [Member]
Convertible preferred stock shares conversion	15,000
July Through December of 2018 [Member] \| Series B Convertible Preferred Stock [Member]
Convertible preferred stock shares conversion						10,926
July Through December of 2018 [Member] \| Common Stock [Member]
Convertible preferred stock shares conversion						569,966

Leases (Details Narrative) $ in Thousands		3 Months Ended	9 Months Ended
Leases (Details Narrative) $ in Thousands	Jun. 07, 2019 ft²	Sep. 30, 2019 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2018 USD ($)	Jan. 02, 2019 USD ($)	Dec. 31, 2018 USD ($)
Leases [Abstract]
Lease expired, description			The Company leases office, warehouse and manufacturing space under a single operating lease, which lease originally expired during 2019
Lease extended period, description	On June 7, 2019, the lease was amended to extend the rental period through 2024		The amended lease has two five-year extension options.
Area of lease \| ft²	54,428
Reduction of lease area \| ft²	29,534
Operating lease right-of-use asset		$ 2,440	$ 2,440		$ 700
Operating lease liability		$ 2,343	2,343		$ 900
Non-cash lease expense			$ 264
Operating lease weighted-average discount rate		6.50%	6.50%
Loss on amendment lease		$ 120

Fair Value Measurements (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Weighted average price stock exceeds	$ 594.00
Average daily trading value	$ 126,000
Warrants [Member]
Weighted average price stock exceeds	$ 3.60
Black-Scholes-Merton Valuation Model [Member]
Derivative liability	$ 800	$ 1,600
Monte Carlo Simulation Valuation Model [Member]
Derivative liability

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flow from operating activities
Net loss from continuing operations	$ (3,805)	$ (8,958)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	79	75
Non-cash lease expense	264
Amortization of intangible assets	4
Amortization of lease incentive for tenant improvements		25
Non-cash interest income	(344)
Non-cash interest expense		956
Loss on extinguishment of debt		340
Stock based compensation	2	40
Change in fair value of derivative liabilities	(754)	(6,500)
Loss on extinguishment of derivative liabilities		1,252
Loss on disposal of equipment		54
Loss on impairment of goodwill		6,162
Bad debt expense	(3)
Changes in operating assets and liabilities:
Trade accounts receivable	154
Prepaid expenses and other current assets	33	(246)
Inventories	(35)	(47)
Accounts payable and accrued liabilities	83	(899)
Net cash used in operating activities - continuing operations	(4,322)	(7,746)
Net cash used in operating activities - discontinued operations		(207)
Net cash used in operating activities	(4,322)	(7,953)
Cash flows from investing activities
Purchase of property and equipment	(141)	(152)
Proceeds from notes receivable, net of imputed interest	1,111
Proceeds from sale of property and equipment		8
Purchase of intangible asset		(50)
Net cash used in investing activities	970	(194)
Cash flows from financing activities
Proceeds from issuance of stock in connection with exercise of warrants, net of issuance costs	103	1,652
Proceeds from issuance of common stock, net of fees ($245)	1,285
Proceeds from issuance of preferred stock, net of issuance costs ($668)		6,749
Proceeds from issuance of warrant derivative liabilities, net of issuance costs ($682)		7,577
Payments on operating lease liability	(557)
Proceeds from issuance of debt		705
Payments on debt		(2,282)
Net cash provided by financing activities	831	14,401
Net increase (decrease) in cash and cash equivalents	(2,521)	6,254
Cash and cash equivalents at beginning of period	5,447	539
Cash and cash equivalents at end of period	2,926	6,793
Noncash investing and financing activities
Right-of-use assets and assumption of operating lease liability	2,704
Reduction of derivative liability due to exercise of warrants	44
Hercules and MEF I, LP/Anson Investments Debt Exchange		2,265
Issuance of common stock in exchange for reduction in debt		1,453
Extinguishment of derivative liabilities through exercise of warrants		565
Warrants issued in association with debt		98
Issuance of debt for equipment	21
Supplemental cash flow information
Cash paid for interest	$ 2	$ 405

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 2,926	$ 5,447
Trade accounts receivable, net of allowance of $0 and $56, respectively	113	263
Prepaid expenses and other current assets	137	171
Inventories, net	86	52
Notes receivable, current portion	1,603	1,084
Total current assets	4,865	7,017
Inventories, net	625	624
Property and equipment, net	207	124
Intangible assets, net	43	46
Long-term note receivable, net of current portion	2,383	3,669
Operating lease right-of-use-asset	2,440
Other long-term assets	35	35
Total assets	10,598	11,515
Current liabilities:
Accounts payable	166	301
Accrued liabilities	1,066	838
Derivative liabilities, current portion	317	1,062
Current portion of operating lease liability	475	169
Current portion of debt	6
Other current liabilities	23	10
Total current liabilities	2,053	2,380
Operating lease liability, net of current portion	1,959
Derivative liabilities, net of current portion	452	504
Long term debt	15
Other long-term liabilities	91	232
Total liabilities	4,570	3,116
Commitments and contingencies
Stockholders' equity:
Convertible preferred stock, $0.01 par value, 130,000,000 shares authorized; 249 shares and 4,074 shares issued and outstanding at September 30, 2019 and December 31, 2018.
Common stock, $0.01 par value, 250,000,000 shares authorized; 2,363,991 shares, and 726,455 shares issued and outstanding at September 30, 2019 and December 31, 2018.	24	7
Additional paid-in capital	239,090	237,673
Accumulated deficit	(233,086)	(229,281)
Total stockholders' equity	6,028	8,399
Total liabilities and stockholders' equity	$ 10,598	$ 11,515

Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Payroll and related expense	$ 454	$ 388
Resterilization and repackaging costs	365	344
Other	247	106
Total accrued liabilities	$ 1,066	$ 838

Note Receivable (Details Narrative) - USD ($)		9 Months Ended
Note Receivable (Details Narrative) - USD ($)	Oct. 02, 2018	Sep. 30, 2019
Receivables [Abstract]
Non interest note receivable	$ 6,000,000	$ 4,000,000
Debt description	The 36-month term of the note receivable requires 18 payments of $138,889 followed by 18 payments of $194,444, with maturity of the note receivable on October 1, 2021.
Payments of notes receivable	$ 138,889	$ 194,444
Maturity date of note receivable		Oct. 01, 2021
Debt instrument imputed interest percentage	10.00%
Imputed interest	$ 915,725
Imputed interest, description	The note receivable includes an imputed interest rate of 10%, which totaled $915,725 as of October 1, 2018, and has a 36-month amortization.

Subsequent Events (Details Narrative)	Nov. 02, 2019 $ / shares
Subsequent Event [Member] \| Holders [Member] \| Series B Preferred Stock [Member]
Purchase price per units	$ 1,000

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($) $ in Thousands						1 Months Ended			3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 12, 2019	Jul. 26, 2019	Jun. 04, 2019	Jan. 02, 2019	May 14, 2018	Nov. 30, 2019	Nov. 30, 2019	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Reverse stock split, description		1 for 30 reverse stock split
Loss from continuing operations									$ (1,446)	$ (2,967)	$ (3,805)	$ (8,634)
Net cash used in operating activities											(4,322)	(7,746)
Accumulated deficit									(233,086)		(233,086)		$ (229,281)
Proceeds from issuance of private placement								$ 1,400
Proceeds from issuance of public offering					$ 15,000
Common stock issued for cash											$ 1,285
Common stock issued for cash, shares											457,878
Operating lease asset				$ 700					2,440		$ 2,440
Operating lease liability				900					2,343		2,343
Right-of-use assets and assumption of operating lease liability				$ 700							2,704
Increase in research and development expenses													$ 400,000
Retail Spine Business [Member]
Related party note payable assumed amount									$ 2,500		2,500
Subsequent Event [Member] \| Retail Spine Business [Member] \| Next Seven Months [Member]
Proceeds from sales of business						$ 1,000
Subsequent Event [Member] \| Retail Spine Business [Member] \| Following Eighteen Months [Member]
Proceeds from sales of business							$ 3,500
Preferred Stock [Member]
Common stock issued for cash
Common stock issued for cash, shares
Issuance of common stock due to conversion of preferred stock, shares											(3,825)	(10,598)
Common Stock [Member]
Common stock issued for cash											$ 5
Common stock issued for cash, shares											457,878
Issuance of common stock due to conversion of preferred stock, shares											1,143,784	544,911
Equity Distribution Agreement [Member]
Common stock offering price, description	(i) the sale of Shares having an aggregate offering price of $2.5 million, (ii) the termination of the Distribution Agreement by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) September 12, 2020.
Percentage of maximum transaction fee			4.25%
Additional common stock offering price	$ 1,200
Equity Distribution Agreement [Member] \| Maximum [Member]
Common stock offering price	2,500		$ 1,600
Equity Distribution Agreement [Member] \| Minimum [Member]
Common stock offering price	$ 1,600

Fair Value Measurements - Schedule of Fair Value Measurement Hierarchy of Derivative Liability (Details) - Common Stock Warrants [Member] - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Beginning balance	$ (1,566)	$ (1,357)
Issuances of warrants classified as derivatives		(7,577)
Change in fair value	754	6,500
Exercise of warrants	44	575
Other, net	(1)	(212)
Ending balance	$ (769)	$ (2,071)

Fair Value Measurements - Schedule of Assumptions Used in Estimating Fair Value (Details) - Common Stock Warrants [Member]	Sep. 30, 2019	Dec. 31, 2018
Black-Scholes-Merton Valuation Model [Member] \| Weighted-Average Risk-Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value assumptions, measurement input, percentages	1.56	2.51
Black-Scholes-Merton Valuation Model [Member] \| Weighted-Average Expected Life (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value assumptions, measurement input, term	3 years 7 months 10 days	10 months 25 days
Black-Scholes-Merton Valuation Model [Member] \| Expected Dividend Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value assumptions, measurement input, percentages	0.00	0.00
Black-Scholes-Merton Valuation Model [Member] \| Weighted-Average Expected Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value assumptions, measurement input, percentages	64	157
Monte Carlo Simulation Valuation Model [Member] \| Weighted-Average Risk-Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value assumptions, measurement input, percentages	1.59	2.46
Monte Carlo Simulation Valuation Model [Member] \| Weighted-Average Expected Life (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value assumptions, measurement input, term	2 years 1 month 27 days	3 years 1 month 6 days
Monte Carlo Simulation Valuation Model [Member] \| Expected Dividend Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value assumptions, measurement input, percentages	0.00	0.00
Monte Carlo Simulation Valuation Model [Member] \| Weighted-Average Expected Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value assumptions, measurement input, percentages	65	68

Basic and Diluted Net Loss Per Common Share (Details Narrative) - shares	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Earnings Per Share [Abstract]
Potentially dilutive securities	500,000	800,000

Intangible Assets - Schedule of Intangible Assets (Details) - Trademarks [Member] - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 50	$ 50
Less accumulated amortization	(7)	(4)
Intangible assets, net	$ 43	$ 46

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Allowance of trade accounts receivable	$ 0	$ 56
Convertible preferred stock, par value	$ 0.01	$ 0.01
Convertible preferred stock, shares authorized	130,000,000	130,000,000
Convertible preferred stock, shares issued	249	4,074
Convertible preferred stock, shares outstanding	249	4,074
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	2,363,991	726,455
Common stock, shares outstanding	2,363,991	726,455

Debt (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands					1 Months Ended	9 Months Ended
	May 14, 2018	Jan. 03, 2018	Jul. 28, 2017	Jun. 30, 2014	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2018	Oct. 02, 2018	Jan. 31, 2018
Percentage of loan bear interest rate								10.00%
Total payoff amount							$ 2,282
Debt maturity date						Oct. 01, 2021
L2 Capital Debt [Member]
Debt principal amount	$ 700								$ 840
Debt purchase price									$ 750
Warrant to purchase shares of common stock									68,257
Warrant exercise price per share									$ 3.31
Percentage of loan bear interest rate									8.00%
Percentage of default interest rate									18.00%
Gross proceeds of convertible preferred stock and warrants	15,000
Total payoff amount	1,100
Interest amount	400
Hercules Term Loan [Member]
Debt principal amount		$ 2,300
Hercules Term Loan [Member] \| Closing Date [Member]
Term loan fee amount				$ 200
Final payment fee for debt				1,700
Hercules Term Loan [Member] \| Loan and Security Agreement [Member]
Debt principal amount				$ 20,000
Debt maturity date				Jan. 01, 2018
Hercules Term Loan [Member] \| Senior Secured Convertible Promissory Notes One [Member]
Debt principal amount		1,100
Hercules Term Loan [Member] \| Senior Secured Convertible Promissory Notes Two [Member]
Debt principal amount		$ 2,200
Exchange Notes [Member]
Percentage of loan bear interest rate		15.00%
Debt maturity date		Feb. 03, 2019
MEF I, L.P. and Anson Investments [Member]
Debt principal amount	1,400
Gross proceeds of convertible preferred stock and warrants	15,000
Total payoff amount	1,600
Interest amount	$ 200
North Stadium Loan [Member] \| North Stadium Investments, LLC [Member]
Debt principal amount			$ 2,500
Warrant to purchase shares of common stock			1,834
Warrant exercise price per share			$ 151.20
Percentage of loan bear interest rate			10.00%
Debt maturity date			Jul. 28, 2018
Warrant term			5 years
Fair value of warrants			$ 200
Equipment Loan [Member]
Debt principal amount					$ 20	$ 20
Percentage of loan bear interest rate					12.00%	12.00%
Debt monthly payments					$ 1

Discontinued Operations (Details Narrative) - USD ($) $ in Thousands		3 Months Ended
	Oct. 02, 2018	Dec. 31, 2018
Asset Purchase Agreement [Member]
Total consideration	$ 8,500
Agreement extension description	This agreement extends for a total of 24 months, ending on September 30, 2020.
Sterilization and repackaging cost	$ 500
Asset Purchase Agreement [Member] \| Related Party Note Payable [Member]
Total consideration	2,500
Asset Purchase Agreement [Member] \| Interest Note Receivable [Member]
Total consideration	$ 6,000
Retail Spine Business [Member]
Gain on the sale of business		$ 1,400